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Abstract 
Cell patterning during embryogenesis is essential for establishing the identity of the 
developing body plan. Hox genes are fundamental regulators of tissue organisation 
along the anterior-posterior body axis of the developing embryo. These 
homeodomain-containing proteins act as transcription factors during normal 
development. The function of the homeodomain is to bind sequence-specific DNA 
motifs which allows either activation or repression of downstream effector genes, 
which consequently results in the control of tissue-specific determination and 
differentiation. 
Aberrant expression of such Hox genes, including Hoxa-9 can result in homeotic 
transformations leading to phenotypic malformations and oncogenesis. However the 
normal function of Hoxa-9 is poorly understood. This study explored the potential 
role for Hoxa-9 in normal development and differentiation. An in situ hybridisation 
approach was taken to define the expression of Hoxa-9 in the developing mouse. 
Hoxa-9 was found to expressed in a temporarily and spatially regulated manner, in 
particular being detected in the developing cardiac atria, ventricles and cardiac vessels 
during E9.5-E12 stages of development. The expression of this homeotic gene during 
in vitro differentiation of embryonic stem cells into cardiomyocytes and 
haematopoietic cells demonstrated a profile that correlated with the emergence of 
these cell types. The functioning relationship between Hoxa-9 expression and lineage 
commitment was further explored using over-expression in embryonic stem cells. A 
potential role for Hoxa-9 in normal development is discussed. 
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Acknowledgements 
There are so many people to thank, all of which have contributed in such a way that 
without them, things would have been a bit more of a struggle. I would particularly 
like to thank my supervisor Dr. Nicholas Hole for his continued, invaluable support 
throughout the sweat and tears of my Ph.D years, Dr. Colin Jahoda and Dr. Paul Hunt 
for their expertise. I also owe many thanks to several other people at the University of 
Durham including Dr. Majlinda Lako and Dr. Lyle Armstrong who have not only 
been true friends, but have supported me throughout my Ph.D in every way! I would 
also like to thank Dr. Jane Ives, as without her support, tissues, coffee and chocolate 
things may have seemed a little less possible, and Dr. Jenna Whitehouse for donating 
her reading skills. I am particularly grateful to Ms. Trudy Horton for all her excellent 
technical skills in generating the flow cytometry data in chapter four, Mrs. Christine 
Richardson for her assistance with wax embedding and tissue sectioning and Dr. 
Heiko Peters, Dr. Deborah Henderson, Dr. Lorraine Eley, Helen Imrie and Darren 
Key from the International Centre of Life, Newcastle, for all their help with the 
wholemount in situ hybridisation data in chapter two. 
Finally, I owe this thesis to my family, in particular my husband Derek, who is 
my whole inspiration behind my intentions in life, and without him my life wouldn't 
be full of so much sunshine! Also my Mam, who has supported me continuously 
throughout all my decisions in life, and my brother Paul, who sadly couldn't see this 
through with me, but he taught me to keep smiling and live life to the ful l , so here I 
am!! 
I V 
Abbreviations 
Abd Abdominal 
AFP Alpha feta protein 
AGM Aorta-gonad-mesonephros 
AML Acute myeloid leukaemia 
ANF Atrial natriuretic factor 
Antp Antennapedia 
Bp base pair 
BCIP 5-bromo-4-chloro-inodyl-phosphate 
bFGF basic Fibroblastic growth factor 
BMP Bone morphogenic protein 
BX-C Bithorax 
CD Cluster differentiation 
CFU-A Colony forming unit-Assay 
CFU-B Colony forming unit-basophil 
CFU-Eo Colony forming unit-eosinophil 
CFU-E Colony forming unit-erythrocyte 
CFU-G Colony forming unit-granulocyte 
CFU-M Colony forming unit-macrophage 
CFU-Meg Colony forming unit-megakaryocyte 
ddH 20 Double distilled water 
DEPC Diethyl Pyrocarbonate 
Dfd Deformed 
DIG Digoxigenin 
DMSO Dimethylsulfoxide 
ds Double stranded 
EB Embryoid body 
ES cell Embryonic stem cell 
Exd Extradenticle 
FGF Fibroblastic growth factor 
GM-CSF Granulocyte macrophage - Colony stimulating factor 
GMEM Glasgow Modified Eagle Media 
HTH Helix-turn-helix 
HSC Haematopoietic stem cell 
ICM Inner Cell Mass 
IL Interleukin 
1 litre 
Lab Labial 
LIF Leukaemia Inhibitory Factor 
LTR Long Term Reconstitution 
m(RNA) messenger (RNA) 
m milli-
M Molar 
Mef2 Myosin enhancing binding-factor 2 
Mesp2 Mesoderm enhanced specific protein 
MoMLV Molony-Murine-Leukaemia-Virus 
MyHC Myosin heavy chain 
NBT Nitro blue tetrzolium 
Shh Sonic Hedgehog 
PBS Phosphate Buffered Saline 
Pc-G Polycomb group 
PFA Paraformaldehyde 
RA Retinoic acid 
RARE Retinoic acid response element 
RT-PCR Reverse Transcriptase Polymerase Chain Reaction 
SV40 Simian virus 40 
TAE Tris-Acetic-EDTA (buffer) 
TE Tris-EDTA (buffer) 
Trx Trithorax 
U units 
p. micro 
Ubx Ultrabithorax 
UTP Uridine-5-Triphosphate 
UV Ultra Violet 
vMLC ventricular Myosin Light Chain 
Contents 
Chapter one - Introduction 
1.1 Introduction 
1.1.1 The conservation of the homeobox gene 
1.1.2 The mapping of chromosomal organisation, 
of Hox genes .. 
1.1.3 The relationship between the Hox and 
HOM-C complexes .. 
1.2 Colinear expression patterns of Hox genes.. 
1.2.1 The role of Hox genes in cell patterning 
1.2.2 Hox gene patterning .. 
1.3 Hox gene regulation .. 
1.3.1 Trans-activating proteins 
1.3.2 Signalling molecules .. 
1.3.3 Hox gene silencing and repression 
1.3.4 Auto-regulation 
1.3.5 Cross-regulation 
1.4 Haematopoiesis 
1.4.1 Primitive haematopoiesis 
1.4.2. Definitive haematopoiesis 
1.4.3 The site of long term reconstituting HSC production. 
1.4.4 The transition to adult haematopoiesis 
1.4.5 Why regulate haematopoiesis? 
1.4.6 Hox genes as potential molecular markers of 
haematopoiesis 
1.5 Hox gene expression in differentiating blood cells.. 
1.6 Hox genes and cancer 
1.6.1 Hox genes in leukaemia 
1.7 Aims .. 
Chapter two - Wholemount and in situ hybridisation 
2.1 Introduction .. 36 
2.1.1 The application of in situ hybridisation .. .. 37 
2.1.2 Detection of Hox genes during development using 
wholemount and in situ hybridisation methods .. 37 
2.1.2.1 Expression in neural tube and crest development 38 
2.1.2.2 Cranio-facial development .. .. 39 
2.1.2.3 Axial skeletal and limb development .. .. 39 
2.1.2.4 Gut development .. .. .. .. 40 
2.1.2.5 Other developmental processes .. 41 
2.1.3 Aims 41 
2.2 Materials and methods 43 
2.2.1 Polymerase chain reaction (PCR) .. .. .. 43 
2.2.2 Gel electrophoresis .. .. .. .. .. 43 
2.2.3 Collection of mouse embryos.. .. .. .. 44 
2.2.4 Wax embedding and sectioning .. .. .. 45 
2.2.5 Wholemount and in situ hybridisation riboprobes .. 45 
2.2.6 CT-TOPO-GFP cloning 47 
2.2.7 Riboprobe production.. .. .. .. .. 49 
2.2.8 Testing probe labelling - Dot/Southern blot analysis.. 50 
2.2.9 In situ hybridisation .. .. .. .. .. 51 
2.2.10 Wholemount in situ hybridisation of mouse embryos 54 
2.2.11 Preparation of embryo and heart powder .. .. 57 
2.2.12 Dot blot analysis 57 
2.3 Results 59 
2.3.1 Wholemount in situ hybridisation using Pax-1 59 
2.3.2 Wholemount in situ hybridisation control riboprobes 60 
2.3.3 E7.5 Wholemount in situ hybridisation .. .. 62 
2.3.4 E9 In situ hybridisation .. .. .. .. 62 
viii 
2.3.5 E9.5 Wholemount in situ hybridisation .. .. 65 
2.3.6 E 10.5 Wholemount in situ hybridisation .. .. 65 
2.3.7 E l 1 In situ hybridisation .. .. .. .. 65 
2.3.7.1 Detection of cardiac expression of genes at Ell 68 
2.3.8 El2 In situ hybridisation 71 
2.3.9 E13 In situ hybridisation .. .. .. .. 70 
2.3.9.1 Detection of cardiac expression of genes at El 3 71 
2.3.10 El3 in situ hybridisation using Hoxc-9 riboprobe 74 
2.3.11 In situ hybridisation of adult murine heart .. .. 75 
2.4 Discussion 78 
2.4.1 The expression pattern of Hoxa-9 in the developing 
mouse embryo.. .. .. .. 78 
2.4.1.1 Hoxa-9 expression in the E7.5 mouse embryo.. 79 
2.4.1.2 Hoxa-9 expression in the E9 mouse embryo .. 80 
2.4.1.3 E9.5 wholemount in situ hybridisation in the 
mouse embryo.. .. .. 81 
2.4.1.4 Stain trapping in the whole mouse embryo .. 82 
2.4.1.5 El 0.5 wholemount in situ hybridisation in the 
mouse embryo.. .. .. .. .. 83 
2.4.1.6 Ell In situ hybridisation in the mouse embryo 83 
2.4.1.6.1 Testing RNA quality in the E l 1 mouse embryo 84 
2.4.1.7 El 2 In situ hybridisation in the mouse embryo 84 
2.4.1.8 El3 In situ hybridisation in the mouse embryo 86 
2.4.2 Formation of the developing heart .. .. .. 86 
2.4.3 Gene expression in the developing heart 91 
2.4.3.1 GA TA gene expression in the developing heart 93 
2.4.3.2 basic helix-loop-helix gene expression in the 
developing heart .. .. .. .. 94 
2.4.3.3 Myosin enhancing binding-factor-2 expression 
in the developing heart .. .. 94 
2.4.4 Heart Chamber formation .. .. .. .. 95 
2.4.4.1 Specific heart chamber gene expression .. 95 
ix 
2.4.5 Conclusions 98 
Chapter three -Hoxa-9 expression during embryonic stem cell 
differentiation in vitro 
3.1 Introduction 100 
3.1.1 Embryonic stem (ES) cells .. .. .. .. 100 
3.1.2 ES cell differentiation in vitro.. .. .. .. 101 
3.1.3 Haematopoietic differentiation of ES cells in vitro .. 102 
3.1.4 Cardiomyocyte differentiation of ES cells in vitro .. 103 
3.1.5 Aims 104 
3.2 Materials and Methods 105 
3.2.1 ES cell culture and embryoid body formation .. 105 
3.2.2 mRNA extraction 106 
3.2.3 The generation of cDNA 106 
3.2.4 TheCFU-A 108 
3.3 Results 109 
3.3.1 Haematopoietic differentiation: cellular assay.. .. 109 
3.3.2 Haematopoietic differentiation: gene expression.. .. 112 
3.3.3 Cardiomyocyte differentiation: cellular assay.. .. 121 
3.3.4 Cardiomyocyte differentiation: gene expression.. .. 121 
3.3.5 Hoxa-9 expression during haematopoietic and cardiomyocyte 
differentiation of ES cells .. .. .. .. 127 
3.4 Discussion .. 130 
3.4.1 Confirming the ES cell models .. .. .. 130 
3.4.2 Haematopoietic differentiation of ES cells .. .. 130 
3.4.3 Cardiomyocyte differentiation of ES cells .. .. 131 
3.4.4 Hoxa-9 expression in the ES cell models .. .. 131 
3.4.5 The comparison of cardiogenesis in vivo/vitro .. 132 
x 
3.4.6 Potential roles for Hoxa-9 in the development of the 
heart and blood system .. .. .. .. 133 
3.4.6.1 Hoxa-9 in early heart development .. .. 133 
3.4.6.2 Hoxa-9 as a potential regulator of cell proliferation 133 
3.4.7 Conclusions 134 
Chapter four - Gene overexpression 
4.1 Introduction .. 136 
4.1.1 Retroviral expression of Hox genes in somatic cells: 
in vitro studies.. .. .. .. .. .. 136 
4.1.2 Retroviral expression of Hox genes in somatic cells: 
in vivo studies.. .. .. .. .. .. 138 
4.1.3 Overexpression of transgenes in ES cells .. .. 139 
4.1.4 Hoxa-9 overexpression and acute myeloid leukaemia 140 
4.1.4.1 Hoxa-9 and Meisl associations .. 140 
4.1.4.2 Hoxa-9 and PBX interactions 142 
4.1.5 Aims 143 
4.2 Materials and methods 144 
4.2.1 Cell maintenance 144 
4.2.2 Vector construction .. .. .. .. .. 145 
4.2.3 Vector dephosphorylation .. .. .. .. 146 
4.2.4 Vector-DNA ligation 146 
4.2.5 Vector transformation into bacterial cells .. .. 147 
4.2.6 DNA extraction from bacterial cells .. .. .. 147 
4.2.7 Calcium phosphate transfection .. .. 148 
4.2.8 Electroporation 149 
4.2.9 Flow cytometry 149 
4.2.10 Retroviral tranduction of cultured cells .. .. 150 
4.2.11 Genomic analysis of cultured cells .. .. .. 150 
4.1 Results 152 
4.3.1 Stable transfection of CT-TOPO-GFP in embryonic 
stem cells .. .. .. .. .. .. 152 
4.3.1.1 Electroporation of CT-TOPO-GFP in embryonic 
stem cells .. .. .. .. .. 152 
4.3.1.2 GFP expression analysis .. .. .. 153 
4.3.2 Transient transfection of CT-TOPO-GFP .. .. 156 
4.3.2.1 Transient transfection of CT-TOPO-GFP in 
COS-7 cells 156 
4.3.2.2 GFP expression analysis .. 157 
4.3.2.3 Transient expression using the CT-TOPO-GFP 
construct in ES cells .. .. 157 
4.3.2.4 GFP expression analysis .. .. .. 157 
4.3.2.5 Problems using the CT-TOPO-GFP-a9 construct 
in ES cells 158 
4.3.3 Retroviral overexpression studies .. .. .. 161 
4.3.3.1 Retroviral overexpression of Hox genes .. 161 
4.3.4 The application of the LX-GFP-a9 construct.. .. 161 
4.3.4.1 GFP expression analysis in the Phoenix 
packaging cells .. .. .. .. 161 
4.3.4.2 GFP expression analysis following the retroviral 
transduction of CGR8 ES cells .. .. 162 
4.3.4.3 GFP expression analysis following the retroviral 
transduction of 3T3 cells .. .. .. 162 
4.3.5 Summary .. .. .. .. .. .. 167 
4.1 Discussion 168 
4.4.1 The vector construct .. .. .. .. .. 168 
4.4.2 The vector insert .. .. .. .. •• 169 
4.4.3 The target cells 169 
4.4.4 DNA methylation 170 
4.4.5 Conclusions .. .. .. •• •• 171 
xii 
Chapter five - Final Discussion 
5.1 Summary 173 
5.1.1 Future work .. .. .. .. .. .. 173 
5.1.1.1 Testing DNA methylation .. .. .. 174 
5.1.1.2 Conditional overexpression .. .. 175 
5.1.1.3 Antisense .. .. 176 
5.1.1.4 RNAi 177 
5.1.1.5 Cre-loxP recombination .. .. .. 179 
5.1.2 Further potential roles for Hoxa-9 in development from 
this study 181 
5.1.3 Loss of function in vertebrates .. .. .. 186 
5.1.3.1 Hox gene compensatory mechanisms and redundancy 186 
5.1.4.0 Summary 187 
References .. 189 
Appendices 
Appendix A (Materials and methods) .. .. .. .. 264 
Appendix B (DNA sequences) .. .. .. .. .. 267 
xii i 
Figures and tables 
Chapter one - Introduction 
Figure 1 The conservation of the Hoxa-9 sequence amongst species .. 4 
Figure 2 The nomenclature of vertebrate Hox genes.. .. .. .. 5 
Figure 3 Colinear expression of the homeodomain complexes in 
Drosophila and mouse.. .. .. .. .. .. .. 8 
Figure 4 An outline of the haematopoietic pathway.. .. .. .. 19 
Figure 5 The E7.5 mouse embryo .. .. .. .. .. .. 21 
Figure 5 Haematopoiesis in the E7.5 mouse embryo.. .. .. .. 21 
Figure 6 The E8.5 mouse embryo .. .. .. .. .. .. 22 
Figure 6 Haematopoiesis in the E8.5 mouse embryo.. .. .. .. 22 
Figure 7 Haematopoiesis in the E9.5 mouse embryo.. .. .. .. 24 
Figure 8 Haematopoiesis in the El0.5 mouse embryo.. .. .. .. 24 
Figure 9 Haematopoiesis in the El 1.5 mouse embryo.. .. .. .. 25 
Figure 10 Haematopoiesis in the E12.5 mouse embryo.. .. .. .. 26 
Figure 11 Haematopoiesis in the E14.5 mouse embryo.. .. .. .. 26 
Figure 12 Hox genes expression in haematopoietic cell lineages .. .. 29 
Chapter two - Wholemount and in situ hybridisation 
Figure 13 The CT-TOPO-GFP-a9 vector 46 
Figure 14 The//oxc-9-BluescriptKS+vector.. .. .. .. .. 47 
Figure 15 The vMLC- BluescriptKS+ vector 48 
Figure 16 The enzymes used for plasmid linearisation and transcription .. 49 
Figure 17 The hybridisation and stringency wash temperatures for wholemount 
and in situ hybridisation riboprobes.. .. .. .. .. 53 
Figure 18 Wholemount in situ hybridisation of Pax-1 at E10.5 .. .. 59 
Figure 19 HGMP sequence pile up .. .. .. .. .. 61 
Figure 20 Dot blot analysis of riboprobe specificity.. .. .. .. 62 
Figure 21 Wholemount in situ hybridisation of Hoxa-9 at E7.5 .. .. 63 
Figure 22 In situ hybridisation of Hoxa-9 at E9 .. .. .. 64 
Figure 23 Wholemount in situ hybridisation of Hoxa-9 at E9.5 .. .. 66 
Figure 24 Wholemount in situ hybridisation of Hoxa-9 at E10.5 .. .. 67 
xiv 
Figure 25 In situ hybridisation of Hoxa-9 at E l l .. .. .. .. 69 
Figure 26 In situ hybridisation of vMLC at E l 1 .. .. .. .. 70 
Figure 27 In situ hybridisation of Hoxa-9 at El 2 .. .. .. .. 72 
Figure 28 In situ hybridisation of Hoxa-9 at El 3 .. .. .. .. 73 
Figure 29 In situ hybridisation of vMLC at El 3 .. .. .. .. 74 
Figure 30 In situ hybridisation of Hoxc-9 at El 3 .. .. .. .. 75 
Figure 31 In situ hybridisation of Hoxa-9 in adult murine heart .. .. 76 
Figure 32 In situ hybridisation of vMLC in adult murine heart .. .. 76 
Figure 33 Summary of the wholemount and in situ hybridisation study .. 77 
Figure 34 Hoxa-9 expression at E7.5 in the mouse embryo .. .. .. 79 
Figure 35 Hoxa-9 expression at E9 in the mouse embryo .. .. .. 81 
Figure 36 Hoxa-9 expression at E9.5 in the mouse embryo .. .. .. 81 
Figure 37 Hoxa-9 expression at E12.5 in the mouse embryo.. .. .. 85 
Figure 38 Heart formation at E7.5 in the mouse embryo .. .. .. 87 
Figure 39 Heart formation at E8 in the mouse embryo.. .. .. .. 87 
Figure 40 Heart formation at E8.5 in the mouse embryo .. .. .. 88 
Figure 41 Heart formation at E9 in the mouse embryo.. .. .. .. 88 
Figure 42 Heart formation at E9.5 in the mouse embryo .. .. .. 89 
Figure 43 Heart formation at El0 in the mouse embryo.. .. .. .. 89 
Figure 44 Heart formation at El2 in the mouse embryo.. .. .. .. 90 
Figure 45 The expression of lineage markers during heart formation.. .. 92 
Chapter three Embryonic Stem Cell Differentiation in vitro 
Figure 46 The formation of embryoid bodies from undifferentiated ES cells.. 102 
Figure 47 Sequencing and annealing temperatures for RT-PCR primers .. 107 
Figure 48 Colony Forming Unit Assay.. .. .. .. .. .. 110 
Figure 49 CFU-A - The number of embryoid bodies showing haematopoietic 
commitment.. I l l 
Figure 50 PCR analysis of Beta-Actin in embryonic stem cells.. .. .. 113 
Figure 51 PCR analysis of Activinexpression in embryonic stem cells .. 113 
Figure 52 PCR analysis of Brachyury expression in embryonic stem cells .. 114 
Figure 53 PCR analysis of Collagen alV expression in embryonic stem cells.. 117 
Figure 54 PCR analysis of Alpha feta protein expression in embryonic stem cells 117 
xv 
Figure 55 PCR analysis of c-kit expression in embryonic stem cells.. .. 118 
Figure 56 PCR analysis of jlk-1 expression in embryonic stem cells.. .. 118 
Figure 57 PCR analysis of GATA-1 expression in embryonic stem cells .. 119 
Figure 58 Summary of gene expression during the haematopoietic differentiation 
of ES cells 120 
Figure 59 The number of embryoid bodies showing rhythmic contractions .. 122 
Figure 60 Gene expression in ES cells under cardiomyocyte differentiation.. 124 
Figure 61 Summary of gene expression during the cardiac differentiation of 
ES cells 125 
Figure 62 Southern blot analysis of Hoxa-9 in differentiating embryonic stem cells 129 
Chapter four - Gene Overexpression 
Figure 63 LX-GFP-a9 multiple cloning site .. .. .. .. .. 145 
Figure 64 Stable transfection of CGR8 cells with heterologous promoter expression 
vector.. .. .. .. .. .. .. .. .. 154 
Figure 65 Stable transfection of CGR8 cells with heterologous promoter expression 
vector 155 
Figure 66 Transient transfection of COS-7cells with heterologous promoter 
expression vector .. .. .. .. .. 159 
Figure 67 Transient transfection of CGR8 cells with heterologous promoter 
expression vector.. .. .. .. .. .. .. .. 160 
Figure 68 Transfection of Phoenix cells with retrovirus. .. .. .. 163 
Figure 69 Retroviral transduction of CGR8 cells with retrovirus .. .. 164 
Figure 70 Retroviral transduction of COS-7 cells with retrovirus .. .. 165 
Figure 71 Summary of GFP expression using flow cytometry.. .. .. 166 
Chapter five - Final Discussion 
Figure 72 Cre-loxP recombinase gene targeting in ES cells .. .. .. 180 
Figure 73 Tissue specific deletion of Hoxa-9 at target locus .. .. .. 180 
xvi 
Chapter One - Introduction 
1.1 Introduction 
During embryogenesis, one o f the initial tasks is to lay down the overall body plan o f 
organisation followed by the development o f individual organs such as the limbs, eye, 
and nervous system. Much o f the evidence for the genetic control of these developmental 
events has been found in Drosophila mutants. 
Mutant phenotypes can reveal the hidden logic of the genetic control of development. 
The Drosophila maternal effect mutant torso may serve as an example. Females 
homozygous for loss-of-function alleles of torso provide nonviable embryos that are 
deficient in their anteriormost as well as their posteriormost body parts (SchUpbach and 
Wieschaus, 1986). In contrast, females with at least one gain-of-function allele of torso 
have offspring with enlarged terminal regions and little in-between. Similar unexpected 
phenotypes were found for a group of genes termed pair-rule genes because they affect 
the body pattern with a bisegmental periodicity. For example Drosophila embryos 
homozygous for null alleles of the fushi tarazu gene show half the normal number of 
segments, with each o f the segments being longer than normal, suggesting that fushi 
tarazu and other pair-rule genes are involved in bisegmental periodicity (Duncan, 1986). 
Pattern formation in living organisms can be recognised at different levels of 
organisation, for example the body of the fruit f ly is subdivided into the head, thorax, and 
abdomen, and thus each subdivision can be divided further. The rich, detailed body 
patterns of Drosophila make it a favourable object for many investigations of pattern 
formation (Sander, 1976). There is an abundance of known genes affecting every aspect 
of the body pattern, ranging from maternal effect genes that affect the overall body plan, 
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such as bicoid (Frohnhofer and Niisslein-Volhard, 1986), to cell-autonomous genes, such 
as multiple wing hairs, which control the number and shape of hairs on single cells. 
Mutations in zygotic genes can also have profound effects on the embryonic body 
pattern. For example, in Drosophila adults with mutations in Ultrabithorax (Ubx), the 
third thoracic segment (T3) looks like another copy of the second thoracic segment (T2). 
Normally, T2 carries a pair o f wings while T3 carries a pair of balancer organs. In Ubx 
mutants, as part o f the transformation of T3 into T2, the balancing organs have been 
replaced with another pair o f wings (Akam, 1987). Mutations that transform certain body 
regions into the likeness of another body regions are known as homeotic transformations, 
and the genes that have this kind of mutant alleles are known as homeotic genes (Lewis, 
1978). A large group of homeotic genes which are o f particular importance are the 
homeobox genes. 
1.1.1 The conservation of the homeobox genes 
The homeobox encodes a helix-turn-helix motif consisting of a 60 amino acid residue 
polypeptide (Laughon and Scott, 1984, Shepherd et ah, 1984), also called the 
homeodomain. It was found that this domain directly binds to DNA (Johnson and 
Herskowitz, 1985, Desplan et al., 1985, 1988, Fainsod et al., 1986, Hoey and Levine, 
1988, Cho et al., 1988, Muller et al., 1988, Beachy et al., 1988, Laughton et al., 1988). 
It was discovered that binding to DNA was specific and the target sequences were very 
similar to each other. It was suggested that several distantly related homeodomain 
proteins recognise the same sequence element in vitro (Hoey and Levine, 1988, Desplan, 
1988). 
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As more and more homeobox-containing genes were isolated and sequences were 
compared, it became clear that for closely related homeodomains the sequence similarity 
could be extended upstream and/or downstream of the core 60 amino acids. In contrast, 
highly divergent homeodomain sequences have been identified for which the sequence 
similarity is shorter than the original defined 60 amino acids. 
These homeodomain containing proteins have been found within members of the plant, 
fungi and animal kingdoms, but not in the bacterial kingdom. It is therefore thought that 
such genes came early in the evolution o f eukaryotes. Over subsequent evolution the 
amino acid sequence of the homeodomain has remained highly conserved, and sequence 
preservation maintained (Qian et al., 1992) This is demonstrated in figure 1 comparing 
the homeodomain sequence of Hoxa-9 amongst species. The discovery o f a large number 
of Hox genes that were highly conserved between species suggested ancestral gene 
duplication. To better study this, the genomic organisation was investigated. 
1.1.2 The mapping of chromosomal organisation of Hox genes 
Mapping of the nine Drosophila homeobox genes demonstrated that they were co-
localised to two complexes (Antp and BX-C) on one chromosome. Subsequent mapping 
of the 39 murine homeobox genes revealed the presence of four complexes, showing 
differing levels o f synteny between species (Rabin et al., 1986), shown in figure 2. 
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Helix Helix Helix 
i ZZJ i i 
R R R K R T A Y T R Y Q L L E L E K E F T I F N R Y L T R R R R I E L A H S L N L T E R Q V K I W F Q N R R M K W K K E N Consensus 
T...K CP.. KH.. T L. . . .M D Y.V. . .RL M I. Hoxa-9 c 
T...K CP.. KH.. T L. . . .M D Y.V. . .RL M I. Hoxa-9 Ce 
T...K CP.. KH.. T L. . . .M D Y.V. . .RL M I. Hoxa-9 m 
T...K CP.. K H . . T L . . . . M D Y.V. . .RL M I , Hoxa-9 h 
Figure 1 - The conservation of the Hoxa-9 sequence amongst species 
A consensus sequence based on 346 o f the most frequently encountered 60 amino acid o f the 
Hox gene homeodomain is shown on the top line. Grey boxes highlight the positions o f the 
three helices. One Hox gene, Hoxa-9 is shown for four different species. 
Hoxa-9 c denotes Gallus gallus (chicken), Ca ~ Cavia sp (guinea pig), m ~ mus musculus 
(mouse), h ~ homo sapiens. It is important to note that within Hoxa-9, there is 100% 
conservation in the homeodomain for these species. 
Lines below show identity (dots) or variation in sequence (amino acid codes) between 
species. 
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BX-C 
Abd-B Abd-A Ubx Antp Scr Dfd Zen Pb lab J)rosophila 
a-13 a-ll a-10 a-9 a-7 
b-13 b-9 b-8 b-7 
a-6 a-5 a-4 a-3 a-2 a-1 
Mouse 
• 111 1 • I I I 
b-6 b-5 b-4 b-3 b-2 b-1 
I I I 1 I I I 
Hox A 
HoxB 
c-13 c-12 c-11 c-10 c-9 c-i c-6 c-5 c-4 
| | | | | • • • • 
• • • • • • • • wt 
.HoxC 
d-13 d-12 d-11 d-10 d-9 d-8 
I I I I I I -
d-4 d-3 d-1 
HoxD 
5' 3' 
Figure 2 - The nomenclature of vertebrae Hox genes (Scott, 1992) 
Each Hox gene is shown by black filled boxed regions on four separate 
chromosomes and are named. The unfilled boxes show the Drosophila genes of 
the Antermapedia (ANT-C) and Bithorax (BX-C) complexes. 
The 5' and 3' chromosomal positioning has been indicated above, and w i l l be 
referred to during this manuscript. 
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The genomic and organizational similarities between vertebrae Hox and Drosophila 
HOM-C complexes (the complex of homeobox genes that encode Antp class 
homeodomain proteins in the insect, Lewis 1978) suggest that both families arose by 
duplication and divergence from a common ancestral cluster. This ancestral clustering is 
believed to have been conserved in many other animal species (Akam 1989, Scott et al., 
1989, Kessel and Gruss 1990, Boncinelli et al, 1991, Duboule 1992, Krumlauf 1992, 
McGinnis and Krumlauf 1992). Although the complexes are likely to have arisen from 
duplication (Scott et al., 1992), not all four loci have the same number of paralogue 
members, so some duplicated genes may have been lost or not duplicated. Each cluster 
has selectively retained different subsets of these paralogous genes. These subsets have 
been maintained within vertebras. 
In vertebrates, Hox gene organisation is distinctive in that the 39 family genes are 
clustered in four chromosomal loci, the Hox a, b, c, and d complexes (reviewed by 
McGinnis and Krumlauf 1992). The similarities in amino acid homeodomain sequence 
between Hox genes led to a classification into 13 subfamilies or homology groups (Scott 
et al., 1984). Each sub-family contains 2-4 highly related paralogue genes; of tremendous 
interest is that within each o f the four clusters the position of each paralogue is 
maintained. 
1.1.3 The relationship between the Hox and HOM-C complexes 
Although the Hox and HOM-C complex are very similar, there are some features that are 
not shared. For example in Drosophila the HOM-C complex is comprised of two separate 
clusters- bithorax (BX-C (Lewis 1978)) and Antennapedia (Antp) complex (Kaufman et 
al., 1980, 1990), as oppose to the four clusters o f vertebrae Hox. The HOM-C cluster also 
contains genes encoding Scr implicated in segmental identity and two zen homeobox 
genes involved in dorsoventral patterning (Kaufman et al., 1990). 
The presence of a single HOM-C cluster in Drosophila is consistent with the concept o f 
there being a single ancestral cluster, (Beeman et al., 1989, Kenyon and Wang 1991, 
Salser and Kenyon 1994, Averof and Akam 1995, Pendleton et al., 1993, Holland et al., 
1994). Genes that show high levels of conservation between species suggest a 
conservation of function. However, for Hox genes there is an additional level of 
conservation; position within the cluster which may be of functional significance. 
Evidence for this emerged when early studies examined the pattern o f expression of each 
paralogue during embryogenesis. 
1.2 Colinear expression patterns of Hox genes 
In situ hybridisation studies in Drosophila revealed that the genomic organisation of Hox 
genes is reflected by their expression pattern along the anterior-posterior axis. 
Figure 1.1c, shows how Hox gene expression is related to chromosome position within 
the complex, in that 3' genes are expressed in the anterior region o f the embryo (reviewed 
by Dolle and Duboule, 1993). 
The molecular mechanisms that determine the anterior-posterior axis appear to be 
conserved through evolution. The importance of this characteristic colinearity, and how it 
is achieved to formulate Hox gene function and regulation is not completely understood, 
but is thought to lie in Hox gene regulatory mechanisms. 
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B X - C f L L 
Abd-B Abd-A Ubx 
b-9 b-8 b-7 
Antp Scr DJd 
ANT-C 
HoxB 
Figure 3 - Co-linear expression of the homeodomain complexes in 
Drosophila and mouse (adapted from De Robertis, 1990) 
This figure highlights the co-linear expression pattern of the ANT-C cluster in 
Drosophila in relation to the HoxB cluster in the mouse embryo- The 3' located 
genes {Lab- Dfd and Hoxb-1 -Hoxb-4) are expressed in the anterior regions o f the 
fly and embryo respectively. 
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1.2.1 The role of Hox genes in cell patterning 
The chromosomal organisation of Hox loci is correlated to their axial expression pattern. 
The reasons to this colinearity at the chromosome level are unclear, but it is believed to 
involve the conservation of their mechanisms that regulate expression and function 
(Gaunt, 1989, Douboule and Dolle, 1989, McGinnis and Krumlauf 1992, Krumlauf 
1994). 
A number o f studies have examined i f precise Hox patterning is instructive or permissive 
for morphological patterning. There is a great deal of supporting evidence for instructive 
roles. Ectopic Hox expression or loss o f function can lead to large-scale transformations 
as a result of altered gene expression in flies or mice (McGinnis and Krumlauf 1992) 
Some evidence comes from loss of function studies in the mouse. Hoxc-8 is normally 
expressed in the thoracic region. Following loss of function mutations there are anterior 
homeotic transformations in the vertebral column in the mouse (Le Moulleic et al., 1992). 
When homeodomain proteins are ectopically expressed in the posterior o f the embryo, 
anterior homeotic transformations can be found. For example, a mouse transgenic line 
was generated carrying 40 copies o f the human Hox3.3 (Hoxc-6) gene. The resulting 
mice expressed large amounts o f Hox3.3 protein in posterior regions o f the embryo where 
this homeodomain protein is normally not expressed. The transgene caused homeotic 
transformations of the skeleton, in particular the appearance of an extra pair of ribs in the 
lumbar region, transformation o f the shape of posterior ribs into that of more anterior 
ones, and the joining of an additional pair of ribs to the sternum (Jegalian and De 
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Robertis, 1992). Ectopic expression of Hoxc-8 also results in anterior transformations in 
thoracic segments T l 1, T12 and lumbar 1 (Pollock el ah, 1992). 
Previous experiments in Drosophila have shown that detailed modulation of homeobox 
spatial and temporal patterns of expression within metamers can also play an instructive 
role (Mann 1994, Castelli-Gair et ai, 1994, Castelli-Gair and Akam, 1995). Drosophila 
has segmental fields within the embryo that contain groups of cells with the potential o f 
developing into different organs. 
Antp complex genes have been shown to be expressed in a specific manner within these 
segmental fields of the embryo, which include the region that develops Keilin's organs. 
There are also spatially separate groups of cells that have the potential to develop as 
spiracles, which map to specify Antp expression (Castelli-Gair and Akam, 1995). 
However, neither gene is expressed outside these assigned domains in abdominal 
segments, due to the suppressing power of Ultrabithorax (Ubx) and other bithorax 
complex proteins. In the second and third abdominal segment, Ubx is activated in an 
intricate pattern of cells that includes the spiracle primordial. It is this specific expression 
of bithorax genes including Ubx that controls the specific morphology of each segment. 
In the leg primordia of the same segments, Ubx expression is absent during early stages 
of embryogenesis, which allows Keilin's organs to develop (Akam, 1997). This 
highlights the role o f specificity of each Hox/HOM-C gene expression within a given 
metamar at precise time points in determining cell fate (reviewed Gellon and McGinnis 
1998). 
Similar experiments (Salser and Kenyon 1996) have revealed that upstream regulation o f 
Hox genes is an important process in generating gene expression patterning within 
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functional domains, but why do different animals exhibit distinctive and diverse 
morphological features? What is controlling this variation in design? To answer these 
questions we need to comprehend what determines Hox gene patterning. 
1.2.2 Hox gene patterning 
In Drosophila, HOM-C gene patterning is established during the early blastoderm stage, 
and appears as 'stripes' of expression on the anterior-posterior axis (Akam et ah, 1987). 
At this stage of the embryo there is asymmetry of transcription factor distribution of both 
maternal and zygotic origin, produced by coordinate gap and pair-rule genes (Qian et al., 
1993). These gene products allow every nucleus to be exposed on the anterior-posterior 
axis to unique combinations o f transcription factors. It is thought that alterations or loss 
of function of these proteins can result in constrictions, expansions or deletions of Hox 
expression domains (McGinnis and Krumaluf 1992). 
Hox gene expression domains have been shown to be controlled by segmentation genes. 
These genes can be subdivided into (i) gap genes that are required in regions that are 
several segments wide to act in a repressive manner to 'mark out' the coarsest 
subdivisions in the embryo, (i i) pair-rule genes that affect alternate segments, ( i i i ) 
segment polarity genes that are active in parts o f every segment (Qian et al., 1993). The 
repetitive pattern o f similar segments is converted into a sequential pattern of individually 
different segments by action o f the homeobox genes that gives each segment a unique 
identity. 
It might be expected that given the apparent conservation of expression patterns and 
sequence amongst species (see figure 1.1a), that the regulatory networks upstream of Hox 
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are equally as conserved. It appears that there are many different mechanisms for 
establishing the initial boundaries of Hox gene expression in different animal phyla 
(vertebrates and flies), (Patel 1994, Sommer et al., 1993, Wol f f et al., 1995, Brown and 
Denell 1996). These include trans-activating proteins, signalling molecules, cell 
silencing, auto activation and cross regulation. 
1.3 Hox gene regulation: 
1.3.1 Trans-activating proteins; 
Transactivating genes induce expression of specific transcription factors. These factors 
are able to activate the transcription o f the gene whose promoter or enhancer is bound. 
An example of such a transactivator is Krox20. The Krox-20 gene encodes a zinc finger 
transcription factor that is expressed in regions of rhombomeres 3 and 5 (r3/r5) in the 
wild type murine hindbrain (Chavrier et al., 1988, Wilkinson et ah, 1989). 
Evidence that Krox20 can act as a transactivator of Hox genes has been shown from a 
transgenic model. Cis-acting regulatory regions were characterised by flanking the Hoxb-
2 gene in vitro and in transgenic mice. The Krox20 response element was identified 
acting as an enhancer capable o f imposing spatially restricted domains o f expression in 
rhombomere 3 and 5 or in response to the ectopic expression o f Krox20 (Sham et al., 
1993). This leads to the suggestion that Krox20 is a direct upstream regulator o f Hoxb-2. 
Supporting evidence also comes from the analysis of mouse mutants carrying null alleles 
of the Krox20. In the homozygous mutants, r3 and r5 begin to be established, but there is 
a loss o f Hoxb-2 expression, specifically in r3/5, that confirms Hoxb-2 as an in vivo target 
of Krox20. In later stages there is a loss of r3/5, further suggesting that the Hox genes, 
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controlled via Krox-20, are required to maintain normal rhombomere patterning and 
growth gene (Schneider-Maunoury et al., 1993, Swiatek and Gridley 1993). 
1.3.2 Signalling molecules; 
There are many cell-cell signalling molecules that have been identified as regulators o f 
Hox gene expression in vertebrates. 
Embryo exposure to retinoic acid (RA) can induce homeotic transformation (Boncinelli 
et al., 1991, Marshall et al., 1992, Krumlauf 1994). Exposure to RA also induces ectopic 
expression of Hox genes and alters spatial aspects of Hox gene expression patterns 
(Kessel and Gruss, 1991, Marshall et al., 1992). The role o f retinoids in regulating these 
genes during normal development is unclear. Marshall (Marshall et ah, 1994) identified 
two enhancers, 3' of the mouse Hoxb-1 gene, which together reconstruct the early 
endogenous expression pattern and mediate the early ectopic response to retinoic acid. 
The enhancer that controls the retinoic acid response, and regulates expression 
predominantly in neuroectoderm, contains a retinoic acid response element (RARE). 
Point mutations in the RARE abolish expression in neuroectoderm. Therefore this RARE 
is not only involved in the ectopic expression to RA, but is also essential for establishing 
aspects o f the early Hoxb-1 expression pattern. 
This ectopic expression in this most 3' gene of the Hox B cluster, expressed in the 
anterior part of the embryo reflects a colinear sensitivity in the level and time of response 
of Hox genes to RA that has been shown in both cells lines and embryos (Simeone et al., 
1990, 1991,Papalopulu^a/., 1991, Dekker et al., 1993). 
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It had been assumed that RA works on Hox genes to modify their transcription, via 
indirect pathways that feed into Hox gene regulators searching for RA response elements 
(RARE) within the Hox cluster. It has been shown that ectopic exposure o f mouse 
embryos to RA in late primitive streak stages can induce both transformation of r2 into an 
r4 identity and rapid changes in Hoxb-1 expression in both rhombomeres (Marshall et al., 
1992). However, developmental phenotypes and changes in Hoxb-1 expression can also 
be generated by the ectopic expression of Hoxa-1 in transgenic mice (Zhang et al., 1994). 
This suggests that RA may exert its effect by activating the Hoxa-1 gene which then 
directly or indirectly altering Hoxb-1 expression. 
There are many other signalling molecules, like RA, that could potentially interact and 
regulate Hox genes. 
These include Bone Morphogenic Proteins (BMP) 2, 4 and 7, which in response to Shh 
regulate the transcription of Hox in the growth stage of skeletal and mesenchyme tissue 
development (Iimura et ah, 1994, Roberts et al., 1995, Watanabe et al., 1998). 
FGF8 can also regulate Hox gene expression. Using heterospecific grafting strategies and 
ectopic FGF8 expression, Hox gene expression can be induced in murine rhombomere 1. 
Loss-of-function of FGF8 function suggests that this gene is responsible for defining 
anterior limits of Hox genes in the developing brain (Hoxa-4, a-3, a-1, b-1, b-2, a-2) and 
therefore specifies the extent of rhombomere 1 boundary (Irving and Mason 2000). 
As expression o f Hox genes outside their designated expression domain can result in cell 
transformation, it is of equal importance to keep these genes inactive where their products 
are not morphologically wanted. This is achieved by repression - by which the enhancers 
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can be silenced or blocked to prevent active transcription (Bieberich et al., 1990, MUller 
and Bienz 1991, Puschel et al., 1991) 
1.3.3 Hox gene silencing and repression; 
In Drosophila Hox gene silencing is achieved in two steps (Garcia-Bellido and 
Capdevila, 1978). Initiation is the first step, and this provides the spatial specificity: gap 
gene products that are localised in the early embryo repress homeotic genes in sets of 
primordia (White and Lehman 1986, Harding and Levine 1988, Irish et ah, 1989, Qian et 
al., 1991, Zhang et al., 1991, Shimell et al., 1994), The second step, maintenance, keeps 
the homeotic genes silenced even though the gap proteins have gone and the cell is 
dividing. 
This silencing depends on a set of more than ten genes (Lewis 1978, Struhl 1981, Jurgens 
1985), called the Poly-comb group (Pc-G), which includes the Polycomb (Pc) gene itself. 
The Pc-G maintain cell determination and function, and are uniformly distributed in the 
embryo (Paro and Hogness 1991, Franke et al., 1992, Martin and Adler, 1993). Their 
importance can be demonstrated in loss o f function studies. In Pc mutants, posterior Hox 
genes such as Abd-A and Adb-B are expressed in more anterior regions o f the embryo, 
resulting in partial transformation in posterior abdominal identity (Lewis 1978, Struhl and 
Akam 1985, Wedeen et al., 1986). 
The trithorax group (trx) mutations are characteristic by their ability to suppress Pc group 
phenotypes (Shearn 1989, Kennison 1993). Loss of function does not abolish homeotic 
gene expression but affects the amount of expression, ranging from severe to mild (Breen 
and Harte 1993, Tamkun et al., 1992). 
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In a manner similar to Hox, the sequence and genomic organisation of Pc and Trx are 
largely conserved amongst species (Simon 1995, Muller 1995), and provide a means o f 
maintaining homeotic gene expression during stages of embryonic patterning (Struhl et 
al., 1981, Jiirgens et al., 1985, Paro and Hogness, 1991, Franke et al., 1992, Martin and 
Adler, 1993). 
Bmi-l a murine homologue (posterior sex comb Psc), a member of the polycomb group 
of genes provides evidence that it acts as a regulator o f Hox gene expression in mice. 
Homologous recombination studies of Bmi-7 repression in embryonic stem cells (van der 
Lugt et al., 1994, Alkema et al., 1995), provide evidence that it acts as a regulator o f Hox 
gene expression in mice, and M33 a mouse homologue of polycomb (Pearce et al., 1992, 
Paro and Hogness, 1991), substitutes the function of the Pc protein in transgenic flies, 
therefore further suggesting that the Pc genes play similar, conserved roles in mice and 
flies (Muller et al., 1995). 
It has been highlighted that Hox gene domain expression patterns along the anterior-
posterior axis can be activated by regulator gap and pair-rule genes, trans-activating 
proteins, and retinoic acid as well as other signalling molecules, and the pattern of 
expression is maintained, at least in part the repression of polycomb and trithorax genes. 
However, some Hox genes in Drosophila and mice also rely on auto-activation circuits 
for the maintenance o f expression during development. 
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1.3.4 Auto-regulation; 
Comparisons of Hoxb-1 regulatory regions from different vertebrates identified three 
related sequence motifs critical for rhombomere 4 (r4) expression in the hindbrain. 
Functional analysis in transgenic mice and Drosophila embryos demonstrated that the 
conserved elements are involved in a positive autoregulatory loop dependent on labial 
(lab) family groups. Binding of Hoxb-1 to these elements in vitro requires cofactors, and 
the motifs closely resemble the consensus binding site for pbx-1, a homologue of the 
Drosophila extradenticle (Exd) homeodomain protein (van Dijk and Murre 1994). In 
vitro, exd/pbx serve as a Hoxb-1 cofactor in cooperative binding and in Drosophila 
expression mediated by the r4 enhancer is dependent on both lab and Exd (Popped et ah, 
1995). This provides supporting in vivo and in vitro evidence that r4 expression involves 
direct autoregulation dependent on cooperative interactions of Hoxb-1 with exd/pbx 
proteins as cofactors (Regulski et ah, 1991, Chouinard and Kaufman 1991, Chan et ah, 
1996, Gould e/ ah, 1997). 
Embryos that lack Exd are unable to maintain Dfd or lab transcription, although the 
overall transcriptional regulation of many other Hox genes is unaffected (Chan et ah, 
1996, Pinsonneault et ah, 1997). 
This is supporting evidence of direct auto-activation/regulation - the Hox genes are 
regulated by their products acting through their own control regions (McCormick et ah, 
1990, Jiang et ah, 1991, Regulski et ah, 1991, Popperl and Featherstone 1992, Schier and 
Gehring 1992). 
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1.3.5 Cross-regulation; 
Cross-regulatory circuits among Hox genes can play an important role in determining 
transcriptional patterns. The expression patterns of most Hox genes involve large, 
overlapping domain areas along the axis that extend from the anterior boundary back 
towards the caudal end of the embryo. In Drosophila, where Hox gene expression 
overlaps occur, there is often down-regulation of anterior genes through negative cross-
regulation by loci expressed in a more posterior fashion (Hafen et al., 1984, Struhl and 
White 1985, Carroll et al., 1986, Wirz et al., 1986, Bermingham et al., 1990, Appel and 
Sakonju 1993, Gould et al., 1997). It is not clear that such a system operates in 
vertebrates. Indirect evidence may be seen in the vertebrate hindbrain, where there is 
specific Hox gene patterning in each rhombomere (Lumsden and Krumlauf 1996). Each 
rhombomere appears to express a specific Hox pattern, but there is a high degree of 
spatial overlap, suggesting that there maybe regulatory elements shared between Hox 
genes (Simeone et al., 1988, Krumlauf 1994, van der Hoeven et al., 1996). Direct 
evidence is suggested in the case of Hoxb-3. In the mouse hindbrain Hoxb-3' and Hoxb-4 
share an expression domain caudal to the boundary between rhombomeres 6 and 7. 
Transgenic analysis reveals that an enhancer (CR3) is shared between both genes and 
specifies this domain to overlap (Gould et al., 1997). 
Homeodomain containing Hox genes have been strongly implicated in determining cell 
patterning, proliferation and migration during several developmental processes (reviewed 
by Gehring et al., 1987, Levine and Hoey 1988, Akam 1989). Aberrant expression of 
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these transcription factors in transgenic mice result in morphogenic transformations, 
indicating their importance during development (Balling et al., 1989, Wolgemuth et al., 
1989, Chisaka and Capecchi 1991, Fromental-Ramain et al., 1996, reviewed by Krumlauf 
1994.) Hox genes are best represented by their important roles in cell proliferation and 
normal differentiation control. One adult system that produces highly differentiated 
cellular progeny in a tightly regulated manner is the haematopoietic system, and this has 
become one focus of attention for workers investigating Hox gene function in adult 
tissues. 
1.4 Haematopoiesis 
Haematopoiesis is a series of complex pathways that allows the production of all blood 
cell types (lymphoid, myeloid, erythroid) from a single, multipotent stem cell, the 
haematopoietic stem cell (HSC)(Graham and Pragnell, 1992). 
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Figure 4 - An outline of the haematopoietic pathway. 
This figure highlights the production of eight different blood lineages 
from one pluripotent stem cell type. 
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At present, the molecular controls involved in this differentiation pathway are 
incompletely understood, therefore it has become increasingly important to identify 
candidate genes that regulate 'normal' haematopoiesis. 
Figures 5-11 illustrate the events involved in the development of the haematopoietic 
system in the mouse embryo. It is to be noted that these illustrations are not quantitative, 
but merely an indicator of such events taking place. 
1.4.1 Primitive haematopoiesis 
Haematopoiesis can be first detected as blood islands within the yolk sac of the mouse 
embryo at E7 (Russell and Bernstein 1968), illustrated in figure 5. The blood islands 
contain terminally differentiated blood cells of erythroid and monomyeloid lineages. At 
E8, primitive progenitors which can give rise to lymphoid lineages can also be seen 
(Moore and Metcalfe, 1970, Johnson and Barker, 1985, Wong et al., 1986, Gordon et al., 
1992, reviewed Keller el al., 1999). The blood cells begin to circulate between the 
extraembryonic yolk sac and the embryo at this stage, seen in Figure 1.4.6 (Medvinsky et 
al., 1996). At this time, the yolk sac does not contain cells capable of repopulating the 
entire adult haematopoietic system (or long term repopulating (LTR) cells, (reviewed 
Dzierzak and Medvinsky, 1995, Cumano et al., 1996, Medvinsky and Dzierzak, 1996, 
Dzierzak et al., 1997), and are therefore termed primitive, but such progenitors that are 
found are able to self-renew and generate committed progenitors which lead to mature 
haematopoietic cells after E7-14 (Dzierzak and Medvinsky, 1995). 
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Monomyeloid cell 
Figure 5a (left) The E7.5 mouse embryo 
Figure 5b (right)Haematopoiesis in the E7.5 mouse embryo - transverse section 
shown in 5 a 
Initial haematopoietic events in the mouse begin in the blood island yolk sacs 
(highlighted in blue), where primarily erythroid lineage cells, and fewer monomyeloid 
cells are produced. Stem cells in the yolk sac are thought to be incapable of Long 
Term Reconstitution (LTR) (Cumano et. al. 1996, Medvinsky & Dzierzak et al 1996, 
reviewed Dzierzak et. al. 1998 and Medvinsky et. al. 1993). 
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Figure 6a (left) The E8.5 mouse embryo 
Figure 6b (right) Haematopoiesis in the E8.5 mouse embryo 
Transverse section through Figure 1.4.5. 
At this stage, blood cells begin to circulate between extraembryonic yolk sac 
(highlighted in blue), and the embryo, indicated by the arrow (Gordon et al., 1991, 
Dzierzak et al., 1995, Medvinsky et. al. 1996). 
1.4.2 Definitive haematopoiesis 
The aorta-gonad-mesonephros (AGM) has been identified as the first intraembryonic site 
of definitive, or adult, haematopoietic activity. This mesoderm derived region containing 
the dorsal aorta, genital ridge/gonads and pro/mesonephros has been shown to harbour 
adult-type multipotent haematopoietic progenitors and LTR-HSCs at E9-10 (Medvinsky, 
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1993, Miiller et al., 1994). At these times, illustrated in figures 7-8, the AGM produces 
LTR-HSCs abundantly, and is the most important organ for the generation of the adult 
haematopoietic system as shown by functional haematopoietic assays (Tavassoli et al., 
1991, Medvinsky, 1993). 
By E9.5 the foetal liver is another principal haematopoietic organ producing primitive 
erythroid cells, myeloid and B-cell lymphoid precursors (figure 7). From E9 upwards the 
foetal liver generates haematopoietic progenitors and mature blood cells, and by E l l 
contains definitive LTR haematopoietic stem cells that have migrated from the AGM. At 
E12 the yolk sac contains cells of the same nature that have migrated from other sites 
(Chang et al., 1992, Medvinsky, 1993, Muller et al., 1994, and reviewed Dzierzak et al., 
1998). 
There is only one functional definition of LTR-HSC, but in order to isolate this 
comparatively rare population of cells, the surface antigen phenotype has been closely 
studied, and an indicative phenotype characterised for adult bone-marrow HSC. These 
include c-kit+ and CD34 + , but negative for mature lineage markers such as CD4, CD8, 
B220 and Gr-1 (Sanchez et al., 1996). Evidence from Morrison (Morrison et ah, 1995), 
suggests that the adult bone-marrow HSC can be very highly enriched, i f not a pure 
population of LTR-HSC. In a similar manner, the HSCs found in AGM and foetal liver 
have been studied. 
1.4.3 The site of long term reconstituting (LTR) HSC production 
The presence of definitive HSCs in the AGM with characteristic surface antigens 
suggests that definitive HSCs are produced solely in the AGM and then migrate to the 
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Erythroid progenitor cell 
O Monomyeloid cell 
Figure 7 - Haematopoiesis in the E9.5 
mouse embryo 
The foetal liver (area shown in pink) 
generates the primitive progenitors. 
The Aorta-Gonad-Mesonephros (AGM ), 
highlighted in green, harbours HSCs 
capable of long term reconstitution 
(Medvinsky et al., 1993, Miiller et ah, 
1994). 
O Granulocytic cell 
0 Macrophage cell 
Committed B cell precursor cell ( • ) Definitive HSC 
Figure 8 - Haematopoiesis in the E10.5 
mouse embryo 
The foetal liver (area shown in pink) 
continues to produce haematopoietic 
progenitor cells. 
The intraembryonic (AGM) region, 
highlighted in green, is found to contain 
LTR haematopoietic stem cells (Dieterlan-
Lievre et al., 1992, Medvinsky et al., 1996, 
Miiller at al., 1997, Dzierzak et al., 1998). 
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These organ culture experiments have shown that while yolk sac stem cells initiate 
primitive haematopoiesis as early as E7, they are independent from intraembryonic 
definitive LTR stem cells found in the AGM at E10. The migration of AGM stem cells to 
the yolk sac occurs around El 1 and the liver by El2 (figure 9). 
Figure 9 - Haematopoiesis in the E l 1.5 mouse 
embryo. 
LTR HSCs are more abundant in the AGM, 
highlighted in green, compared to the foetal liver 
(pink) and the yolk sac surrounding the embryo 
(not shown). 
These sites now contain definitive LTR HSCs 
that have migrated from the only site of 
production, the AGM (Dieterlan-Lieve and 
LeDourain 1993, Medvinsky et al., 1993, Miiller 
et al., 1994, Dzierzak et al., 1998). See 1.11 for 
cell key. 
1.4.4 The transition to adult haematopoiesis 
The foetal liver is the principal site of mid- and late- gestation haematopoiesis in mammals, 
beginning at E10 in mice. The adult haematopoietic system begins in the foetal liver and 
includes the emergence of a large and expanding pool of multipotent progenitors (Ikuta et al., 
1990). From E16 the foetal bone marrow takes over as the principal haematopoietic organ and 
produces adult type erythrocytes, macrophages, T-cells and conventional B cells (reviewed 
Bonifer et al., 1998). This site of multi lineage cell production remains throughout adult life. 
®® 
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Figure 10 - Haematopoiesis in the E12.5 
mouse embryo. 
Definitive haematopoiesis increases in the 
foetal liver (pink), whilst activity in the 
AGM (green) declines. 
The extraembryonic yolk sac now begins to 
degenerate, as the intraembryonic sites take 
over production (Medvinsky and Dzierzak 
1996). 
Erythroid progenitor cell 
O Monomyeloid cell 
Committed B cell precursor cell 
O Granulocytic cell 
Q Macrophage cell 
( • ) Haematopoietic Stem Cell 
o 
Figure 11 - Haematopoiesis in the 
E14.5 mouse embryo. 
Definitive haematopoietic events have 
shifted to the foetal spleen (purple), whilst 
production continues in the foetal liver 
(pink). 
Haematopoietic activity wil l move to the 
bone marrow, and contain precursor cells 
needed for adult life (reviewed 
Medvinsky and Dzierzak 1996). 
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1.4.5 Why regulate haematopoiesis? 
The haematopoietic system of human adults produces approximately one trillion blood 
cells each day (Emerson, 1991). This continual process involves the sequential 
commitment of multipotential haematopoietic cells to gradually more-restricted 
progenitor cells, and finally to functionally eight distinct cells of mature blood shown in 
figure 1.4.13. The molecular mechanisms that determine these lineages remain central to 
the field of haematopoiesis. 
Lineage-specific transcription factors have essential roles in lineage decisions (reviewed 
Shivdasani and Orkin, 1996), and include GATA-l-FOG-1 interactions in erythroid and 
megakaryocyte differentiation (Pevny et al., 1991, Fujiwara et al., 1996, Shivdasani et 
al., 1997, Crispino et al., 1999, Vyas et al., 1999, Nichols et al., 2000), PU-1 in the 
development of monocytic, granulocytic and lymphoid lineages (Scott et al., 1994, 
Hromas et ah, 1993, McKercher et al., 1996). PU-1 interacts with GATA-1 to down 
regulate PU-1 expression in erythroid cells, (Moreau-Gachelin et ah, 1996). Enforced 
expression of GATA-1 in myelo-monocytic cells perturbs their differentiation (Kulessa et 
al., 1992) highlighting GATA-1 as a regulator in this lineage pathway. Scl is essential for 
all ontogenetic stages of haematopoiesis. Following targeted mutagenesis of this gene, all 
haematopoietic lineages are eliminated (Robb et ah, 1995, Porcher et al., 1996). 
Ikaros is essential for lymphoid development. Targeted mutagenesis leads to the 
complete absence of B-cell and abnormal T-cell development (Wang et al., 2996). 
It is important that each lineage can be derived continually, and more importantly that on 
demand (following damage), the molecular mechanisms are able to activate the 
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production pathway of a particular lineage. However these pathway mechanisms are 
incompletely understood and require further study. 
1.4.6 Hox genes as potential molecular markers of haematopoiesis 
It would seem logical to study developmental genes in such a system that is initiated 
during embryogenesis and continued on into the adult. 
A distinguishing hallmark of Hox complexes is the correlation between physical order of 
genes along the chromosome and their expression pattern along the anteroposterior axis 
of the embryo (Lewis 1978). This mechanism for representing and possibly predicting the 
regulation of regional identity, may suggest that Hox genes contribute to the control of 
this developmental pathway. 
1.5 Hox gene expression in differentiating blood cells 
Evidence from embryonic Hox gene expression studies has shown temporal patterning. 
There is increasing evidence of Hox gene transcripts present in a variety of primitive and 
definitive blood cell progenitors. Genetic manipulation by gene overexpression into 
primary cell lines, has revealed several Hox genes as key regulators in the production of 
blood cell lineages. 
Figure 12 below highlights the expression patterns of specific Hox genes as potential 
regulators of lineage specific pathways, and the methods used for analysis. 
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Hox Gene Lineage pathway 
involvement 
Study Reference 
HOXA cluster CD34 + (primitive) R T - P C R analysis Vieille-Grosjean et al., 1992 
HOXA5 Myeloid R T - P C R analysis 
anti-sense oligo 
Fu l l ered / . , 1999 
Crooks etal., 1999 
HOXA9/a-9 Myeloid 
T-cell 
B-cell 
Targeted disruption 
Targeted disruption 
Overexpression 
Lawrence et al., 1997 
Izon etal., 1998 
Thorsteinsdottir et al., 2002 
HOXA 10 Myelomonocytic 
Myeloid 
mRNA analysis 
Overexpression 
Transgenic mice 
Overexpression 
Lowney et al., 1991 
Thorsteinsdottir et al., 1997 
Bjornsson et al., 2001 
Buske et al., 2001 
HOXB3 Lymphoid Overexpression Sauvageau etal., 1995, 1997 
HOXB4 Erythroid 
Myeloid 
Anti-sense oligo 
Overexpression 
Overexpression 
Shen etal., 1989 
Helgason etal., 1996 
Helgason etal., 1996 
HOXB5 Erythroid Library screening Shen etal., 1989 
HOXB6 Erthroid 
Granulocytic 
Normal bone marrow 
Anti-sense oligo 
Targeted disruption 
R T - P C R 
Library screening 
Shen etal., 1989, 
Kappen et al., 2000 
Giampaolo etal., 1994 
Shen etal., 1989 
HOXB7 Erythroid 
Granulocyte 
Myelomonocytic 
Myeloid 
R T - P C R 
Targeted disruption 
Anti-sense oligo 
R T - P C R 
Sauvageau et al., 1994 
Yaron et al., 2001 
Lill etal., 1995 
Sauvageau et al., 1994 
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Hox Gene Lineage pathway 
involvement 
Study Reference 
HOXB8 Myeloid Overexpression 
Library screening 
Blatter al., 1988, 1992 
Kongsuwan et al., 1988 
HOXC4 Lymphoid Rnase protection 
assay 
Meazza et al., 1995 
HOXC5 Lymphoid R T - P C R 
RISH 
Bijl etal., 1996 
HOXC6 Erythroid Anti-sense oligo Takeshita et al., 1993 
Figure 12 - Hox gene expression patterns in haematopoietic cell lineages. 
In summary, much of the work on Hox gene expression in normal haematopoietic cells 
has been carried out on human and mouse transformed cell lines (Kongsuwan et ah, 1988, 
Shen et al., 1989, 1990, Lowney et al., 1991, Magli et al., 1991, Mathews et al., 1991, 
Vieille-Grosjean et ah, 1992), primitive haematopoietic cells (CD34+) (Sauvageau et al., 
1994) , and undifferentiated bone marrow cells (Sauvageau et al., 1994). The expression 
of HOXA cluster is associated with the myelomonocytic lineage (Lowney et al., 1991, 
Vieille-Grosjean et ah, 1995), expression of HOXB genes to cells differentiating with 
erythroid potential (Shen et ah, 1989, 1990, Mathews et ah, 1991, Sauvageau et ah, 1994, 
1995) , and HOXC genes are largely expressed in cells of the lymphoid system (Takeshita 
etal., 1993, Meazza et ah, 1995, Bijl et ah, 1996). 
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Information on the expression of Hox regulator genes, such as polycombs is limited, but it 
is known that the expression pattern of Pc genes does change during the differentiation of 
human bone marrow cells in vitro (Lessard et al., 1998). 
These findings of Hox gene expression during normal lineage development and 
differentiation suggest several potential roles for these homeotic genes as potential 
regulators of embryonic and or adult haematopoiesis. 
The precise function of these genes awaits closer analysis. One approach is to examine 
their expression in pathological conditions, particularly ones in which normal 
commitment and differentiation is subverted; such an example can be found in neoplasia. 
1.6 Hox genes and cancer 
Disturbances in normal adult Hox gene expression can be found in carcinomas (Cillo et 
al., 1992). In primary kidney tumours HOX genes can be turned off (HOXB5, B9) or on 
(HOXC11) or can display different-sized transcripts (HOXD4) i f compared to the 
expression in normal kidneys (Cillo et al., 1995). This association between altered HOX 
gene expression and kidney cancer, has subsequently been proven for other HOX and 
homeobox genes. 
Dysregulated expression of HOXA9, HOXB7, and HOXD11 has been detected in 
metastatic liver lesions that have originated from colorectal tumours, suggesting a 
possible involvement of HOX genes in colon cancer (De Vita et al., 1993). 
There is an association between the progression of small cell lung cancer and the 
inactivation of several HOX genes that are expressed in the normal lung (Tiberio et al., 
1994). 
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In mammary glands, Hoxc-6 transcripts, active during puberty and maturity, become 
silent during pregnancy (Friedmann et al., 1994), transcripts are also undetectable in 
mammary adenocarcinomas . In contrast, Hoxa-1, silent in normal mammary gland 
tissue, becomes active in the presence of breast cancers in both mice and humans. 
Furthermore, in mammary epithelial cells, Hoxa-1 and Hoxb-7 are regulated by 
extracellular matrix-dependent signals (Srebrow et al., 1998). The transduction of 
HOXB7 has been shown to induce bFGF expression and alter growth characteristics of 
breast cancer cells (Care et al., 1998). 
There is also evidence that the expression of several HOX genes expression is altered in 
other forms of cancer including: cancer of the prostate (Robbins et al., 1996, Sciavolino 
et al., 1998); corectal cancer (Vider et al., 1997); papillomas (Chang et al., 1998); 
melanomas (Care et al., 1996); and neuroblastomas (Osborne et al., 1998). 
However, the strongest data for a role of Hox in neoplasia is in the onset of leukaemia. 
1.6.1 Hox genes in leukaemia 
The potential regulatory roles of Hox genes in the normal development and commitment 
of haematopoiesis have been shown (table l.le). It can be suggested from these previous 
studies that Hox genes play a regulatory role during leukemogenesis (Shen et al., 1989, 
Borrow et al., 1996, Nakamura et al., 1996, 1996a, Knoepfler et al., 1997, Lawrence et 
al., 1997, Thorsteinsdottir et al., 1997). 
The transduction of normal bone marrow with a retroviral-T/ox^-S construct together with 
the activation of the IL-3 gene was able to induce myeloid leukaemia in mice (Perkins et 
al., 1990). Also in mice, the overexpression of Hoxa-10 induces myeloid leukaemia after 
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long latency periods in mice (Thorsteinsdottir et al., 1997). Cooperation between 
HOXB3, HOXB4 and Pbxl homeoproteins are likely to play an important part in blood 
cell proliferation and transformation (Krosl et al., 1998). 
Retroviruses can be used to induce myeloid leukaemia in BXH-2 mice by insertional 
mutation of cellular proto-oncogenes or tumour suppressor genes. Potential disease genes 
can thus be identified by proviral tagging through the identification of common viral 
integration sites. Using this technique, Nakamura (Nakamura et al., 1996a), identified 
that proviral activation o f Hoxa-7,and Hoxa-9, associated independently correlated with 
proviral activation of Me is] (a Pbx related homeobox gene), resulting in the onset of 
acute myeloid leukaemia, suggesting that a Pbx-1 related gene cooperates with these two 
Hox genes in leukaemia formation. 
Homeodomains of paralogue groups 1 to 10 are stabilised in their binding activity by 
PBX1, whereas AbdB-Wke Hox proteins require interaction with meisl in order to bind to 
their target (Shen et al., 1997). 
Hoxa-9 overexpression in mouse bone marrow cells is closely associated with the 
development o f acute myeloid leukaemia. Thorsteinsdottir (Thorsteinsdottir et al., 2002) 
used two different mouse models (transplantation chimeras of overexpressing bone 
marrow cells and transgenics) to study the effects o f Hoxa-9 overexpression on 
haematopoietic cells prior to the occurrence of leukaemic transformation. They 
demonstrated that contrary to a previous loss of function study (Izon et al., 1998), both 
the HSC and myeloid progenitor cell pools are significantly increased in the Hoxa-9 
transplantation chimeras. In both models there was a reduction in B-cell progenitors, 
suggesting a further role for this Hox gene in lymphoid cell development. 
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Evidence for a role for Hox genes in leukaemia comes from spontaneous human 
leukaemia. In human acute myeloid leukaemia ( A M L ) , the translocation t ( 7 ; l l ) 
(p 15;p 15) fuses the nucleoporin gene NUP98 in frame with the HOXA9 gene (Borrow et 
ah, 1996, Nakamura et ah, 1996). Chimeric fusion proteins resulting from the 
transcription activator domain of one protein and the DNA binding domain of the other 
protein display increased oncogenic properties when compared to the components. 
Fusion between PBX1 and E2A proteins alters the sequence-specific binding to the HOX 
genes directing the homeoprotein on a different target and inducing leukemogenesis 
(Knoepfler et ah, 1977). There are several invaluable studies investigating the role o f 
Hoxa-9 in leukaemia however, the function of Hoxa-9 in normal haematopoiesis remains 
to be elucidated. 
1.7 Aims 
Hox genes are invaluable and essential for cell identity in regulating several embryonic 
developmental processes in a broad variety of species. 
There is already evidence for several Hox genes playing key roles during definitive 
haematopoiesis and in particular Hoxa-9 in haematopoietic disease, which lead this study 
to focus on the understanding o f the function of Hoxa-9 during normal stages o f blood 
cell development, especially in the embryo. To investigate the role of Hoxa-9 during 
embryonic mouse development, it was intended to use conventional wholemount and in 
situ hybridisation techniques on a series of mouse embryos from E7-E14. This allowed 
the anatomical study to screen the different events seen by the expression pattern o f 
Hoxa-9 during the course of essential haematopoiesis in the embryonic mouse (E7-E14), 
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as well as allowing the study of other potential roles for Hoxa-9 during embryonic 
development. To extend this expression study further, an embryonic stem cell model was 
used to detect the expression patterns o f Hoxa-9 during the early differentiation and 
development of ES cell derived cell lineages. In order to investigate a potential function 
for Hoxa-9 during this developmental process, genomic manipulation techniques were 
applied to this conventional differentiation model to study the effects on lineage 
commitment following the overexpression of Hoxa-9. 
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Chapter Two - Wholemount and in situ hybridisation 
2.1 Introduction 
Hox genes have been shown to be crucial in several developmental processes during 
embryogenesis. Several of these findings were identified using in situ and wholemount 
hybridisation techniques, with further functional studies using knock out and 
overexpression procedures. 
Previous overexpression and targeted mutation studies have shown that Hoxa-9 like 
several other Hox genes (figure 12) play a regulatory role in myeloid, and lymphoid cell 
development (Lawrence et al., 1997, Izon et al., 1998, Thorsteinsdottir et al., 2002). This 
gene is also associated with the onset of acute myeloid leukaemia in mice (Nakamura et 
al., 1996, Thorsteinsdottir et al., 2002), and humans (Nakamura et al., 1996b, Borrow et 
al., 1996, Dash et al., 2002). 
It followed therefore to use conventional in situ and wholemount hybridisation 
techniques to study the expression pattern o f Hoxa-9 in normal embryonic development 
of the mouse of the core time course of embryonic haematopoiesis (E7-E14). 
Previous Hoxa-9 in situ hybridisation studies generated invaluable data on the expression 
pattern during embryogenesis. However, these limited studies did not address the 
patterning at haematopoietic sites. Therefore due to the potential regulatory roles of 
Hoxa-9 during haematopoiesis and the correlation with A M L onset, it would seem logical 
to use these methods that have been used in previous Hoxa-9 gene studies to further 
investigate the normal molecular control o f Hoxa-9 during haematopoiesis in the mouse 
embryo. 
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2.1.1 The application of in situ hybridisation 
The detection of specific nucleic acid sequences in cells, tissues, or whole organisms by 
in situ hybridisation has important applications in many areas of biology. There is an 
abundance of cloned genes with potential roles in embryonic tissues. Analysis o f the 
spatial and temporal regulation of the expression of these genes by in situ hybridisation to 
mRNA is a crucial step towards understanding gene function and elucidating the biology 
system at the molecular level. 
The ease and speed with which patterns of gene expression can be visualised by 
wholemount and in situ hybridisation makes it an attractive technique for screening large 
numbers of candidate clones for region- or tissue-specific expression. This method also 
enables the detection of significant changes in gene expression that may occur only in 
small sub-populations of cells. 
2.1.2 Detection of Hox genes during development using wholemount and in situ 
hybridisation methods: 
There is increasing use o f in situ and wholemount hybridisation to detect expression and 
identify functions of Hox genes in several areas o f developmental biology. The most 
explored developmental areas using these techniques have largely contributed to 
understanding the regulation of the neural crest, hindbrain, axial skeleton, limbs and gut, 
all of which wi l l be discussed in this chapter. 
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2.1.2.1 Expression in neural tube and crest development; 
In situ and wholemount hybridisation techniques with Hox genes in the chick have 
identified expression boundaries and regulatory mechanisms in neural crest cells. 
In the chick, the expression pattern o f Hoxa-2 was analysed during early development in 
the rhomboencephalic neural tube and derived neural crest using wholemount and in situ 
hybridisation techniques. 
The experiments using a digoxigenin-labelled riboprobe in stage 9 and 10 chick embryos, 
showed that Hoxa-2 has a rostral limit of expression in the rhombencephalic neural tube 
corresponding to the boundary between rhombomeres r l and 2. This in situ data along 
with corresponding grafting experiments showed the specificity of Hoxa-2 expression in 
neural crest-derived rhombomere patterning (Prince and Lumsden, 1994). 
A similar experiment using in situ and wholemount hybridisation demonstrated Hoxa-3 
expression throughout chick development, in the neural plate and later in the neural tube, 
corresponding to the boundary between rhombomeres 4 and 5. This method followed 
Hoxa-3 expression in caudally migrating neural crest cells from their rhombomeres of 
origin to determine neural crest cell regulation (Saldivar et al., 1996). 
The maintenance and regulation of vertebrae hindbrain segmentation into rhombomeres 
in not fully understood. Using wholemount in situ hybridisation following screening from 
a subtracted embryonic chick hindbrain cDNA library, a large proportion of genes, 
including Hoxd-3, with restricted expression patterns and previously unknown functions 
in the embryonic brain were identified (Christiansen et al., 2001). Further regulatory 
mechanisms in hindbrain development have been identified using these techniques. 
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Hoxb-2 and Hoxa-2 gene expression in rhombomeres 3 and 5, have been shown to 
regulate patterning o f the vertebrae hindbrain via Krox20 (Nonchev et al., 1996). 
2.1.2.2 Cranio-facial development; 
In situ hybridisation was used to establish temporal and spatial expression patterns of 
Hox-7, in the developing embryonic cranium and nervous system of the mouse between 
E9.5 and El5.5. It was suggested from the resulting expression patterns that Hox-7 might 
be a good candidate as one o f the genes involved in the formation and development o f the 
outer ear, and the differentiation of the cell types of the anterior pituitary (MacKenzie et 
al., 1991). 
By using specific probes against the message of eight HOX genes, HOXB1, A2, B2, A3, 
B3, D3, B4 and C4 were found to be expressed in the human embryonic hindbrain and 
branchial arches at 4 weeks of development. The combinatorial patterns o f expression of 
genes representing the first three paralogous groups parallel the patterns described for 
their homologues in various animal models, demonstrating a high degree of conservation 
of the 'brachial Hox code' (Vieille-Grosjean et al., 1997) - the developmental strategy 
whereby positional specification made axially within the neural tube is transmitted to the 
periphery via migrating neural crest cells (Hunt et al., 1991). 
2.1.2.3 Axial skeletal and limb development; 
Mapping the altered patterns o f gene expression in mutant embryos can yield valuable 
information about the mutant phenotype and elucidate the genetic interactions that are 
involved. 
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Mice were generated with a targeted mutation of Hoxb-9 (Chen and Capecchi, 1997),. 
Homologous mice showed defects in the development o f the first and second ribs, and a 
significant role was suggested in the role for Hoxb-9 in specifying thoracic skeletal 
elements. It has been reported that in some cases a mutation in one Hox gene can affect 
the expression of a neighbouring Hox gene (Suemori et ah, 1995, Borrow and Capecchi, 
1996). To determine i f the Hoxb-9 mutation affected Hoxb-8 or Hoxb-7 expression, 
wholemount in situ hybridisation was carried out on E10.5 and E12.5 embryos o f all 
three Hoxb-9 genotypes. It appeared from using this technique that the absence of 
functional Hoxb-9 did not affect the expression of neighbouring genes. 
In limb development, several Hox genes (Hox-1.8 (a-10), 1.9(a-ll), LlO(a-lS) have been 
shown to be expressed in a temporal and spatial manner using in situ hybridisation 
(Haack and Gruss, 1993). 
2.1.2.4 Gut development; 
To elucidate the anteroposterior patterning o f the digestive tract, expression patterns of 
Hox genes belonging to paralogue groups 6, 7, 8, and 9 were examined using 
wholemount in situ hybridisation. The expression patterns of these genes showed co-
linearity along the wall of the digestive tract, with later expression in individual gut 
subdomains, suggesting a function for Hox genes in specifying mesenchymal 
differentiation o f the gut (Sekimoto et al., 1998). Roberts (Roberts et ah, 1995) found a 
similar expression pattern in the developing gut of the chick using wholemount in situ 
hybridisation. 
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2.1.2.5 Other developmental processes 
In situ and wholemount studies using Hox genes have also contributed to a lesser degree 
in other areas of development including tooth initiation and shape - Hoxc-8 was detected 
during the initiation and development of the molar and incisor teeth in the neural crest-
derived mesenchyme tissue beneath the site of future tooth formation in the embryonic 
mouse (MacKenzie et al., 1992). Hox 2.2 (Hoxb-6), has been suggested to play a role in 
epidermal development following detected transcripts in 17-day foetal skin using in situ 
hybridisation (Mathews et al., 1993). An association between HOXB6 and erythropoietin 
(EPO) expression in the E8.5 mouse embryo was found using wholemount in situ 
hybridisation. It was shown that the sequential transfer o f erythropoiesis in different 
organs during development was followed by a similar transfer o f HoxB6 and EPO gene 
expression (Zimmermann and Rich, 1997). 
The importance o f wholemount and in situ hybridisation applications to Hox genes during 
development have been shown to contribute largely to understanding functional roles for 
these genes during the maturity of several processes. 
2.1.3 Aims 
The significant association o f Hoxa-9 in the onset of leukaemia has previously been 
highlighted, and therefore understanding the normal biology o f Hoxa-9 during 
haematopoiesis becomes significant for further investigation. 
Previous developmental studies of Hox genes have applied conventional wholemount and 
in situ hybridisation techniques to detect and highlight expression patterns in the embryo, 
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which can be further analysed to identify potential functional roles. Subsequent Hoxa-9 
expression studies did not report findings in the haematopoietic system o f the embryo. 
To further the current study, the established hybridisation techniques described above, 
were used to analyse the Hoxa-9 expression pattern in the mouse embryo throughout the 
crucial developmental stages o f embryonic haematopoiesis from initiation in the yolk sac 
(E7.5) to definitive stages (El2) , in an attempt to further understand the normal functions 
of this gene during blood cell production and differentiation. 
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2.2 Materials and Methods 
A l l chemicals were supplied by Sigma, (Poole, Dorset, England) unless otherwise 
specified. 
A l l procedures were carried out at room temperature unless otherwise stated. 
Dilutions were carried out using DEPC treated water (A.4), unless otherwise stated. 
2.2.1 Polymerase Chain Reaction (PCR) 
The PCR was set up by mixing together 0.5 u.g cDNA with 5 u.1 5x PCR N H 4 reaction 
buffer (Bioline, London, England), 1.5 m M M g C l 2 (Bioline), 10 m M dNTPs (Promega, 
Southampton, Hampshire, England), 0.1 ng of both forward and reverse PCR primers 
(Invitrogen) and 1 unit of Taq polymerase (Bioline). 
The PCR reactions were run using Omn-E thermal cycler (Hybaid, Ashford, Middlesex, 
England) using the following programme: 
94°C for four minutes 
94°C for one minute 
x°C (hybridisation temperature) for one minute 
72°C for one minute 
72°C for ten minutes 
x35 cycles 
2.2.2 Gel electrophoresis 
PCR products were run on 2% agarose gels, made by dissolving 2% (w/v) agarose 
powder (Bioline) in IxTAE buffer (see A. 18). Once cool (50°C) 0.5 ug/ml ethidium 
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bromide was added and poured into a pre-cast gel tray containing combs and left to 
solidify at room temperature. Once cool, the combs were removed and the gel placed into 
a gel tank submerged in l x T A E buffer. 15 ul of PCR product was mixed with 2 uJ 
loading stain (Promega) and loaded into individual wells. Once all samples had been 
loaded 5 units of a DNA ladder (Promega) was added and the gel run at 150 volts for 
forty minutes. The DNA on the gel was then visualised using Bio-Rad 'Gel Doc' Ultra 
Violet illuminator at 366nm, and the results recorded. 
2.2.3 Collection of mouse embryos 
Mouse embryos from Balb/C mice were collected between E9 and El 2 days of gestation. 
Their developmental stage was confirmed according to Kaufmann's stages o f 
development (Kaufman, 1992). Males were introduced to a cage with females for twelve 
hours overnight and dated matings were identified by the presence o f vaginal mucous 
plug, and considered to be embryonic day 0.5. Pregnant females were sacrificed by a 
schedule I procedure of cervical dislocation. The abdominal skin was cleaned with 70% 
v/v ethanol, the uterus removed and dissected in order to remove the embryos. Up to nine 
embryos were collected at each time point, and for every wholemount and in situ 
hybridisation in chapter two, three whole embryos were used for independent 
experimental procedures. Whole mouse embryos for wholemount in situ hybridisation 
were a kind gift from Dr. Heiko Peters at The International Centre for Life at the 
University o f Newcastle, and used as described in Peters et al., 1995, 1999. 
A l l embryos were fixed overnight in 4% paraformaldehyde (w/v) (PFA) in PBS at 4°C. 
Following a brief rinse in Diethyl Pyrocarbonate (DEPC) treated PBS (see appendix A.4. 
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A. 15), embryos were dehydrated through an ethanol series starting at 50% (v/v), 70% 
(v/v), 85% (v/v), 95% (v/v) and finally 100% ethanol, each for 30 minutes at room 
temperature, transferred to Histoclear and stored in a pre-baked glass jar at 4°C. 
2.2.4 Wax embedding and sectioning 
Histoclear was removed from the embryo tissue and replaced with wax, by immersion 
into molten paraffin wax that had been pre-warmed in a 60°C oven, for three, two-hour 
incubations. The embryos were left in the final wax change overnight, at 60°C. 
Paraffin wax was then poured into sterile casts (BDH), and the tissue placed centrally, 
approximately 0.5 cm below the surface, and the wax block submerged immediately into 
cold water, to solidify. 
The paraffin wax blocks containing fixed embryos were oriented into the required plane 
to enable transverse or sagittal sectioning and mounted on a Leitz 152 microtome stage. 
The microtome, bench area and cutting accessories were cleaned thoroughly with 0 .1% 
(v/v) DEPC in 96% (v/v) ethanol to ensure as far as possible that they were RNAse-free. 
7u-tn thick sections were cut using a standard Leitz 152 microtome and allowed to dry 
overnight on pre polysine-treated slides. 
Embedded embryos were either used immediately or stored in sealed plastic bags at 4°C 
until needed. 
2.2.5 Wholemount and in situ hybridisation riboprobes 
Anti-sense and sense, single stranded RNA probes were synthesised for wholemount and 
in situ hybridisation from cDNA clones contained in vectors. The Hoxa-9 sense and anti-
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sense were generated by inserting the fu l l coding sequence (813bp) into a CT-TOPO-
GFP vector in both a sense and anti-sense orientation, therefore using only one promoter 
site. However the other riboprobes (Hoxc-9, vMLC) were synthesised in a Bluescript 
vector, therefore being inserted in a sense orientation and using the two RNA polymerase 
promoter sites to generate both sense and anti-sense probes. The cDNA clones used for 
this purpose are described below: 
(i) The murine Hoxa-9 cDNA clone was generated by PCR and cloned using the 
CT-TOPO-GFP cloning kit (Invitrogen, Paisley Scotland, UK) . 
PCR insert 
<fl Q.W 1 
m c o a x r " 
pcDNA3 
TOPO 
Figure 13 - The CT-TOPO-GFP-o9 vector 
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2.2.6 C T - T O P O - G F P cloning 
This vector, used to generate the Hoxa-9 clone required that the PCR product that was to 
be inserted into the CT-TOPO-GFP directly carried a Kozak sequence at the 5' terminus. 
Therefore, PCR primers were designed to add the ' A C C codon, before the ' A T G ' start 
codon in the insert DNA, shown in sequence appendix, B . l . 
CT-TOPO-GFP acquired the insert by incubating up to 5 fig o f Kozak sequence 
containing PCR product with l u g of the CT-TOPO-GFP vector for five minutes at room 
temperature. After five minutes, l u l o f ' s top ' solution (see A.21) was added to complete 
the reaction. 
2 ul of the CT-TOPO-GFP-DNA mix was added to one shot TOP 10 chemically 
competent E.coli (Invitrogen, #C4040-10) competent cells respectively and stored on ice 
for thirty minutes. 500 u.1 of provided SOC medium was added and incubated on a 
platform shaker for thirty minutes at 37°C. Following incubation, 50-100 u.1 o f mix was 
plated out onto LB agar plates (see appendix A.9) containing 50 ug/ml ampicillin for 
vector ampicillin resistance, and incubated overnight at 37°C. 
ii) Murine Hoxc-9 cDNA clone provided from IMAGE clone consortium 
(#101188). The cDNA clone has been inserted into pBluescript KS+ (Stratagene). 
T7 Promoter 
T A A T A C G A C T C A C T A T A G G G C G A A T T G G A G C T C C A C C G C G G T G G C G G C C G C T C T A G A 
EcoRl 
Hoxc-9 
Wind HI 
A C T A G T G G A T C C C C C G G G C T G C A G G A A T T C G A T A T C A A G C T T A T C G A T A C C G T C G A C 
T3 Promoter 
C T C G A G G G G G G G C C C G G T A C C C A G C T T T T G T T C C C T T T A G T G A G G G T T A A T T G C G C G C 
Figure 14 - The Hoxc-9 - Bluescript KS+ vector The mutliple cloning site o f 
the pBluescript RPMS+ vector, highlighting the points of the Hoxc-9 insertion 
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The Hoxc-9 DNA insert contained the majority of the Hoxc-9 fu l l coding sequence 
(719bp) shown in B.6, and was again sequenced in both directions to ensure there were 
no errors, and confirm orientation. 
Hi) Ventricular Myosin Light Chain2 (vMLC2) was a kind gift from Professor David 
Wilson (University of Southampton). 
T7 Promoter 
A C T A G T G G A T C C C C C G G G C T G C A G G A A T T C G A T A T C A A G C T T A T C G A T A C C G T C G A C 
C T C G A G G G G G G G C C C G G T A C C C A G C T T T T G T T C C C T T T A G T G A G G G T T A A T T G C G C G C 
Figure 15 - The vMLC2 - Bluescript vector - The multiple cloning site of the 
pBluescript K.S+ vector, highlighting the points of the vMLC insertion 
The vMLC2 coding sequence was ligated into Bluescript KS+ (Stratagene), and 
sequenced as shown in B.4. 
iv) Pax-1 was a kind gift from Dr. Heiko Peters, at The Centre of Life in Newcastle-
Upon-Tyne as reported in Peters et al., 1995, 1997. 
In order to control for non-specific staining of a riboprobe, throughout this study, a 
negative control sense strand riboprobe (inverse vector insertion of the gene), that would 
T A A T A C G A C T C A C T A T A G G G C G A A T T G G A G C T C C A C C G C G G T G G C G G C C G C T C T A G A 
Hind III Smu 
vMI.C J 
T3 Promoter 
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not recognise the single strand RNA in the mouse embryo sample, was always hybridised 
under the same conditions as the corresponding anti sense strand. 
2.2.7 Riboprobe production 
Prior to digoxigenin labelling each plasmid had to be linearised by mixing 4 units o f a 
sequence specific enzyme that cuts only at the multiple cloning site, to 1 u.g of plasmid 
DNA, and 5x enzyme buffer in a 50 [i\ total volume mix. This mix was left at 37°C for 
three hours and confirmed by gel electrophoresis. The single stranded RNA probes 
incorporated digoxigenin (DIG)-UTP and were produced by in vitro transcription with T7 
or T3 RNA polymerase (shown in figure 16). The residues are incorporated at 
approximately every 20-25 t h nucleotide of the transcript (Roche, Lewes, East Sussex, 
England). 
Figure 16 - The enzymes used for plasmid linearisation and transcription 
Riboprobe Linearisation enzyme Polymerase used for 
transcription 
CT-TOPO-GFP -Hoxa-9s Pvul T3 
CT-TOFO-GF?-Hoxa-9a Pvul T3 
Bluescript-//o.vc-9.s EcoRl T7 
Bluescript-//axr-9a Hindlll T3 
Bluescript - vMLC2s Smal T7 
Bluescript - vMLC2a Hindlll T3 
s = sense strand a = anti-sense strand 
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1 ug o f linearised plasmid was added to a DIG labelling mix following the manufacturers 
instructions. Briefly, the linearised plasmid was mixed with 2 \x\ lOx DIG RNA labelling 
mix, 2 fj.1 lOx transcription buffer, lunit of respective polymerase (figure 16). The mix 
was left for two hours at 37°C and treated with lunit DNAse 1 (Promega) at 37°C for 
fifteen minutes. A 5 u.1 sample of the reaction was run on a 1% agarose gel to confirm 
labelling. The labelled probe was stored under lOOul 100% ethanol at -20°C. When 
needed, the probe could be diluted to a concentration of 0.1 ng/fj.1 using DEPC water. 
2.2.8 Testing probe labelling - Dot/Southern blot analysis 
Dot blot analysis was carried out in order to test whether the riboprobe had been labelled 
efficiently. 
Riboprobe vector, as described using the CT-TOPO-GFP-//o;ca-9 was linearised as 
described and a range of concentrations from 100 pg of linearised vector to 1 pg, and 1 ul 
of the vector was dotted onto a positively charged nylon membrane and allowed to air-
dry. 
The blot was then denatured by immersion in a denaturing buffer (see appendix A.2) for 
10 minutes, followed by a neutralisation step for a further ten minutes (see appendix 
A. 12). After air-drying the blot, the DNA was fixed by being exposed to a 
transilluminator ultra violet light (366nm) for three minutes. Pre-hybridisation of the blot 
was carried out by immersion in hybridisation buffer (Clontech, Basingstoke, Hampshire, 
England) for thirty minutes at 37°C. lOOng of labelled probe was added to 5ml of fresh 
hybridisation buffer, and the filter was incubated in a hybridisation oven, under constant 
agitation for one hour at 37°C. 
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Stringency washes were carried out at room temperature initially in wash solution 1 (see 
appendix A.22) twice for five minutes each wash, and then twice in wash solution 2 (see 
appendix A.23) at the hybridisation temperature for five minutes. 
After being rinsed in maleic acid buffer (see appendix A . l 1), non-specific binding was 
blocked by incubating for thirty minutes at room temperature in l x blocking solution (see 
appendix A . l ) . Anti-DIG alkaline phosphatase antibody (Roche, Lewes, East Sussex, 
England) was added at a dilution of 1:5000 in l x blocking solution and the blot was 
incubated at room temperature for a further 30 minutes. 
A further two fifteen minute washes with maleic acid buffer at room temperature 
followed, and then a brief rinse in detection buffer (see appendix A.3). A dilute colour 
solution of 0.4mg NBT (nitro blue tetrazolium) and 0.175 mg BC1P (5-bromo-4-chloro-
inodyl-phosphate) (both from a 50 mg/ml stock in 70% and 100% dimethylformamide 
respectively) was added to the detection buffer and then incubated with the blot in the 
dark, until development was sufficient. 
The blot was either stored in 50 ml Tris-EDTA buffer (TE buffer) (see appendix A.20), 
until being dried at room temperature on filter paper, or on occasions the blot was re-
probed by submersion in 100% dimethylformamide for twenty minutes at room 
temperature to strip the DIG colour stain from the blot, and then rinsed briefly in TE 
buffer, before being re-submerged in hybridisation buffer. 
2.2.9 In situ hybridisation 
Al l glassware was baked overnight to ensure minimal RNAse activity. 
A l l the solutions were made up fresh and used on the day, except where directed. 
51 
Three independent sets of wholemount and in situ hybridisation results were generated 
for each set of results shown in figures 18-32. 
To remove the paraffin wax, the sections prepared as described in 2.2.4 were placed in 
Histoclear for ten minutes at room temperature, followed by seven, five minute 
rehydration step series through methanol starting with two immersions in 100% methanol 
followed by 90% (v/v), 70% (v/v), 50% (v/v) methanol and finally into PBS twice. 
Sections were bleached in a final concentration of 6% (v/v) hydrogen peroxide in PBT 
(PBS + 10% (v/v) tween 20) for one hour at room temperature, followed by three PBT 
washes. 
In order to increase the accessibility of target RNA, the sections were incubated in 
lOmg/ml proteinase K in PBT for fifteen minutes at room temperature. 
Sections were washed for five minutes in PBT and post fixed in 0.2% (v/v) 
glutaraldehyde in 4% (w/v) paraformaldehyde (in PBS) for twenty minutes at room 
temperature, and then rinsed in two, five minute washes o f PBS. The sections were then 
dehydrated for five minutes each in 25% (v/v) methanol, 50% (v/v) methanol, 75% (v/v) 
methanol, and finally immersed into 100% methanol, and then allowed to air dry. 
A specific concentration (see figure 17) of labelled probe as determined by dot blot 
analysis, was diluted in hybridisation buffer to make a final volume of 100 u.1 (see 
appendix A.6). For each slide 100 fj.1 of diluted probe was placed in a 'sureseal' cover 
slip (BDH) and incubated overnight in a moist chamber at the indicated hybridisation 
temperature. 
The sections, were then given two washes o f thirty minutes in ' /« situ' solution 1 (see 
appendix A.7), twice, for thirty minutes at the indicated washing temperature, followed 
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by three thirty-minute washes in 'in-situ' solution 2 (see appendix A.8) at the same 
temperature. Sections were then washed twice for ten minutes in TBST (see appendix 
A. 19), and a further wash in TBST with the addition o f 30mM levamisole for thirty 
minutes to minimise any background alkaline phosphatase activity. 
Meanwhile 6mg embryo or heart powder, produced as described in 2.2.11, was heated to 
65-70°C for one hour in tml TBST to deactivate any residual complement activity. Anti 
DIG was diluted 1:5000 in 5% (v/v) lamb serum (in PBS) and added to the embryo or 
heart powder, and agitated for one hour at 4°C. The reaction mix was centrifuged at 
4000g (Sigma 2-15) for two minutes at room temperature. 1ml o f the resulting 
supernatant was added to a further 1ml o f lamb serum. This mixture was further added to 
98 ml TBST and the sections were left overnight at 4°C. 
Vector Hybridisation 
Temperature 
Stringency Wash 
Temperature (°C) 
Amount of labelled 
probe added for 
(°C) hybridisation 
Hoxa-9 55 50 300 ng 
Hoxc-9 63 60 500 ng 
VMLC2 65 60 300 ng 
Pax-l 70 70 100 ng 
Figure 17 - to show the hybridisation and stringency wash temperatures 
for the wholemount and in situ hybridisation sense and anti sense 
riboprobes. 
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Sections were washed three times for twenty minutes in PBT, followed by three thirty 
minute washes in N T M T (see appendix A. 14) containing 2 m M levamisole. 
Sections were then placed in a moist chamber in the dark, and a colour substrate of 
0.4 mg NBT and 0.175 mg BCIP were added to 1ml N T M T , until the desired colour 
intensity had developed. 
The sections were then viewed using a bright field microscope, mounted, and 
photographs taken using bright field microscopy and the 'SPOT' image capture unit, and 
'SPOT RT software version 3.0, Diagnostic Instruments Incorporated'. 
2.2.10 Wholemount in situ hybridisation of mouse embryos 
Embryos were collected as in 2.2.3 and were prepared for wholemount in situ 
hybridisation by puncturing the amnion (E8) or myencephalon (E9 and older) using a 
sterile needle. This procedure has been previously shown to improve probe penetration 
and reduce non-specific stain trapping (reviewed Wilkinson 1992). Subsequent 
procedures were carried out with embryos resting in small sieves (Costar netwell inserts). 
Washes and hybridisation steps were carried out in twelve well plates ( I W A K I , Paisley, 
Scotland). Embryos were fixed overnight at 4°C, in 4% (w/v) PFA in DEPC treated PBS 
(see appendix A.4, A. 15). Following fixing, the embryos were washed in PBT (see 
appendix A. 16) at 4°C for five minutes, and dehydrated through a methanol series in 
lxPBT starting with 25% (v/v), 50% (v/v), 75% (v/v), followed by two 100% methanol 
immersions. Each dehydration step was carried out for five minutes each at room 
temperature. I f necessary, the embryos could be stored in the final methanol step at -20°C 
for up to four weeks. 
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The embryos were rehydrated at room temperature for five minutes each down a 
methanol series starting with 75% (v/v) in PBS, 50% (v/v), 25% (v/v) into a final PBS 
and then rinsed in PBT for five minutes. They were then bleached in 6% (v/v) hydrogen 
peroxide in lxPBT for one hour at room temperature, followed by three, five minute 
washes in lx PBT. To increase RNA accessibility, embryos were incubated in proteinase 
K (10p.g/ml) in PBT for fifteen minutes at room temperature, and then rinsed in 2mg/ml 
glycine in PBT, followed by a PBT wash for five minutes. 
Embryos were re-fixed in 2% (v/v) glutaraldehyde in 4% (w/v) paraformaldehyde in PBT 
for twenty minutes at room temperature, and rinsed in lxPBT. 
Labelled riboprobe was added at the desired concentration (see figure 17), to the 
wholemount hybridisation solution (see appendix A.24), and the embryos left to 
hybridise overnight. Evaporation was suppressed by an overlay of mineral oil being 
added on top of the embryos during hybridisation. 
After hybridisation embryos were washed twice at 70°C for thirty minutes in a pre 
warmed, wholemount post hybridisation washing solution 1 (see appendix A.25), 
followed by three, five minute washes at room temperature, in wholemount post wash 
solution 2, (see appendix A.26), diluted at 50:50 in the previous wholemount post wash 
solution 1. lOOug/ml RNAseA was then added to the final post wash solution 2 and the 
embryos were incubated for a further thirty minutes, at 37°C. 
This procedure was followed by a rinse in wholemount post wash solution 3 (see 
appendix A.27) for five minutes, and a further thirty minutes in fresh wash solution 3 at 
65°C. 
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Embryos were washed three times for five minutes each in TBST (see appendix A. 19) A 
pre-blocking stage followed, in which the embryos were incubated for 150 minutes at 
room temperature in 10% (v/v) sheep serum in lxTBST. 
Meanwhile 3 mg of embryo powder (see method 2.22) was incubated for thirty minutes 
at 70°C in 0.5ml TBST. The solution was cooled on ice and Anti DIG alkaline 
phosphatase antibody added to a dilution of 1:5000. The solution was agitated on a 
shaker platform for one hour at 4°C, and then centrifuged at 3000g (Sigma 2-15) for two 
minutes at room temperature. The supernatant was collected and added to a 10% sheep 
serum solution in TBST, and the embryos were incubated overnight at 4°C in this 
antibody solution. 
After the overnight incubation, the embryos were then subjected to a wash series in 
TBST at room temperature: three washes of five minutes each, followed by five washes 
of sixty minutes each. The tissue was then given three washes o f ten minutes each in 
N T M T (see appendix A. 14). 
Embryos were then placed in a freshly made colour substrate o f 0.4 mg NBT and 0.175 
mg BCIP in 1ml TBST, and kept in the dark until the colour had developed. Once this 
was reached the embryos were washed in N T M T for ten minutes and post-fixed in 4% 
(w/v) paraformaldehyde in PBS and 0 .1% (v/v) glutaraldehyde for one hour at room 
temperature. 
The embryos were then taken through a glycerol series (50%, 70%, 80% and 100%) (v/v 
with PBS) for five minutes for bright field microscopy and photography using the SPOT 
image capture unit, and the 'SPOT RT software version 3, Diagnostic Instruments, 
Incorporated'. 
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2.2.11 Preparation of embryo and heart powder 
To reduce non-specific binding of Anti-DIG alkaline phosphatase, it was pre-absorbed 
with powder prepared from the target tissue : adult heart or embryo. 
To prepare the powder, either ten E13 embryos were collected in PBS as described in 
previous sections (2.2.3), or three hearts from adult mice previously perfused with 4% 
(w/v) PFA (courtesy of Dr. Chris Thompson) were used. 
A l l glassware and instruments were baked overnight to ensure minimal RNAse activity. 
The tissues were snap frozen by immersion in liquid nitrogen ground down by pestle and 
mortar. Nitrogen was allowed to evaporate and the resulting ground material suspended 
in 20 ml ice cold acetone, and left on ice for thirty minutes. 
The samples were then centrifuged at 3000g (Sigma 2-15) for ten minutes at room 
temperature, and the supernatant removed. 
The pellet was resuspended in I ml cold acetone and re-centrifuged as before for 2 
minutes. The supernatant was again removed and the pellet collected and left to air-dry 
under sterile conditions. 
Once dry, the pellet was loosened, and could be transferred into a sterile container, and 
stored at 4°C until needed. 
2.2.12 Dot blot analysis 
The dot blot analysis to test the specificity of the riboprobes was carried out by dotting 
100 pg of linearised vector (both Hoxc-9 and Hoxa-9) onto positively charged nylon filter 
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paper and allowing to air dry before being fixed by exposure to a transilluminator ultra 
violet light (366nm) for three minutes. The blot was further treated as in 2.2.8. 
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2.3 Results 
In order to better understand the function o f Hoxa-9 in normal development, the 
expression pattern o f this gene in the early mouse embryo was assessed using 
wholemount and conventional in situ hybridisation. A wholemount approach was used in 
those developmental stages where both size was small enough for effective probe 
penetration, and where numbers o f specimens were not l imiting. Conventional in situ 
hybridisation was used for all other stages. The first test in a complex procedure, such as 
in situ hybridisation, is to confirm that all steps are functioning. To address this, 
wholemount in situ hybridisation was used to assess the expression o f Pax-1, a gene 
whose expression profile has previously been well characterised was used. 
2.3.1 Wholemount in situ hybridisation using Pax-1 
Pax-1 riboprobe was hybridised to whole El0.5 mouse embryos (figure 18). In three 
independent experiments, expression was found in the segment boundaries o f the 
developing sclerotomes and mesenchyme tissue o f the developing brachial arch, a result 
in clear agreement wi th previously published reports (Peters et al, 1995, 1999). This data 
suggested that the technique was functioning correctly. The expression o f Hoxa-9 could 
now be examined. 
A 
400 urn 
Figure 18 - A In situ hybridisation of Pax-1 on E10 
mouse embryo (/) indicates developing 
sclerotomes, ( i f ) indictaes the brachial arches. 5 9 
2.3.2 Wholemount in situ hybridisation control riboprobes 
In order to be confident that results seen by in situ hybridisation for Hoxa-9 were 
transcript-specific, and not due to non-specific binding o f probes, groups of embryos 
from each stage under examination were subjected to two parallel, but discrete 
hybridisations. A control hybridisation, using a 'sense' probe which would not hybridise 
to the target transcript and therefore acts as a control for non-specific binding, and a 
hybridisation with 'anti-sense' probe, complementary to the mRNA transcript under 
study. Comparison between this pair allows interpretation of specific hybridisation, and 
thus for every embryonic stage, results are shown for both specific (anti-sense) and 
control (sense) hybridisation. In each case at least three embryos were used for both sense 
and anti-sense hybridisations. 
The Hox gene family are highly conserved, and share substantial sequence similarity (see 
figure 1). The risk therefore is that riboprobes derived from one family member, such as 
Hoxa-9, could hybridise to another family member, particularly one that shares the 
highest homology (a paralogue), such as Hoxc-9. Hoxa-9 and Hoxc-9 share more than 
98% homology, and show some regions that are close to 100% homology (figure 19). I f it 
were possible to use Hoxa-9 riboprobe hybridisation conditions that discriminated 
between Hoxa-9 and Hoxc-9 targets then this would give greater confidence in the 
specific nature of hybridisations seen using in situ techniques. 
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Figure 19 - H G M P sequence pile up to show the sequence between Hoxa-9 
(GI#3080547), and Hoxc-9 (GI#4059801), the sequence prior to that shown shares 
100% homology. The numbers correspond to the base pair number in the sequence 
used by GENBANK. 
Dot blot analysis was carried out to further confirm the specificity o f the Hoxa-9 
riboprobe (figure 20). In this experiment 100 pg of respective Hoxa-9 and Hoxc-9 
plasmids were hybridised independently with both Hoxa-9 and Hoxc-9 anti sense and 
sense riboprobes under identical hybridisation conditions as used for previous 
experiments. It appeared that the Hoxa-9 riboprobe only recognised the Hoxa-9 targets 
(both dsDNA sense and anti sense), whilst Hoxc-9 failed to recognise Hoxa-9, and was 
only detected when bound to Hoxc-9 targets. This series of experiments confirmed the 
riboprobe specificity, and showed that cross hybridisation was not an issue in this study. 
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Hoxa-9 anti-sense ds plasmid 
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Hoxa-9 sense ds plasmid -
Hoxc-9 anti-sense ds plasmid 
Hoxc-9 sense ds plasmid • m 
Figure 20 - Dot blot analysis of riboprobe specificity 
2.3.3 E7.5 Wholemount in situ hybridisation 
As haematopoiesis can first be detected around E8 the earliest embryo studied was E7.5. 
The results f rom the control Hoxa-9 sense and anti-sense riboprobe are shown in figure 
21. 
The control hybridisation shows no detectable staining. I n contrast the respective 
wholemount in situ hybridisation using Hoxa-9 anti-sense shows a widespread staining 
pattern in all three germ layers. 
2.3.4 E 9 In situ hybridisation 
The widespread expression pattern seen at E7.5 is also shown in the developing E9 
mouse (figure 22). There was no obvious tissue patterning, but this hybridisation was 
specific shown by the sense strand hybridisation that showed undetectable levels o f 
background staining. 
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Figure 21 - Wholemount in situ hybridisation of Hoxa-9 at E7.5 
A - Wholemount in situ hybridisation o f sense Hoxa-9 
B - Wholemount in situ hybridisation o f anti sense Hoxa-9 embryos 
C - Illustration o f the extraembryonic tissue (1), ectoderm tissue(2), exocoelomic tissue (3), 
and amniotic tissue (4) shown in B 
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Figure 22 - In situ hybridisation of Hoxa-9 at E 9 
A - Sagittal section taken through the centre o f the E9 mouse embryo 
B - In situ hybridisation o f sense Hoxa-9 
C- In situ hybridisation o f anti sense Hoxa-9 
2.3.5 E9.5 Wholemount in situ hybridisation 
Control sense riboprobe hybridisation with whole E9.5 mouse embryos showed some 
non-specific staining in the head region (figure 23), a result consistent with stain trapping 
following insufficient cerebral puncture (Wilkinson, 1992). In contrast, anti-sense 
hybridisation showed clear and reproducible staining in the heart atrium (/), the first 
brachial arch (ii), and the gut region (Hi) (figure 23). Close examination of the cardiac 
region suggested that this expression did not extend to the ventricle or surrounding 
cavities. Expression of Hoxa-9 was also found in vertebrae and the developing gut at this 
stage of development. 
2.3.6 E10.5 Wholemount in situ hybridisation 
El0.5 embryos showed a specific hybridisation pattern that was very similar to that seen 
at E9.5 (figure 24). Expression was observed in the cardiac atrium, the gut and vertebrae. 
However, In contrast to E9.5, expression was also observed in the outflow tract. 
Expression of Hoxa-9 was not observed in structures adjacent to these tissues. 
2.3.7 E l l In situ hybridisation 
Control hybridisation of E l l embryos with sense Hoxa-9 riboprobe demonstrated 
negligible non-specific staining. However, in marked contrast with hybridisations in 
embryos at E9-10.5, apparently widespread hybridisation with anti-sense probe was seen 
(figure 25). 
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Figure 23 - Wholemount in situ hybridisation of Hoxa-9 at E9.5 
A - Wholemount in situ hybridisation of sense Hoxa-9 
B - Wholemount in situ hybridisation of anti-sense Hoxa-9 
C, D - Illustration of the heart atrium (i), the first brachial arch (ii), and the gut 
region (Hi) shown expressing in B 
E - Wholemount in situ hybridisation of anti-sense Hoxa-9 showing expression 
in the atrial (/') region and undetectable levels in the ventricle (ii) 
F - Wholemount in situ hybridisation of anti-sense Hoxa-9 showing stain 
trapping in the head region 
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Figure 24 - Wholemount in situ hybridisation of anti-sense Hoxa-9 at E10.5 
A - Hoxa-9 expression seen in the anatomical areas of the heart atrium (z), 
the gut region (z'z), and the notochord (in). 
B, C, D - Hoxa-9 expression detected in the atrial region (z) 
Close examination of the staining pattern did however identify some distinction in the 
staining of different tissues. In particular, a consistent, intense Hoxa-9 expression pattern 
at the liver/heart boundary (atrial septum). However, in marked contrast to hybridisation 
with embryos staged only 0.5 days earlier (figure24), there appeared to be little difference 
in staining between the cardiac atrial, ventricular and vascular tissues. Although this 
pattern was reproducible (as with all hybridisation experiments described here, three 
embryos were independently examined), this remarkable change in apparent expression 
profile demanded the study of additional controls. 
To confirm that in situ hybridisation could discriminate expression of the cardiac genes in 
these embryos, riboprobes specific for vMLC were produced and used in this technique. 
The cardiac-specific expression of this gene has been previously well characterised. 
2.3.7.1 Detection of cardiac expression of genes at E l l 
To examine the RNA quality of E l l embryos, riboprobes specific for known ventricular 
marker gene (vMLC) were hybridised with E l l mouse embryos under conditions 
identical to those used for Hoxa-9 hybridisations described above (figure 26). Control 
sense strand vMLC riboprobe produced a detectable background staining. However it was 
possible to distinguish this from the cardiac specific hybridisation seen with anti-sense 
riboprobe hybridisation (figure 26). This suggested that at least ventricular RNA in these 
embryos was of sufficient quality to detect specific levels of gene expression seen with 
vMLC. However, the high level of background staining seen with anti-sense probes for 
this cardiac-specific gene in these embryo stages suggests that the widespread staining 
seen with the Hoxa-9 anti-sense riboprobe is not necessarily due to specific transcript 
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Figure 25 - In situ hybridisation of Hoxa-9 at E l l 
A - Sagittal section taken through the centre of the E l 1 mouse embryo 
B - In situ hybridisation of sense Hoxa-9 
C - In situ hybridisation of anti sense Hoxa-9. Illustrated are the 
developing liver region (/') and the gut (/'/) 
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Figure 26 - In situ hybridisation of vMLC at E l l 
A - Sagittal section taken through the centre of the E l 1 mouse embryo 
B - In situ hybridisation of sense vMLC 
C - In situ hybridisation of anti-sense vMLC , the arrow illustrates expressing 
ventricle of the heart 
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hybridisation but may reflect other, non-specific effects, such as may be caused by 
preparation of embryos at this time point. 
2.3.8 E12 In situ hybridisation 
The areas that had previously been expressing high levels of Hoxa-9 at E9.5 and El0.5 
include the gut and atrial region. At El2, there appeared to be a high level of expression 
not only in the heart atrium as at E9.5-10.5, but also in the developing ventricle (figure 
27). 
Non-specific binding, also seen in the sense strand hybridisations include tissue dense 
and ductal areas in which the stain is trapped in the deep cavities, potentially due to 
insufficient washing (Wilkinson, 1992). 
2.3.9 E13 In situ hybridisation 
At El3, specific Hoxa-9 expression became undetectable. The sections hybridised with 
the sense strand Hoxa-9 were clean and very similar in staining intensity to anti-sense 
hybridisations (figure 28). 
As these undetectable levels by the anti sense strand have not been seen previous in this 
study, the RNA quality of E l 3 sections was tested as before. 
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Figure 27-In situ hybridisation of Hoxa-9 at E12 
A - Sagittal section taken through the centre of the E l 2 mouse embryo 
B - In situ hybridisation of sense Hoxa-9 
C , D - In situ hybridisation of anti-sense Hoxa-9, D highlights the heart 
atrium (i), the heart ventricle (ii) expressing in C 
E - In situ hybridisation of anti-sense Hoxa-9, x illustrates some ductal 
areas of non-specific binding 
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Figure 28 - In situ hybridisation of Hoxa-9 at E13 
A - Sagittal section taken through the centre of the E l 3 mouse embryo 
B - In situ hybridisation of sense Hoxa-9 
C - In situ hybridisation of anti-sense Hoxa-9 
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2.3.9.1 Detection of cardiac expression of genes at E13 
Compared with the sense strand control, the anti sense hybridisation with vMLC showed 
intense specific staining of the ventricle (figure 29). This suggests that the RNA quality 
of embryo sections at this stage was at least good enough to detect expression levels seen 
with this gene. 
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Figure29 - In situ hybridisation of vMLC at E13 
A - In situ hybridisation of sense Hoxa-9 B - In situ hybridisation of anti-sense Hoxa-9 
The arrows indicate the ventricular area 
2.3.10 E13 In situ hybridisation using Hoxc-9 riboprobe 
The undetectable staining using the Hoxc-9 sense strand (figure 30), can be seen in clear 
comparison with the widespread expression patterns produced from hybridising with the Hoxc-9 
anti sense strand, and shows a different pattern from hybridistaion using Hoxa-9 anti-sense at this 
time point (figure 28), demonstrating further the specificity of the Hoxa-9 riboprobe. 
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Figure 30 - In situ hybridisation of Hoxc-9 at E13 
A - In situ hybridisation of sense Hoxc-9 B - In situ hybridisation of anti-sense Hoxc-9 
2.3.11 In situ hybridisation of the adult murine heart 
By El3, the major morphological changes associated with heart development in the 
mouse are largely complete. However gene expression in the fully formed adult heart 
needs to be examined. Hybridisation with Hoxa-9 anti-sense riboprobe was unable to 
demonstrate detectable staining in the adult heart; indeed this result was indistinguishable 
from the sense control (figure 31). Although a reproducible result, one possibility is that 
RNA quality in this tissue was insufficient for successful hybridisation. In order to test 
this, adult heart sections were tested for hybridisation with sense and anti-sense 
riboprobes for vMLC. 
The ventricle of the adult heart stained very quickly with undetectable levels in the 
adjacent atrium as expected (figure 32), suggesting at least that RNA quality was 
sufficient for the detection of cardiac genes expressed at least at the level of this gene. 
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Figure 31 - Sagittal section in situ hybridisation of Hoxa-9 in the murine adult heart 
A - In situ hybridisation of sense Hoxa-9 B - In situ hybridisation of anti-sense Hoxa-9 
m 
2000 um 
Heart 
Ventricle 
2000 um 
Figure 32 - Sagittal section in situ hybridisation of vMLC in the murine adult heart 
A - In situ hybridisation of sense Hoxa-9 B - In situ hybridisation of anti-sense Hoxa-9 
The heart ventricle is shown to be expressing 
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2.4 Discussion 
It has been intended in this study to combine the successful techniques of in situ and 
wholemount hybridisation as seen in previous work, to analyse the expression pattern of 
Hoxa-9 during embryonic mouse development to further investigate the role of Hoxa-9 
during normal developmental processes, including haematopoiesis. A previously 
unreported Hoxa-9 expression pattern was identified from this study using such 
techniques in the developing heart of the mouse embryo. In this discussion, previous 
Hoxa-9 expression studies will be analysed, along with how the findings in this study 
may potentially implicate embryonic heart development. 
2.4.1 The expression pattern of Hoxa-9 in the developing mouse embryo 
The mouse Hoxa-9 gene is the most 3' located gene amongst the whole set of Hox a 
genes phylogenetically related to Drosophila Abdominal B (Adb-B) homeotic gene 
(Rubin et ah, 1987), which control the development of mid to posterior parasegments in 
the insect. 
Previous work using in situ hybridisation and other techniques has revealed that during 
the midgestational mouse embryo, the gene is expressed along the primary body axis, 
including the spinal cord and prevertebral column, and limb buds (Duboule and Dolle, 
1989, Chisaka & Capecchi 1991, James and Kazenwadel, 1991, Fromental-Ramain et ah, 
1996, Sekimoto et al, 1998, Shin et al., 1998). The in situ hybridisation studies used in 
previous studies supported expression patterns shown by this study at E9.5 and El0.5 
(James and Kazenwadel, 1991, Sekimoto et al., 1998, Shin et al., 1998), however, this 
study also identified additional expression in the developing heart and vasculature. 
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2.4.1.1 Hoxa-9 expression in the E7.5 mouse embryo; 
Previous in situ hybridisation studies have shown high expression levels of Hoxa-9 in all 
three germ layers of the murine embryo (ectoderm, endoderm and mesoderm) at E7.5, as 
well as in extraembryonic tissues including the amnion and ectoplacental cone, shown in 
figure 35 (Shin et al, 1998). 
Using similar wholemount in situ hybridisation in this study, supporting evidence has 
been shown that Hoxa-9 has a widespread expression pattern in the mouse embryo at 
E7.5 (Shin et al., 1998). As previously mentioned, it is at this time point when 
haematopoiesis is initiated in the blood islands of the yolk sac (Moore and Metcalfe, 
1972), but on a ful l 360° examination of wholemount embryos, there did not appear to be 
intense levels of expression at the cellular level in this extraembryonic tissue. 
The presence of Hoxa-9 transcripts at E7.5, although widespread, suggested a potential 
role during early development of the mouse. It therefore became important to study any 
I 
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Figure 34 Hoxa-9 expression at E7.5 in the 
mouse embryo 
Hoxa-9 is highly expressed in all three germ layers, 
Including extra embryonic tissue in the mouse 
embryo (Shin et. al. 1998). 
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changes in expression pattern during the next stage of development (E8.5), at a time point 
when primitive erythroid progenitor cells begin to circulate from the yolk sac and the rest 
of the embryo (see figure 6). 
2.4.1.2 Hoxa-9 expression in the E9 mouse embryo; 
This widespread patterning continued in E9 embryos in this study, with similar findings 
to that from published reports demonstrated in figure 35 (Shin et al., 1998). 
Gene knockout data by Fromental-Ramain suggested that at this stage in the developing 
embryo, expression was seen to the somites and developing limbs (Fromental-Ramain et 
ah, 1996). To some extent, this current study has shown expression in those areas, but 
there was also a high degree of expression outside these areas. These differences in data 
could be due to the different approaches and techniques used in the two studies, and the 
report regarding Hoxa-9 knockouts was incomplete (Fromental-Ramain et al., 1996). 
Although there was no distinct Hoxa-9 expression seen in embryonic sites of 
haematopoiesis, there was some positive expression identified during critical stages of 
early development. These widespread expression findings of Hoxa-9 in this study largely 
support that of other reports and therefore suggested that expression should be further 
studied. 
80 
J s \ \ // ' • A 
' ! \ Figure 35 Hoxa-9 expression at E 9 in the 
/ / / >' ' ! 
([< ; ' -
/ ( mouse embryo 
/ ' ' ' 'i / Hoxa-9 expression continues to be widespread 
i ' // / within embryonic endoderm, ectoderm and 
/ 1 V / 
1 11 \ f f 
* s I 
/ mesoderm at E8.5 as well as in extra- embryonic 
\ / ' ; / A / tissues including the amnion and ectoplacental 
\ t I cone (Shine/, al. 19981 
2.4.1.3 E9.5 wholemount in situ hybridisation in the mouse embryo 
Previous Hoxa-9 in situ hybridisation studies showed expression in the developing gut at 
E9.5 (James and Kazenwadel, 1991, Sekimoto et al., 1998) (figure 35) and data presented 
here supports this finding. 
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Figure 36 Hoxa-9 expression at E9.5 in the 
mouse embryo 
Hoxa-9 expression is found in the thoracic vertebrate (v) 
(Sekimoto et. al. 1998). 
Expression is also found in the visceral mesoderm in the 
developing gut (DG), (James and Kazenwadel, 1991 and 
Sekimoto et. al. 1998) 
and the neural tube (NT) (Shin et. al. 1998). 
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However, in addition to these regions, there was specific Hoxa-9 expression detected in 
the developing wall o f the heart atria and the vasculature. This expression pattern was 
restricted to the atria in contrast to the adjacent ventricle that showed undetectable levels. 
There are considerable differences between the expression pattern seen in E9 using in situ 
hybridisation, and E9.5 using wholemount hybridisation. However, this difference was 
noted in two other independent experiments. As only in situ hybridisation was carried out 
at E9, detecting expression in the posterior region o f the developing heart vessel prior to 
this looped state of the heart at E9.5, was not carried out. 
It is at E9.5 that the foetal liver and aorta-gonad-mesonephros (AGM) regions became 
primary sites for producing haematopoietic precursors including committed B-cells, 
monomyelocytic cells and erythroid progenitors. (Medvinsky et al., 1993, Muller et al., 
1994). However, at the level of analysis adopted in this study, expression in these areas 
was not detected. 
2.4.1.4 Stain trapping in the whole mouse embryo 
Stain trapping results from insufficient puncturing of the embryo prior to the wholemount 
procedure, and is characterised by a concentration of stain colour in cavity areas 
(Wilkinson, 1992). There was evidence in this study of stain trapping in the head of the 
E9.5 embryo, as the cavities of the developing eye and ear were also heavily stained like 
the surrounding head region. 
When these wholemount embryo was sectioned coronally, the staining diffused out from 
the head region but remained in the positively expressing areas - the gut, heart atrium and 
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vertebrae (data not shown), eliminating the speculation of stain trapping occurring in the 
heart. 
2.4.1.5 E10.5 wholemount in situ hybridisation in the mouse embryo 
This high levels of expression in the atrium of the developing heart continued into El 0.5, 
and became more obvious in the outflow vasculature. There were no published in situ or 
wholemount studies to compare these findings with, and it therefore seemed important to 
continue our investigation further in development. 
At this time, the gut also continued to express Hoxa-9 and although difficult without 
coronal sectioning o f this embryo, there was possible expression in the developing 
notochord lying below the neural tube. 
At El 0.5, the continued expression of Hoxa-9 in the developing heart suggested that the 
patterning should be studied further in El 1 mouse embryos. 
2.4.1.6 E l l In situ hybridisation in the mouse embryos 
Due to the larger size o f E l l embryos, probe penetration becomes more difficult 
(Wilkinson, 1992) and therefore for E l l mouse embryos onwards, the technique was 
switched to using conventional in situ hybridisation techniques in sectioned material 
using the same Hoxa-9 riboprobe. 
The staining pattern once again became widespread at E l l , but with consistent 
expression in the boundary between the liver and the heart (atrial-septum) o f the embryo, 
also seen in duplicate E l 1 embryos (data not shown). 
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It could be suggested that this E l 1 stage could be an 'intermediate' between the high 
levels of specific expression in the developing heart (gut, and vertebrae) at E9.5 and 
E10.5, and the more specific patterning seen at E12. 
2.4.1.6.1 Testing RNA quality in the E l l mouse embryo 
To eliminate the poor quality of RNA causing non-specific binding in the E l l mouse 
embryo, the embryo was hybridised with a known ventricular marker - ventricular 
myosin light chain (yMLC) under identical conditions. The clear ventricular expression 
suggested sufficient RNA quality for the Hoxa-9 riboprobe to bind to in the E l l in situ 
sections. 
The expression found in this in situ and wholemount hybridisation study o f Hoxa-9 in the 
developing mouse embryo showed initial wide spread expression at E7.5 with specific 
distinct patterning in the heart atrium wall at E9.5 and El0.5, followed by widespread 
patterning at E l l . The reasons for this change in patterning are unclear, and require 
further investigation by studying the expression at E l2 . 
2.4.1.7 E12 in situ hybridisation in the mouse embryo 
The in situ hybridisation with the Hoxa-9 riboprobe on E12 mouse embryos highlighted 
several areas o f interest. Firstly the similar areas o f staining that were seen in both the 
sense strand control and the anti-sense strand were eliminated. These were tissue dense 
ductal areas and cavities including the peritoneal cavity, which trap the stain following 
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insufficient washing (Wilkinson, 1992) and were discarded as positive Hoxa-9 expressing 
areas. 
It has been demonstrated that in E l 2 embryos hybridised with anti sense Hoxa-9 there 
was specific expression in the atrium of the heart as seen before in days E9.5 and 10.5, 
this expression pattern had continued into the heart ventricle by E l 2 , wi th an intermediate 
widespread expression at E l 1. 
Previous in situ and wholemount hybridisation studies on Hoxa-9 did not report this same 
expression pattern in the developing embryonic heart (figure 37), and this encouraged 
this study to look further into this atrial expression during later stages o f development. 
0 DG 
Figure 37 Hoxa-9 expression at E12 in the 
mouse embryo 
Hoxa-9 expression can be found on the rostral border 
Between the ileum and the caecum ( IL) 
(Sekimoto et. al. 1998). 
Expression can also be seen in the spinal cord (SC), 
the heart (H), Liver (Li ) , kidney (K) , forelimb (FL), 
and hindlimb bud (HL) , and the dorsal root ganglia (DG) 
(Shine/, al. 1998) 
85 
2.4.1.8 E13 in situ hybridisation in the mouse embryo 
By El 3 the structural development of the heart is almost complete. It could be suggested 
that the undetectable levels of Hoxa-9 seen by in situ hybridisation in this thesis at E l3 
are due to this gene no longer being required during cardiogenesis. 
By E14 haematopoiesis has shifted to the foetal spleen, but continues in the liver, in 
preparation for the bone marrow taking over as the primary site o f production for 
adulthood. Again, using the methods adopted to this study, expression levels at these 
anatomical sites were undetectable. Hoxa-9 expression was also undetectable in the adult 
murine heart, suggesting a more embryonic role for Hoxa-9. However there is evidence 
from other studies for Hoxa-9 in adult cell tissues (Fromental-Ramain et al., 1996, Taylor 
etal, 1997, Chen and Capechhi, 1999).. 
In order to understand the apparent spatial and temporal expression of Hoxa-9 in the 
developing heart, it is important to recognise how the heart is forming during these 
developmental stages. 
2.4.2 Formation of the developing heart 
The heart is the first organ to form in vertebrates, and it arises through a series o f 
complex interactions involving cells from several embryonic origins. Figures 38-44 
illustrate cellular events involved in the formation of the multi-chambered heart. 
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Data presented here suggests specific Hoxa-9 expression shows a temporal and spatial 
pattern over critical time points of heart formation. Cardiac cell commitment and lineage 
differentiation begins during early gastrulation, in response to peptide growth factor 
signals from adjacent endoderm, which include BMP2 and 4 (Schulthesis et al. 1995, 
1997), Fibroblast Growth Factor (Lough et al., 1996) and Activin ( Ladd et al., 1998) 
(reviewed by Schwartz & Olson 1999). In response to growth factor stimulation, the 
paired regions of the anterior lateral mesoderm develop into parallel cardiac primordia, 
which in turn fuse, forming the heart tube in the ventral midline of the embryo. 
Looping and chamber maturation follow around E10, when Hoxa-9 expression is 
apparent, to form a fully functional multi chambered heart (Olson & Srivastava 1996, 
Fishman & Chien 1997). The fate of each cell type in becoming the chambers o f the heart 
is highlighted in figures 41-43. 
2.4.3 Gene expression in the developing heart 
Embryonic patterning is a necessary first step for development of the primordial heart 
and throughout this orderly developmental system the expression of several other known 
homeobox genes and transcription factors have been demonstrated. 
Figure 45 shows the temporal expression of genes that are known to regulate heart 
formation. 
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The Drosophila homeobox gene, tinman (Azpiazu and Frasch 1993, Bodmer, 1993, 
reviewed in Harvey 1996), and its homologues in mouse (Nkx2-5 (Lints et al., 1993)), 
play vital roles in establishing normal cardiac development . The gene is expressed in 
primitive mesoderm tissue and its mutation leads to the absence of a heart in Drosophila, 
and severe, early cardiac defects in mouse (Barinaga 1994). 
Vertebrae homeobox genes Msx-1 and Msx-2, related to Drosophila wish, have shown 
expression restricted to a distinct subpopulation of myocardial cells. In later stages, o f 
heart development there are cells that are found to coincide morphologically with the 
cardiac conduction system, suggesting a potential model for conduction tissue 
development (Chan-Thomas et al., 1993). 
Overexpression of the homeobox gene Pitx2 in chick and xenopus (Campione et al., 
1999, Logan et al., 1998, Piedra et al., 1998, Ryan et al., 1998) and knockout studies o f 
the same gene in mice (Gage et al., 1999, Kitamura et al., 1999, Lu et al., 1999), support 
the idea that this family of genes play an important role in asymmetric morphogenesis o f 
multiple organs, including the heart. 
There is also a clear evidence to support a role of transcription factors, other than 
homeobox genes, in cardiac cell specificity. 
2.4.3.1 G A T A gene expression in the developing heart 
Certain members o f the GATA family of transcription factors appear to participate in 
cardiac muscle differentiation. GATA-4 is expressed in the precardiac mesoderm and 
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subsequently in the endocardial and myocardial layers of the heart tube in the developing 
heart (Heikinheimo et al., 1994). Inhibiting GATA-4 expression, using anti sense RNA, 
blocks the differentiation o f cardiac myocytes in a pluripotent carcinoma cell line (Ip et 
al., 1994, Grepin et al., 1995). GATA-5 and GATA-6 bind the same DNA sequence as 
GATA-4 and their expression patterns overlap that of GATA-4 in the cardiogenic lineage, 
suggesting that they may perform similar functions (Laverriere et al., 1994, Jiang et al., 
1996, reviewed Olson and Srivastava 1996). 
2.4.3.2 basic helix-loop-helix gene expression in the developing heart 
Two transcription factors HAND1 and HAND2 control aspects of cardiac left-right 
differentiation. The two are structurally related basic-Helix-Loop-Helix (bHLH) proteins, 
and their mRNAs are present bilaterally during early fusion stages of heart development 
(Srivastava et al., 1995, Srivastava et al., 1997). 
Other bHLH genes expressed in early mouse cardiac cell development include Mesp2 
(Saga et al., 1997) and Id (Evans et al., 1993). 
2.4.3.3 Myosin enhancing binding-factor-2 expression in the developing heart 
Myosin enhancing binding factor-2 (Mef2), like Hoxa-9 is a transcription factor 
expressed in precursors o f the cardiac, skeletal, and smooth muscle lineages, as well as in 
other cell types (Edmondson et ah, 1994, Chambers et al., 1994, Wong et al., 1994). 
Loss-of-function studies in Drospohila (D-Mef2) show a block in all muscle cell type 
differentiation in the embryo (Lil ly et al., 1995, Bour et al., 1995, Ranganayakulu et al., 
1995). Phenotypic consequences of Mef2 mutations in mouse are not yet known, but 
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evidence from D-Mef2 studies and expression patterns suggest a likely role in 
cardiomyocyte differentiation (reviewed Olson and Srivastava 1996). 
Chisaka and Cappechi showed that the targeted disruption of Hoxa-3, which is expressed 
at El2.5, results in atrial hypertrophy, aortic and pulmonic valve defects and left 
ventricular hypertrophy as well as other non-cardiac defects (Chisaka and 
Capecchi,1991). 
2.4.4 Heart chamber formation 
Data in this chapter demonstrated expression initially in the left and right atrial wall of 
the developing heart between E9.5-10.5. During this stage, heart looping occurs which is 
the first insight into left/right symmetry. This stage is essential in distributing this organ 
system correctly in connecting the outflow and inflow vasculature systems. It is at E10 
when the chambers of the heart form from specific sites within the tubular heart during 
and after looping (Christoffels et al., 2000). 
These chambers (atria and ventricles) differ in morphology, physiology and in the muscle 
contractile protein genes each expresses (Zadeh et al., 1986, Evans et al., 1988, Wang et 
al., 1996). 
2.4.4.1 Specific heart chamber gene expression 
Many cardiac genes are broadly expressed in the early heart and become restricted to the 
atria or ventricles as development proceeds. 
Chamber myocardium tissue forms locally from the embryonic myocardium of the 
tubular heart. 
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It has been proposed that diversification of atrial and ventricular cells may occur earlier 
than chamber formation around E10 (mouse), because an atrial-specific MyHC gene 
(myosin heavy chain), AMHC1, is first expressed in the posterior region o f the fusing 
cardiac tube, and is a future atrial component (Yutzey et al., 1994). 
Another myosin heavy chain gene MyHC 3, has been identified as atrial specific during 
chamber development in the quail heart. Initially the gene is expressed throughout the 
tubular heart, but as the heart chamberises, expression is down regulated in the ventricles, 
but maintained in the atria (Schleinitz and Stockdale, unpublished data, Wang et al., 
1996). 
In situ and wholemount data has shown BMP-10 expression in the developing heart. 
Transcripts were first detected at E9.0 in the common ventricular chamber and by the 
beginning of E12.5 additional expression was found in the inner atrial wall (Neuhaus et 
al., 1999). This temporal expression pattern demonstrated by BMP-10 is very similar to 
that shown by Hoxa-9 in this manuscript, but the spatial expression is in different 
chambers of the heart eg. Hoxa-9 first shows expression in the atria of the heart and 
develops into the ventricle at El2.5 
It could be suggested that these two gene expression patterns may share a degree o f 
repressive or activating mechanisms. Bone Morphogenic Proteins {BMP) 2, 4 and 7 have 
been demonstrated previous as upstream signallers of Hox genes in response to Shh 
regulate during the growth stage o f skeletal and mesenchyme tissue development (limura 
et al., 1994, Roberts et al., 1995, Watanabe et al., 1998), and therefore there may be a 
relationship in the developing heart. 
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The atrial natriuretic factor (ANF) gene is specifically expressed in this developing 
chamber myocardium and is one of the first hallmarks of chamber formation. In the 
mature heart ANF gene expression is restricted to the atrial auricles, and during 
development its expression is specific for the formation of atrial and ventricular chambers 
(Christoffels et al., 2000). 
Signalling molecules in pre-atrial cells are not clearly understood, but studies have 
shown that retinoic acid (RA) synthesis and activity within the embryonic mouse heart 
support the importance of endogenous RA for cardiac anterior posterior patterning (Moss 
et al., 1998). As the murine heart forms, the RA-synthesising enzyme RALDH2 is only 
present in pre-atrial regions. Transgenic mice carrying a reporter gene under the control 
of a RA-responsive promoter element demonstrate that retinoid signalling within the 
myocardium controls atrial differentiation (Moss et al., 1998, reviewed Yelon and 
Stainier 1999). Posterior transformations of anterior digits, rhombomeres or vertebrae by 
RA are thought to be controlled by RA-mediated shifts in Hox gene expression (Langston 
and Gudas, 1994). It is yet not clear what roles Hox genes play in cardiac anterior 
posterior regions, but several Hox genes have been upregulated in RA-treated precardiac 
avian experiments, which include Hoxd-3, Hoxa-4 and Hoxd-4, suggesting a role in heart 
patterning and the regulation of early lineage specification (Searcy & Yutzey, 1998). 
However, as yet a retinoic acid response element to regulate function has not been 
detected in Hoxa-9 transcription. 
Another homeodomain protein belonging to the Iroquois family, Irx4, directs ventricular-
specific gene expression (Bao et al., 1999) and the orphan nuclear receptor COUP-TF 
(chicken ovalbumin upstream promoter-transcription factor) I I , is required for atrial, but 
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not ventricular development (Pereira et al., 1999). Members o f the HRT family o f hairy-
related bHLH proteins, are expressed in a spatial manner in the embryonic heart - HRT1 
in the atria and HRT2 in the ventricles (Nakagawa et al., 1999, Leimeister et al., 1999, 
reviewed Yamagishi et al., 2001). 
These cardiac genes must demonstrate spatial and temporal expression patterns to ensure 
they regulate the correct cell type at the intended time point. Hoxa-9 has shown both o f 
these criteria, but its regulation and function in the atrium remains unclear. 
2.4.5 Conclusions 
In situ and wholemount hybridisation techniques have been used successfully to 
demonstrate the anatomical expression patterns of desired genes during stages o f 
embryonic development. However these did not focus on the expression pattern at 
haematopoietic sites during the essential stages of blood cell development in the embryo 
(E7-E14). This study, using similar techniques on Balb/C mouse embryos showed initial 
widespread patterning in the early E7.5 embryo, with a previously unreported specific 
expression pattern in the developing atrium of the heart at E9.5-E10.5, as well as the 
previously known areas of the gut and vertebrae. Hoxa-9 expression then appeared more 
widespread, but with specific expression seen in the heart atria and ventricle at E l2 , 
before becoming undetectable by El3 . This patterning has not been seen in previous 
Hoxa-9 reports, and could have important implications in future heart development 
studies. 
This specific patterning seen in the heart, gut and vertebrae, does not correlate with the 
time course of the corresponding haematopoietic pathway in this mouse strain, although 
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there appeared to be a degree of positive staining in the liver at E l l , when 
haematopoietic function was high in this organ. However, the undetectable levels o f 
Hoxa-9 in relation to haematopoietic organs in these in situ and wholemount 
hybridisation embryos does not mean that Hoxa-9 is not involved in the haematopoietic 
pathway. It may be, that this conventional technique is not suitable for detecting low 
levels of expression at the cellular level, for example the foetal liver is a vital 
haematopoietic organ, but it is the blood islands within the liver that are important for 
producing haematopoietic progenitors. This study cannot exclude the possibility of 
expression at these sites, but the techniques adopted did not show detectable levels and 
therefore alternative gene expression models should be studied to investigate further 
Hoxa-9 expression during haematopoiesis, but perhaps more importantly to further 
investigate the expression patterns identified in the heart in this study and a possible role 
for Hoxa-9 during cardiogenesis. 
99 
Chapter Three - Hoxa-9 expression during embryonic stem cell 
differentiation in vitro 
3.1 Introduction 
In situ and wholemount hybridisation analysis in the previous chapter identified an 
expression pattern for Hoxa-9 in the atrium of the developing heart, but levels at 
haematopoietic sites were undetectable. This does not mean however, that Hoxa-9 
definitively is not involved in this process (Lawrence et al., 1997, Izon et al., 1998, 
Thorsteinsdottir et al., 2002), it merely suggests that the methods used may not be 
sensitive enough to detect expression at those sites, and an alternative technique should 
be used to further investigate a potential functional role. One approach that has been 
previously used to investigate a functional role for developmentally regulated genes has 
been to exploit the biology of embryonic stem cells. 
3.1.1 Embryonic stem cells 
Early embryogenesis is characterised by the formation, expansion and differentiation of a 
population of pluripotent cells. At the end of this early developmental stage, cleavage 
divisions occur within the cells and the developmental potential is from the resulting 
inner cell mass (ICM) o f nascent blastocysts. 
In vivo, the ICM is a stem cell population from which develops all tissues of the embryo 
proper including germ cells (Hogan et al., 1994). In vitro it is possible to avoid the loss of 
pluripotency, seen during gastrulation in vivo (Hogan et al., 1994), and isolate immortal 
stem cell lines known as embryonic stem cells (ES cells) (Evans and Kaufman, 1981, 
Martin et ah, 1981, Brook and Gardner, 1997). 
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ES cells are derived from the epiblast of preimplanted blastocysts. The discovery that 
LIF can suppress this differentiation (Smith and Hooper, 1987, Smith et al., 1988, 
Williams et ah, 1988) has allowed the in vitro culture o f these cells as ES cells. Their 
continued pluripotency following in vitro culture can be demonstrated following injection 
into host blastocysts (reviewed Robertson et al., 1986, Smith et al., 1992); the ES cells 
can contribute to all tissues of the developing embryo. This functionality has made them 
a powerful tool in the study and analysis of the molecular mechanisms involved in in vivo 
development of different cell lineages. However, their potency, and their ability to 
spontaneously differentiate in vitro in the absence of LIF have also encouraged several 
groups to investigate the potential of ES cells as in vitro assays o f cell differentiation. 
3.1.2 E S cell differentiation in vitro 
A number of techniques have been used to facilitate the differentiation o f ES cells into 
different tissue types. One approach has been to form ES cells into aggregates prior to 
differentiation (figure 46). These differentiating structures are known as embryoid bodies 
and have been shown to generate a variety of tissues, including, muscle (Doetschman et 
al., 1985, Rohwedel et al., 1994), neuronal (Zhu et al., 1996, Brustle et al., 1999), and 
endothelial (Wang et al., 1992, Reynolds et al., 1996, Weiss et al., 1996). However, o f 
particular relevance to studies o f Hoxa-9, differentiation of ES cells in vitro has also been 
used to produce haematopoietic (Schmitt et al., 1991, Keller et al., 1993, McClanahan et 
al., 1993) and cardiac tissue cell types (Robbins et al., 1990, Miller-Hance et al., 1993). 
The latter two wi l l be reviewed here. 
Hanging drop cultures 
Containing cells in the presence 
of LIF 
E S cells maintained 
in LIF 
Cell aggregates harvested after 
48 hours 
Tissue determination 
Assay 
Suspension cultures 
EBs differentiate in absence of 
LIF 
Figure 46 The formation of embryoid bodies from undifferentiated E S 
cells. Following the removal o f LIF growth factors can be added in suspension 
cultures and the tissue phenotype analysed using a variety o f assays. 
3.1.3 Haematopoietic differentiation of E S cells in vitro 
Haematopoietic development in EBs is efficient and highly reproducible. EBs have been 
shown to contain cells o f erythroid, myeloid and to a lesser extent lymphoid progenitor 
cells. EBs themselves could provide an environment that supports haematopoiesis, as 
genes encoding various growth factors and their receptors are expressed early in EB 
development (Schmitt et ah, 1991, Keller et al., 1993, McClanahan et al., 1993). The 
earliest stages o f haematopoietic development within EBs (defined as the onset o f 
specific gene expression) follows an ordered sequence o f events similar to those in the 
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developing embryo (Keller et al. 1993, Burket et al., 1991, Schmitt et al., 1991, 
McClanahan et al., 1993). Haematopoiesis from ES cells, as in the mouse embryo, has 
been observed as islands of haemoglobinised erythroid cells or blood islands within the 
developing EBs (Doetschuman et al., 1985). 
Haematopoietic studies in ES cells have investigated and developed the understanding o f 
the early foetal development and commitment o f the multi lineages from the pluripotent 
HSC (Burket et al., 1991, Wiles and Keller, 199], Keller et al., 1993, Bigas et a!., 1995). 
The understanding of lymphopoiesis, has been greatly enhanced using ES cell in vitro 
models to study the development, commitment and generation of lymphoid cells (Chen, 
1992, Chen et al., 1992, Gutierrez-Ramos and Palacios, 1992, Miiller and Dzierzak, 
1993, Nakano et al., 1994, Nisitani et al., 1994). There is evidence that long-term 
repopulating stem cells can be produced (Hole et al., 1996). As an adjunct to these 
studies, morphogens (such as dimethyl sulphoxide (DMSO) and retinoic acid (RA)) have 
been used to modulate this haematopoietic commitment, and this has proved useful in 
characterising the expression of developmentally regulated genes in haematopoietic 
commitment (Lako et al., 2000). The expression of Hoxa-9 during haematopoietic 
differentiation of ES cells in vitro has however, not been described. 
3.1.4 Cardiomyocyte differentiation of E S cells in vitro 
Several groups have defined the culture conditions that allow ES cells to generate 
cardiomyocyte lineages (Wobus et al., 1991, 1997 Drab et al., 1997, Kolossov et al., 
1998, Miiller et al., 2000). ES cell-derived cardiomyogenesis has been unequivocally 
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shown that at the terminally differentiated stage, all different cardiac phenotypes - sinus 
nodal, pacemaker, atrial and ventricular-like cells can be detected (Wobus et al., 1997). 
In vitro differentiation o f ES cells into cardiac lineages has proven to be a useful screen 
to identify genes involved in cardiogenesis including GATA-4 (Narita et al., 1996), and 
Hand-1 (Riley et al., 2000). There is currently no published information on the 
expression of Hoxa-9 during cardiac differentiation o f ES cells in vitro. 
3.1.5 Aims 
The aim of this study was to examine the expression patterns o f Hoxa-9 during 
haematopoietic and cardiac differentiation o f ES cells in vitro, and examine whether such 
expression correlates to the appearance of lineage specific molecular markers o f 
differentiation. 
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3.2 Materials and methods 
3.2.1 E S cell culture and embryoid body formation 
The CGR8 ES cells were routinely passaged and maintained in an undifferentiated state 
as described by Smith (Smith et al., 1991) in ES cell medium (GMEM; Gibco BRL, 
Paisley, Scotland, UK) with 7.5% NaHCCh, lOOx non-essential amino acids (Gibco 
BRL), 2 mM L-glutamine (Gibco BRL), and 1 m M pyruvate (Gibco BRL), 0.1 m M 2-
mercaptoethanol and 10% foetal calf serum (Gibco BRL) with 66 u.1 LIF /10ml media 
(v/v) leukaemia inhibitory factor (LIF) which was produced as described (Smith, 1991). 
In order to form embryoid bodies (EBs), ES cells were cultured in hanging drops (10 uT) 
at a concentration o f 3 x 10 4 cells/ml in the presence of LIF for 48 hours in a humidified 
5% CO2 atmosphere at 37°C. ES cell aggregates were harvested into a petri dish (10 3 
aggregates/10ml ES cell medium) and allowed to differentiate in the absence of LIF for 
up to 6 days, in figure 3.1.2. Medium was replaced every two days. Selected samples 
were treated with either 1% (v/v) dimethylsulfoxide (DMSO) or 10"g M all - trans retinoic 
acid (RA) for the first 48 hours of differentiation (see figure 46). 
The cardiomyocyte differentiation of ES cells was carried out essentially as described 
(Muller et.al. 2000). Briefly, the ES cell aggregates were produced in hanging drops, as 
described above, and after fourty-eight hours were collected by centrifugation at 800g 
(Sigma 2-15), for three minutes. The aggregated ES cells were then transferred into 
ungelatinised petri dishes ( I W A K I , Paisley, Scotland) in CGR8 media containing LIF 
(described above). After 72 hours, the cells were passaged and transferred to 1% (v/v) 
gelatinised petri dishes in CGR8 media with LIF being removed and allowed to 
differentiate. 
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3.2.2 mRNA extraction 
Each series of ES cell differentiation was carried out using three independent 
experiments. For each sample, approximately 100 EBs were collected for each time 
point, washed in PBS (see A. 14) and spun at 4000g for three minutes (Sigma 2-15). The 
supernatant was removed and mRNA extracted by adding 1ml of RNAzol (Biogenesis, 
Poole, Dorset, England) to the pellet, followed by 100 ul chloroform and leaving on ice 
for five minutes. The samples were centrifuged for ten minutes at 4000g (Sigma 2-15), 
and the upper phase containing RNA transferred to a fresh tube. 
RNA was precipitated with an equal volume of propan-2-ol and centrifuged at 4000g for 
ten minutes. The pellet was washed in fresh 70% (v/v) ethanol and allowed to air-dry 
before being resuspended in 20ul of TE buffer (see A.20). 
3.2.3 The generation of cDNA 
mRNA was reverse transcribed using the 1 s t strand cDNA synthesis kit from Roche 
(Lewes, East Sussex, England) following their instructions. In brief, 1 \xg o f mRNA was 
denatured by incubating at 90°C for ten minutes, followed by cooling on ice for five 
minutes. For each 1 u.g of mRNA, lunit of AMV-reverse transcriptase enzyme, 2 ul 5X 
A M V - R T buffer, 2 (xg random primers, 10 m M dNTPs, and sterile water up to 10 ui total 
volume, were mixed and incubated at 37°C for one hour. Following incubation, the 
cDNA reaction was stored at -20°C. PCR was carried out as described in 2.2.1. 
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Figure 47 - Sequences and annealing conditions for R T - P C R primers 
Gene/ 
Accession 
number 
Product 
size(bp) 
Anneal 
temp. °C 
(x) 
5' R T - P C R primer 3' R T - P C R primer 
Activin Bp 426 50°C gtcaatttgacgtggtttcc gcaagaatgtgctgatcaac 
AFP 410 50 °C gctcacaccaaagcgtcaac cctgtgaactctggtatcag 
B-Actin 934 63 °C aggggccggactcatcgtactc gtgacgaggcccagagcaagag 
Brachyury 947 50 °C tccaggtgctatatattgcc tgctgcctgtgagtcataac 
c-kit 765 55 °C tgtctctccagtttccctgc ttcagggactcatgggctca 
Collagen 463 55 °C caagcatagtggtccgagtc aggcaggtcaagttctagcg 
flk-1 398 60 °C taggtgcctccccataccctgg tggccggctctttcgcttactg 
GAT A-1 404 60 °C ggaattcgggccccttggtgagg 
ccagagag 
cggggtacctcacgctccagcca 
gattcgaccc 
GATA-4 
MMU85046 
211 55 °C ctgtcatctcactatgggca tacgcggtgattatgtcccc 
Hoxa-9 
AB005457 
724 59 °C atcatggccaccaccggggc cgtcttttgctcggtccttg 
Mef2C 
MUSMEF2CA 
269 60 °C gtactctctgagtagcgcag gtgtgttgtgggtatctcga 
Mesp2 
NM 008589 
577 60 °C gctcagatgcttggtcctag caggtcttcctgccaaagtt 
MLC 
NM_010861 
188 65 °C gaaggctgactatgtccgggaga 
tgc 
tgtgggtcacctgaggctgtggtt 
cag 
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Gene/ 
Accession 
number 
Base 
pair size 
(bp) 
Anneal 
temp. °C 
(x) 
5' R T - P C R primer 3' R T - P C R primer 
Nkx-2.5 
AF083133 
248 55 °C cagtcaaagacatcctgaac caccagcacgggcaccgcga 
Troponin T 
AB052890 
578 57 °C cagcagcgtattcgcaatga ttcttcttccgggcctcatc 
3.2.4 Colony forming unit-assay (CFU-A) 
The in vitro colony forming unit-assay (CFU-A) o f embryoid bodies was carried out 
essentially as described previously (Pragnell et al. 1988, Hole and Smith 1994). In brief, 
a feeder layer consisting of 0.6% agar in a modified Eagle's medium (a -MEM; Gibco 
BRL) with conditioned medium from two cell lines (AF1-19T; a source of granulocyte 
macrophage colony stimulating factor, GM-CSF; and L929 a source of CSF-1) was 
poured into 3 cm diameter tissue culture grade dishes ( IWAKI)(1 ml per layer). 
Embryoid bodies (normally 50 per dish) were added to 0.3% agar in a - M E M and plated 
to form an upper layer. The dishes were incubated for 11 days at 37° C in a humidified 
atmosphere with 5% 02l 10% CCh. The presence or absence of haematopoietic progeny 
in the differentiated EBs was determined by the formation o f mixed colonies with 
diameter greater than 2 mm after 11 days of incubation. CFU-A assays were normally 
carried out in triplicate as an average percentage of the number of EBs showing 
proliferation and commitment. 
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3.3 Results 
Two distinct ES cell differentiation strategies were used, optimised for either 
haematopoietic or cardiomyocyte differentiation. In each case these approaches were first 
studied for the appearance of functional cells and then for the appearance of molecular 
markers of lineage commitment. Having validated these systems and determined the time 
course o f lineage commitment and differentiation, the expression of Hoxa-9 was 
examined by RT-PCR and correlated with molecular and cellular events occurring during 
ES cell differentiation in vitro. 
3.3.1 Haematopoietic differentiation: cellular assay 
Haematopoietic commitment o f the embryoid bodies was assessed using the Colony 
Forming Unit Assay (CFU-A) (Pragnell, 1988). This assay detects the presence of early 
haematopoietic progenitors (Pragnell, 1988) and is thus appropriate for the examination 
of the onset of haematopoiesis in ES cell differentiation in vitro (Hole et al., 1996). When 
haematopoietic committed progeny are present within the EBs, they proliferate and can 
be visualised as a haematopoietic halo, as shown in figure 48 (Hole et al., 1996). Figure 
49 shows the percentage of EBs that demonstrated this haematopoietic halo in CFU-A at 
different time points. This graph shows the mean of the three independent experiments, 
and indicates that EBs differentiating in media alone (control) showed haematopoietic 
commitment first detected at day 4. The percentage of embryoid bodies containing 
detectable haematopoietic progenitors increased to a maximum of 40% after 6 days. The 
presence of DMSO or RA dramatically changed this differentiation profile. The 
percentage of EBs that demonstrate haematopoietic commitment was dramatically 
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increased following treatment with 1% DMSO for 48 hours, resulting in 80% of EBs 
showing detectable CFU-A activity after 6 days. In contrast, the presence o f low 
concentrations of RA early in ES cell differentiation appear to suppress haematopoietic 
commitment. These results are in ful l agreement with previous work (Lako et al., 2000). 
Figure 48 - Colony forming unit assay showing the haematopoietic 
halo of proliferative haematopoietic cells 
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Having determined reproducible haematopoietic commitment o f ES cells following 
differentiation in vitro, the molecular events occurring at or around the time points o f 
commitment could be examined. The purpose o f this study was to examine the onset o f 
expression o f Hoxa-9 during ES cell differentiation, and therefore a completely 
quantitative approach was not required. Therefore RT-PCR was used to examine gene 
expression. A measure o f semi-quantitative analysis was offered as long as controls for 
cDNA production and gel loads were included. To address this, all samples were 
normalised with respect to RT-PCR of p-actin, a gene commonly used as an internal 
control for such studies (Lako et al., 2000) (figure 50). 
3.3.2 Haematopoietic differentiation: gene expression 
The lineages to emerge during development are ectoderm, endoderm and mesoderm. The 
expression of genes characteristic of these germ layers were examined in this model of 
haematopoietic differentiation of ES cells in vitro. Activin pp as a marker of primitive 
ectoderm (Albano et ah, 1993). In this study, this gene was expressed in the early stages 
of differentiation (figure 51). However, EBs treated with 1% DMSO showed reduced 
levels of expression of this ectodermal lineage marker. In contrast, there appeared to be 
an increase in the level o f Brachyury expression, a mesoderm marker (Herrman et al., 
1990) (figure 52). 
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Figure 50 - P C R analysis of Beta-Actin in ES cells differentiating in: 
media ( A ) ; media and 1% dimethyl sulphoxide (B); media 
and 10"8 M retinoic acid (C). This RT-PCR was used to 
optimise equal amounts of cDNA for further experiments 
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Figure 51 - PCR analysis of Activin /3 in ES cells differentiating in: media 
(A); media and 1% dimethyl sulphoxide (B); media and 10"8 M 
retinoic acid (C). 
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Figure 52 - PCR analysis of Brachyury in ES cells differentiating in: 
media ( A ) ; media and 1% dimethyl sulphoxide (B); media 
and 10"8 M retinoic acid (C). 
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This apparent down regulation of molecular markers of ectodermal commitment, 
coupled with an increase in molecular markers of mesoderm is consistent with previous 
data(Lako et al., 2001). 
The endoderm markers, Collagen alV (Adamson and Ayers, 1979), and AFP (alpha feta 
protein) (Dziadek and Andrew, 1983) were only detected in later stages of differentiation 
in EBs that showed limited haematopoietic (mesoderm) commitment, shown in figures 
49, 53 and 54. 
Two markers of early haematopoietic progenitors, c-kit (Bernex et al., 1996) and flk-1 
(Shalaby et al., 1995) were examined, c-kit expression levels in the DMSO treated cells 
were expected to be higher than demonstrated, as such cells showed haematopoietic 
commitment in the CFU-A assay. However, it is important to note that the expression of 
c-kit started earlier in these treated cells compared to controls, demonstrating the 
generation of haematopoietic lineages in the presence of DMSO. The undetectable levels 
of c-kit and flk-1 in the RA treated cells, further confirmed the reduced haematopoietic 
commitment in these cells. 
This result from these two lineage markers highlight to an extent some the limitations of 
using the ES model to study gene expression. The expression of these two early 
haematopoietic markers in the differentiation alone cultures was as expected, as this 
mixture of differentiating EBs contain some with mesoderm potential (shown by CFU-A 
in figure 49), however this is a mixed population. In an effort to generate a more 
"mesodermally derived" population, 1% DMSO was added to the culture, and by CFU-A 
analysis there was an increase in the number of EBs showing haematopoietic 
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commitment. However, not every cell of the EB is committed to haematopoiesis, so 
although there was up to 80% commitment, it is important to be aware that it is not a pure 
mesoderm population, demonstrated here by levels of non-mesoderm lineages (Activin) 
(figure 51) detected in EBs cultured in DMSO. 
It was encouraging from the RT-PCR data shown in this thesis that the expression shown 
in figures 50-66 were reproducible in three independent experiments, suggesting that the 
experimental procedures were consistent. This reproducibility was important when 
analysing the expression offlk-1 (figure 56) in 1% DMSO. The expression of this gene 
has been shown to be important in successful early haematopoietic commitment (Shalaby 
et al., 1995), and it might be expected to correlate with the appearance of haematopoietic 
progenitors detected by CFU-A in this system. However results shown in figure 56 
suggest that detectable expression was restricted to day 3 alone. This empathatic result 
was seen in three independent experiments (data not shown) and is consistent with 
previously published work (Lako et al., 2000). 
GATA-1 is a marker of the more committed haematopoietic cell (Simon et al., 1992). 
HSC activity has been previously seen, in vivo, at day 4 (Hole et al., 1994). It has been 
demonstrated in this thesis that high levels of this protein were found at this same time of 
high HSC activity (figure 57), and when haematopoietic commitment began to increase 
(figure 49), suggesting that although this ES cell model has limitations, this expression 
pattern demonstrates some compatibility to in vivo systems. 
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Figure 53 - PCR analysis of CollagenalV in ES cells differentiating in: 
media (A) ; media and 1% dimethyl sulphoxide (B); media 
and 10"8 M retinoic acid (C) 
B 
Figure 54 - PCR analysis of AFP (alpha feta protein) in ES cells 
differentiating in: media (A) ; media and 1% dimethyl sulphoxide (B); 
media and 10"8 M retinoic acid (C) 
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Figure 55 - PCR analysis of c-kit in ES cells differentiating in: media 
( A ) ; media and 1% dimethyl sulphoxide (B); media and 10"8 M 
retinoic acid (C) 
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Figure 56 - PCR analysis of flk-1 in ES cells differentiating in: media 
( A ) ; media and 1% dimethyl sulphoxide(B); media and 10"8 M 
retinoic acid (C) 
B 
Figure 57 - PCR analysis of GATA-1 in ES cells differentiating in: 
media (A) ; media and 1% dimethyl sulphoxide (B); media and 10"8 M 
retinoic acid (C) 
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Figure 58 - Summary of gene expression during the haematopoietic 
differentiation of ES cells 
The haematopoietic marker genes are shown in normal text, 
with the cardiac markers shown in bold type. 
Evidence from CFU-A for haematopoietic progenitors and RT-PCR for differentiation 
markers indicated that this model of haematopoietic differentiation was appropriate for 
studying the expression of developmentally regulated genes during haematopoietic 
commitment. However, this model was not optimised with respect to cardiomyocyte 
development. The system for in vitro differentiation of cardiomyocytes from ES cells was 
therefore examined. 
3.3.3 Cardiomyocyte differentiation: cellular assay 
In this differentiation assay ES cells were removed from the conventional suspension 
cultures, and placed onto pre-gelatinised plates to encourage the differentiation of 
cardiomyocytes. The formation of functional cardiomyocytes was determined by the 
appearance of 'twitching' EBs; the rhythmic contraction of these structures. This has 
previously been used as a measure of cardiomyocyte commitment (Wobus et al., 1997). 
The percentage of EBs demonstrating "twitching" was recorded over the period of 
differentiation (figure 59). EBs containing functional cardiomyocytes were first detected 
at day 3 of differentiation. The percentage of EBs demonstrating rhythmic contractions 
increased over time up to a peak of 29% at day 10. 
3.3.4 Cardiomyocyte differentiation: gene expression 
A profile of cardiac genes expressed during cardiomyocyte differentiation of ES cells is 
shown in figure 60 and summarised in figure 61. 
For comparison, the same endo, ecto and mesoderm markers studied in the 
haematopoietic differentiation of ES cells were examined for this data set. 
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Figure 59- A- The number of embryoid bodies showing rhythmic contractions 
during cardiomyocyte differentiation 
B - Graph to show data shown in A 
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The ectoderm marker gene Activin ftp consistently showed expression in undifferentiated 
ES cells which contain lineages from all three germ layers, and demonstrated a continued 
high level of expression throughout this differentiation process, in contrast to the 
decreasing levels of expression seen in the haematopoietic differentiation system. In the 
previous ES cell differentiation pathway, AFP expression was undetectable in 
undifferentiated ES cells, but expression during the cardiomyocyte differentiation 
increased to higher levels by day 6 where expression was maintained. Collagen alV gene 
expression could be seen in undifferentiated ES cells, with enhanced levels recorded 
during days 6-11 of cardiomyocyte differentiation. It could be suggested that the 
detection of such markers is due to the cardiomyocyte culture containing a more diverse 
mixed population of all three germ layers, compared to the EBs treated with DMSO. 
The expression of GAT A 1-3 are largely confined to the haematopoietic system (Tsai et 
al., 1994, Pandolfi et al., 1995, Fujiwara et al., 1996, Ting et al., 1996), whilst GATA 4-6 
are expressed predominantly in the heart and gut (Kelley et ah, 1993, Grepin et al., 1994, 
Lavierriere et al., 1994). GATA-4 is a zinc finger protein found in pre-cardiac mesoderm. 
Knock out mice show defects in early heart tube formation (reviewed Fishman and Chien 
1997). 
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Figure 60 - Gene expression in E S cells under cardiomyocyte differentiation. 
Cell suspensions were collected from hanging drops (see 3.2.1) and 
LIF was removed at dO. The differentiating EBs were then plated onto 
gelatinised plates at d3. 
Beta-actin was used to optimise equal amounts of cDNA for further 
RT-PCR analysis 
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Figure 61 Summary of gene expression during the cardiac 
differentiation of ES cells, shown in figure 63 
GATA-4 expression in this investigation has been shown during the differentiation 
process of cardiomyocytes derived from ES cells. As expected, expression was high and 
enhanced in populations of EBs showing rhythmic contractions. 
Mesp2, like GATA-4 is an early cardiac marker gene. This basic-helix-loop-helix protein 
is involved in the development of pre-somite mesoderm tissue and the migration of 
mesoderm cells (Saga et al., 1997, 1998). Expression of Mesp2 was found from day 3 of 
cardiomyocyte differentiation with increasing levels during the period when the rhythmic 
contractions increased. 
It may be expected that being an early marker like GATA-4 that expression levels of 
Mesp2 would be higher at the earlier stages of differentiation. However, this was not a 
pure cardiomyocyte population, and therefore expression patterns may be different from a 
cardiomyocyte population alone. It is important to note that the expression levels of both 
genes appeared to be the greatest when the number of EBs showing rhythmic 
contractions peaked. 
Mef2C is a transcription factor that belongs to the MADS family and primarily expressed 
in all muscle types (Edmondson et al., 1994, Chambers et al., 1994). It is also expressed 
in precardiac mesoderm, at E7.5, but mutants show that this gene is required from cardiac 
looping and right ventricle development as well as being expressed in a subset of cardiac 
cells (reviewed Lyons, 1996). RT-PCR reveals high levels of expression from day 6 in 
differentiating embryoid bodies. 
vMLC is the earliest ventricular chamber specific gene expressed in the heart (O'Brien et 
al., 1993). High levels of expression are seen throughout the differentiation process 
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including early stages, this too was consistent with in vivo data in this study, where 
expression levels increased from day 6 of differentiation. 
Nkx2.5 or Csx, the tinman homologue is a murine specific expressed gene, initially found 
in cardiac progenitors and pharyngeal endoderm from E7.5 (Lints et ah, 1993). Knockout 
mice show defects in heart tube looping as a result of abnormal muscle growth (Newman 
et al., 1998). It is therefore critical for early morphogenic determination pathways. 
Expression levels appeared comparatively low in this current study as detected by RT-
PCR, compared to other cardiac markers that are not as prominent as Nkx2.5 during heart 
development, and this could be explained by the technical difficulties reached in 
optimising PCR conditions for Nkx2.5. 
Troponin T is expressed in a restricted region of the developing heart. This protein is part 
of the regulatory system of contractions of skeletal and cardiac muscle (reviewed 
Ricchiuti et al, 1997). 
Having defined the time course of cellular differentiation and appearance of molecular 
lineage markers in both haematopoietic and cardiomyocyte differentiation models, and 
validated them with respect to other published work, the expression of Hoxa-9 in these 
systems could be examined. 
3.3.5 Hoxa-9 expression during haematopoietic and cardiomyocyte differentiation of 
ES cells in vitro 
Studies of Hox gene expression have often used the technique of southern blot 
hybridisation with gene-specific probes following RT-PCR ( see 2.2.1). This both allows 
detection of low level transcripts and confirms the specific nature of the amplified cDNA. 
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Using this technique, two size variants of Hoxa-9 were found to expressed in 
undifferentiated embryonic stem cells (figure 62). The presence of two bands is 
consistent with alternative splicing of Hoxa-9 message, as reported previously (Fujimoto 
etal, 1996). 
In the model of ES cell differentiation designed to optimise haematopoietic commitment, 
Hoxa-9 expression is shown in EBs cultured in media alone from day 4 onwards. 
However the presence of 1% DMSO appeared to advance the onset of detectable Hoxa-9 
expression to day 3 of differentiation. In this semi-quantitative assay, levels of expression 
of Hoxa-9 appeared to be enhanced. By contrast, expression was down-regulated in the 
presence of RA. These levels of expression appear to be reasonably well correlated with 
the development of haematopoiesis as detected by CFU-A assay and RT-PCR of 
molecular markers. In this model of ES cell differentiation designed to optimise 
cardiomyocyte commitment, Hoxa-9 expression tended to increase in expression up to 
ten days of differentiation. For comparison, the percentage of embryoid bodies showing 
rhythmic contractions is shown in figure 62. 
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Figure 62 - Southern blot analysis of Hoxa-9 expression in differentiating 
embryonic stem cells 
differentiating in: media (A) ; media and 1% dimethyl sulphoxide (B); 
media and 
10"8 M retinoic acid (C); or under cardiomyocyte differentiation 
conditions (D), using adult murine heart and kidney as controls. 
E shows the number o f embryoid bodies showing rhythmic contractions 
(figure 61) in relation to Hoxa-9 expression 
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3.4 Discussion 
In this chapter, an in vitro ES cell differentiation model has been used to model 
commitment to haematopoietic and cardiac lineages. The first issue to address was 
whether the model systems were competent to demonstrate these two lineage 
commitments. 
3.4.1 Confirming the E S cell models 
In vitro functional assays and RT-PCR analysis were used to demonstrate lineage 
commitment and gene expression throughout the two differentiation systems, confirming 
the validity o f using the ES cell models further to study Hoxa-9 expression. 
3.4.2 Haematopoietic differentiation of E S cells 
Consistent with previous reports, substantial haematopoietic commitment was detected at 
day 4, a result consistent with previous published reports (Hole et ah, 1996). The 
enhancement or repression of detectable haematopoietic commitment with DMSO or RA 
respectively was equally in broad agreement with other studies (Lako et ah, 2000). The 
high levels of expression of early haematopoietic markers such as Flk-1, c-kit, and more 
committed genes (GATA-1) in these treated EBs, were in agreement with previous reports 
and confirmed the derivation o f haematopoietic progenitors (Shalaby et ah, 1995, Bernex 
etah, 1996). 
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3.4.3 Cardiomyocyte differentiation of E S cells 
The detection of genes expressed by cardiomyocytes (Nkx2.5, MespC, Mef2C, vMLC, 
GATA-4, Troponin T) in the differentiating ES cell systems was characteristic of the onset 
of cardiomyogensis. Coincident with the expression of these genes was the appearance of 
rhythmically beating embryoid bodies, which correlates with the emergence o f functional 
cardiomyocytes (Wobus et al., 1997). The RT-PCR data for pre-cardiac mesoderm 
markers, and lineage characteristic cardiac genes showed profiles of expression 
consistent with other reports of cardiac differentiation both in vitro and in vivo , for 
example the requirement for Nkx2.5 throughout cardiogenesis (Lints et al., 1993), and the 
requirement for Mesp2 during early stages of cardiac development (Saga et al., 1997, 
1998), but more importantly they were expressed consistently in relation to each other, 
for example, early marker GATA-4 expression was down regulated after day 10 of 
differentiation, whilst the chamber specific markers (vMLC2) was still being expressed at 
high levels at these later stages. 
3.4.4 Hoxa-9 expression in the E S cell models 
The aim of using ES cell models, was to allow the study o f Hoxa-9 expression in in vitro 
haematopoietic and cardiac systems, in order to detect changes in Hoxa-9 expression, and 
potentially to compare the expression with specific lineage marker genes. 
Southern blot analysis showed changing levels of Hoxa-9 expression in both 
developmental systems. In the haematopoietic system an enhanced Hoxa-9 expression 
was found coincident with the emergence of detectable haematopoietic commitment 
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including more committed markers of c-kit (Bernex et ah, 1996), and Flk-1 (Shalaby et 
al, 1995). 
In the cardiomyocyte differentiation system, Hoxa-9 expression was again detected by 
RT-PCR in the early developmental stages where ES cell derived cardiomyocytes. Could 
be first detected Expression became undetectable at the same time during ES cell 
differentiation when 'twitching' was no longer noticeable. 
3.4.5 The comparison of cardiogenesis in vivo/vitro 
The formation of the functional heart is very complex and is restricted to a specific time 
course (see figures 38-44). It was difficult to compare our time course o f the ES cells that 
were derived from E5 mouse blastocysts, to what would be occurring in the cardiac 
system of the embryonic mouse at that time. 
However, some evidence has been demonstrated of morphological similarities by the 
expression o f cardiac marker genes at selected time points during our differentiation 
process; for example Mef2C is required for cardiac looping and right ventricle 
development at around E10 of embryonic development, which respectively could be 
suggested to be around day 5 in the ES cell model, this expression is shown in figure 60. 
However in this study a direct comparison between in vitro and in vivo systems has been 
largely avoided. 
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3.4.6 Potential roles for Hoxa-9 in development of the heart and blood system 
3.4.6.1 Hoxa-9 in early heart development 
On cardiomyocyte initiation, expression levels increased in the early stages o f 
differentiation up until day 10 when comparatively asymmetry of the functional heart is 
prominent and the chambers have formed in the mouse embryonic heart. The expression 
patterns were similar to those of early determinating cardiac genes such as Mesp2 in 
mesoderm migration to determine cell fate, Nkx2.5 involved in cardiac looping, and 
Troponin T involved in contractile components. The patterning appeared not to be 
consistent with the later development morphological specific cardiac genes such as the 
ventricular chamber specific vMLC or GATA-4 involved in heart tube formation, 
therefore suggesting a potential functional role for Hoxa-9 in early cardiac development. 
However, 'early' cardiac development is very complex and requires a large amount o f 
interactions between signalling molecules to differentiate cardiac tissue (see figures 38-
41), and defining or suggesting a functional role for Hoxa-9 based on this expression data 
alone is difficult, and speculations can only be made by comparing Hox-a9 expression to 
the RT-PCR data collected from the expression of the lineage markers, and correspond 
these patterns of expression to morphological changes that occur at those time points in 
the embryo. 
3.4.6.2 Hoxa-9 as a potential regulator of cell proliferation 
It is important at this point to consider the conclusions drawn from the wholemount and 
in situ hybridisation data o f a possible role for Hoxa-9 as a regulator of cell proliferation 
in the developing atrial and ventricular heart cells. After all, Hoxa-9 has played several 
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parts in other proliferation steps during development (Kessel et ah, 1991, Yamada et ah, 
1994). 
I f there were a potential role for Hoxa-9 during the proliferation of early cardiomyocytes, 
then it would be expected to see Hoxa-9 expression throughout the time point when 
different structural features are being formed from dividing cells. Coincidentally, 
detectable levels of Hoxa-9 expression using RT-PCR are identified from day 0 to day 10 
of in vitro development, when comparatively in vivo, the formation of the four heart 
chambers has taken place. 
It could also seem probable that Hoxa-9 is fu l f i l l ing a similar proliferative role in the 
early stages of haematopoiesis, as there were high levels of Hoxa-9 expression and an 
increase in haematopoietic commitment around day four o f in vitro differentiation, when 
in vivo, the number of haematopoietic progenitors begin to expand (reviewed Medvinsky 
andDzierzak, 1996). 
Hoxa-9 expression levels became undetectable by day 11. In the developing heart 
respectively, by this time in development the heart is ful ly formed and functioning, and 
much of the morphological and terminal differentiation steps of cardiac cells has taken 
place which may further suggest a functional role for Hoxa-9 during heart formation, in 
that expression is no longer detected once formation is complete. 
3.4.7 Conclusions 
Evidence from in situ and wholemount hybridisation data o f Hoxa-9 expression in the 
developing embryonic heart has been further explored by using an in vitro ES cell 
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differentiation model to derive cardiac and haematopoietic tissue, to further investigate 
Hoxa-9 function, during cardiogenesis and haematopoiesis. 
The ES cell systems employed and demonstrated consistent and reproducible lineage 
commitment to cardiomyocyte and haematopoietic cell types. Hoxa-9 expression was 
identified throughout early developmental stages of these two processes. Expression o f 
Hoxa-9 was correlated with the emergence of both cell types, and one interpretation o f 
this data is that expression of this gene may play a role in lineage determination. 
However identifying a functional role is difficult from expression data alone, and 
therefore this study requires the application o f functional assays, including gene 
overexpression, to the in vitro ES cell model in order to analyse any phenotypic changes. 
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Chapter Four - Gene overexpression 
4.1 Introduction 
In situ and wholemount hybridisation studies along with data collected from in vitro ES 
cell differentiation models have outlined a possible role for Hoxa-9 during cardiogenesis, 
and detected expression under conditions where early haematopoietic progenitors were 
found. 
In order to identify a functional role for Hoxa-9 during these developmental processes, 
genomic manipulation studies were considered. One approach to examining the 
functionality of such genes is to study the effect o f over- or ectopic expression in somatic 
or ES cells. Previous findings using these approaches to understand Hox gene function 
wi l l be discussed in this chapter. 
4.1.1 Retroviral expression of Hox genes in somatic cells: in vitro studies 
Members of the Hox gene family have previously shown to be expressed during 
haematopoietic differentiation (see figure 12), the expression is, but not exclusively 
confined to primitive cells (Giampaolo et al., 1994, Sauvageau et ah, 1994). Retroviral 
overexpression studies with HOXB3, HOXB4 HOXA9 and HOXA\0 have all utilised the 
transduction of primary murine bone marrow cells to study the functional effects on this 
expression on lineage-specific pathways of the haematopoietic system (Helgason et al., 
1996, Nakamura et ah, 1996a, Sauvageau et ah, 1997, Thorsteinsdottir et al., 1997, 2002, 
Kroon et al., 1998, Bjornsson et al., 2001, Buske et al., 2001). 
Retroviral transduction has successfully highlighted a role for HOXB3 in proliferation 
and differentiation of both early myeloid and lymphoid development shown in recipients 
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of transduced bone marrow cells that demonstrated a decrease in the number of 
committed T-cells and an increase in thymocytes (Sauvageau et al., 1997). 
The overexpression effects of HOXBA on haematopoietic lineage commitment and 
differentiation have been more closely studied. In situ hybridisation studies with murine 
embryos revealed expression in derivatives o f the mesoderm (Graham et al., 1988, 
Holland et al., 1988), which ultimately give rise to cells in the haematopoietic system and 
HOXBA mRNA has also been observed in the foetal liver, a major site of embryonic 
haematopoiesis (Graham et al., 1988). Lethally irradiated recipients of HOXB4-
transduced bone marrow cells demonstrated an expansion in primitive haematopoietic 
cells (CD34+), as well as an increase in haematopoietic stem cell (HSC) regeneration 
which was sustained for up to one year, without haematopoietic differentiation being 
altered in definitive cell types (Sauvageau et al., 1995, Thorsteinsdottir et al.. 1999, 
Antonchuk et al., 2001), suggesting a role for HOXB4 during early progenitor stages o f 
haematopoiesis. 
There is evidence to suggest that HOXA10 overexpression in bone marrow cells increases 
the proliferation of early progenitor cells and can lead to the development of myeloid 
leukaemia (Thorsteinsdottir et ah, 1997). 
Another further overexpression study investigated more closely the role of HOXA10 in 
normal primitive haematopoietic progenitors. Buske (Buske al., 2001) overexpressed 
HOXA10 in human purified CD34 + haematopoietic progenitor cells derived from human 
cord blood or foetal liver sources, and the impact of the aberrant gene expression on 
differentiation and proliferation in vitro and in vivo was analysed. Data from this study 
provided evidence that the balanced expression o f HOXA10 is important for normal 
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human haematopoietic development and that aberrant expression contributes to impaired 
myeloid differentiation and increased proliferation of human progenitor cells (Buske et 
al., 2001). 
As well as studying the effects of Hox gene overexpression in cell lines, retroviral gene 
transfer has been used to investigate the phenotypes of ectopic expression in whole 
somatic cells in vivo. 
4.1.2 Retroviral expression of Hox genes in somatic cells; in vivo studies 
Hoxa-9 overexpression in bone marrow is associated with the onset of A M L within three 
to ten months (Kroon et al., 1998, Thorsteinsdottir et al., 1999). To gain a further insight 
into how Hoxa-9 affects haematopoietic development at the pre-leukaemic stage, 
Thorsteinsdottir (Thorsteinsdottir et al., 2002), retrovirally engineered its overexpression 
in HSC and generated bone marrow chimeras, and also overexpressed Hoxa-9 in 
lymphoid cells of transgenic mice. The results showed that Hoxa-9 had the potential to 
expand HSCs when overexpressed in a bone marrow transplantation model. The 
involvement of Hoxa-9 in chromosomal translocation in human leukaemia together with 
the evidence that mouse HSCs lacking Hoxa-9 compete poorly in a bone marrow 
transplantation model may suggest a role as a regulator of stem cell function (Lawrence 
etal, 1998). 
Hoxa-9 overexpression in lymphoid cells, compared with controls, partially blocked B 
lymphopoiesis. Interestingly, despite high levels of Hoxa-9 expression in T and B 
lymphoid lineages, none o f the Hoxa-9 transgenic mice developed lymphoid 
malignancies within the eighteen-month observation period in this study. This was in 
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contrast to previous reports which showed the onset of A M L within three to ten months 
(Kroon et al., 1998, Thorsteinsdottir et al., 1999). 
Bjornsson (Bjornsson et al., 2001), generated transgenic mice with a conditional reporter 
vector. The transgenic mouse model contained the HOXA10 gene controlled by a 
tetracycline-responsive element and a minimal promoter. A retroviral vector containing 
tetracycline transactivator gene was used to induce expression o f HOXA10 in bone 
marrow cells from the transgenic mice. HOXA10 induction led to the formation o f 
haematopoietic colonies in vitro containing blast-like cells and megakaryocytes. There 
was also a noticeable increase in the proliferation of primitive haematopoietic progenitors 
(CFU-S) (Bjornsson et al., 2001). 
Previous HOXk\Q overexpression studies showed that this inducible model was 
sufficient to give rise to A M L in recipient mice after a long latency period 
(Thorsteinsdottir et al., 1997). Bjornsson and Buske's studies (discussed in 4.1.1) suggest 
that this was not a primary event, but that it requires a secondary mutation to take place. 
This argument was supported by the latency period before A M L onset. There may be a 
need for the additional overexpression of HOXA\0 cofactors in order to increase the 
levels o f HOXA\Q expression to the desired threshold for A M L onset. 
An alternative approach to investigate early differentiation is to examine overexpression 
in ES cells. 
4.1.3 Overexpression of transgenes in E S cells 
The HOXB4 overexpression study by Helgason (Helgason et a!., 1996) contributes to the 
data using ES cells as targets for Hox gene overexpression. In this study ES cells were 
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retroviral-transduced with HOXB4 to study the effects on haematopoiesis. The 
overexpression significantly enhanced the number o f haematopoietic progenitors detected 
at various times in the ES differentiation cultures. There was enhanced early proliferation 
of erythroid and myeloid progenitors, without a reduction in granulocyte or macrophage 
yield. Therefore suggesting a more primitive proliferative role for HOXB4 in a lineage-
specific manner (Helgason et ah, 1996). 
Jackson (Jackson and Baird et al., 2002) used episomal vectors to study the effects o f 
both loss o f function and overexpression of a novel homeobox gene Ehox in in vitro ES 
cell differentiation. Data suggested a role for Ehox in the regulation o f early stages o f 
murine ES cell differentiation that were not restricted to haematopoiesis. 
4.1.4 Hoxa-9 overexpression and acute myeloid leukaemia: 
One investigation in studying the functions of Hoxa-9 in normal biology, is to look at the 
close association with acute myeloid leukaemia. 
4.1.4.1 Hoxa-9 and Meisl associations; 
Myeloid leukaemia was induced in leukaemic cell line mice (BXH-2) by the insertional 
mutation o f cellular proto-oncogenes or tumour suppressor genes. Following proviral 
integration into the genome of BXH-2 mice (leukaemic mice), there was correlation to 
high expression levels of Hoxa-9 or Hoxa-7, associated with Meisl. The proviral 
activation of each o f the Hox genes was strongly correlated with the proviral activation of 
Meisl suggesting that they may cooperate to produce myeloid leukaemia formation. This 
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was early genetic evidence that Meisl, a Pbx associated protein, cooperates with Hox 
genes in the onset o f A M L (Moskow et al., 1995, Nakamura et al., 1996a). 
Further studies have shown that the retroviral mediated overexpression of Hoxa-9, Pbx] 
or Meisl alone are incapable o f transforming primary bone marrow cells, nor the 
combination of Hoxa-9 and Pbxl. Only the overexpression of Hoxa-9 and Meisl a 
simultaneously induced growth factor dependent A M L in < 3 months when transplanted 
into syngenic mice (Kroon et al., 1998). 
Overexpression o f Hoxa-9 and Meisl in mouse primary bone marrow cells lead to A M L 
(Kroon et al., 1998). The protein products of these genes can form heterodimeric 
complexes that show DNA binding, suggesting that both form similar complexes with 
PBX proteins, so which is their preferred binding partner in inducing leukaemia? Three-
way DNA site selection experiments were set up in order to ascertain which proteins 
would preferentially bind (Hoxa-7, Hoxa-9, Meisl). In every experiment, a similar 
HOXA9-PBX complex resulted (Shen et ah, 1999). Electrophoretic mobility shift assay 
showed a trimeric complex also formed in the presence of MEIS1, suggesting that MEIS1 
had enhanced the in vitro HOXA9-PBX protein complex formation in the absence of 
DNA through a specific recognition site (Shen et al., 1999). It was o f interest that 
coexpression of HOXA9 and PBX1 does not elucidate leukaemic transformation (Kroon 
et al., 1998), and that it is the combined gene expression with ME1S1, it's preferred 
binding partner that results in disease. 
This may be due to the overexpression levels o f ME1S1 and HOXA9 that changed the 
normal levels of PBX, leading to the formation o f different DNA-protein complexes, or 
the high levels of PBX in the myeloid cells of previous experiment may have reflected 
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levels of this protein sufficient for interaction with exogenous HOXA9 and MEIS1 
(Kroon et al., 1998). 
Constitutive overexpression of Hoxa-9 in primary bone marrow evoked a block in 
promyelocyte differentiation in the absence o f Meis gene expression, through a 
mechanism that requires DNA binding, but not at the same binding consensus as Pbx or 
Meis (Calvo et al., 2000). This suggested that Hoxa-9 immortalisation is independent o f 
Meis gene expression(Calvo et al., 2000). 
As well as the association with Meisl, Hoxa-9 also binds other proteins. 
4.1.4.2 Hox and PBX interactions 
A number of studies have demonstrated that HOX proteins collaborate in the in vitro 
DNA binding with members o f the TALE (three-amino-acid loop extension) subclass o f 
homeodomain-containing proteins comprising PBC (mammalian PBX and Drosophila 
extradenticle (exd)) and MEIS (mammalian MEIS and PREP1 and Drosophila HTH 
proteins) families (Mann 1995). Interactions with PBX provide both increased DNA 
binding affinity for many HOX proteins (Shen et a!., 1997, 1999) and substantial DNA 
selectivity for HOX proteins from paralogue groups 1 to 10 (Chang et al., 1996). HOX 
proteins from paralogue groups 1 to 8 require tryptophan within a conserved Y P W M 
motif in order to interact with PBX, while paralogue groups 9 and 10 proteins use a 
tryptophan in a conserved A N W sequence. The remaining paralogue groups from 9 to 13 
form a cooperative DNA binding complex with another homeodomain protein, MEISI 
(Shen et al., 1997). Therefore HOX proteins from paralogue groups 9 to 10, possess the 
unique capacity to form DNA binding complexes with either PBX or MEIS on distinct 
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DNA target sequences as they are located at the transition between the Y P W M -
containing proteins and the ANW-containing proteins. There are also studies that have 
identified binding complexes showing PBX-MEIS binding sites (Chang et al., 1997, 
Knoepfler et al., 1997). 
4.1.5 Aims 
Three novel approaches to analysing the effects o f Hox gene overexpression have been 
discussed. It has been shown that retroviral transduction using Hox genes have been 
previously successful in determining a function role in haematopoiesis, in both in vitro 
somatic cells and in vivo animal studies. The application of two expression vector 
vehicles - retroviral and episomal have also been shown to be successful in 
overexpressing candidate genes in ES cell models. Previous Hoxa-9 overexpression 
studies, with one exception (Thorsteinsdottir et al., 2002), have explored the onset of 
A M L following Hoxa-9 transduction in bone marrow transplantation models. However, 
unlike the intentions o f the studies in this thesis, these reports used the transplantation 
models to additionally analyse the expression levels of Hoxa-9 interaction molecules, to 
evaluate the leukemogenic mechanisms. It is the intention in this thesis to expand the 
findings observed in the atrial and ventricular of the embryonic heart (figures 18-32) and 
identify a function for Hoxa-9 in cardiac development using retroviral mediated 
overexpression of Hoxa-9 in in vitro ES cells. 
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4.2 Materials and methods 
A l l cells were maintained in 10ml/25cm2 flask in the described media, unless otherwise 
stated. 
4.2.1 Cell maintenance 
COS-7 cell maintenance 
The COS-7 cell line was purchased from American Type Culture Collection (ATCC), 
and maintained in 50% (v/v) HAMS F12 (GibcoBRL #27165-029), 40% v/v G M E M 
(GibcoBRL #21710-025), 10% foetal calf serum in a humidified 5% C 0 2 atmosphere at 
37°C. 
3T3 cell maintenance 
The 3T3 cell line was a kind gift from Prof. Chris Hutchinson at the University o f 
Durham. The cells were passaged when confluent and maintained in D M E M (GibcoBRL 
#11966-025), 10% (v/v) heat inactivated foetal calf serum, 1% (v/v) 5000u/ml 
Penicillin/streptomyocin in a humidified 5% CO2 atmosphere at 37°C. 
Phoenix packaging cell maintenance 
The Phoenix cell line were purchased from ATCC and maintained as necessary in 
Glutamax-1 (GibcoBRL #31966-021), 10% (v/v) heat inactivated foetal calf serum, 1% 
(v/v) 5000u/ml penicillin/streptomyocin in a humidified 5% CO2 atmosphere at 37°C. 
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4.2.2 Vector construction 
The LX-GFP retroviral vector (Miller and Rossman, 1989) was a kind gift from Dr. L 
Fairbairn at the University o f Manchester. This retroviral vector allows stable gene 
expression in the host cell. DNA was ligated into this vector following the appropriate 
treatment of the vector with digestive enzymes. Briefly, for LX-GFP retrovirus vector, 10 
fig of vector DNA was incubated with 5 ul of the appropriate digestive enzyme buffer 
( lOmM Tris-HCl, 300mM KCL, 5mM MgCl 2 , 0.1 mM EDTA, 
1 m M DTT, 0.5 mg/ml BSA, 50% Glycerol), 40 units of BamHI enzyme (Promega), and 
sterile water up to the total volume of 50 ul. This solution was then incubated at 37°C for 
3 hours, and then a sample was electrophoresed on a 1.8% agarose gel (as described in 
2.2.1) to confirm the linearisation. 
The DNA to be inserted into the LX-GFP vector was treated as before (2.2.6), in that 
PCR primers were designed to add the appropriate BamHI sequence to the beginning of 
the 3' sequence of the Hoxa-9 insert, to allow for efficient ligation in the LX-GFP vector. 
5 ' sequencing primer 
GTCAAGCCCT TTGTACACCC 
14 5 1 GAAGCCTTGG CTTTTGACCC CCCTCCCTGG GTCAAGCCCT TTGTACACCC 
1 5 0 1 TAAGCCTCCG CCTCCTCTTC CTCCATCCGC CCCGTCTCTC CCCCTTGAAC 
1 5 5 1 CTCCTCGTTC GACCCCGCCT CGATCCTCCC^_l^mTCCAGC CCTCACTCCT 
Hoxa-9 insert B a m l l l 
1 6 0 1 TCTCTAGGCG CCGGAATTAG CTTATCGATA GGGGGATCCG CCCCTCTCCC 
3' Sequencing Primer 
CGCTTGGAAT AAGGCCGGTG 
1 6 5 1 TCCCCCCCCC CTAACGTTAC TGGCCGAAGC CGCTTGGAAT AAGGCCGGTG 
17 0 1 TGCGTTTGTC TATATGTTAT TTTCCACCAT ATTGCCGTCT TTTGGCAATG 
Figure 63 L X - G F P - a 9 multiple cloning site 
The BamHI cloning site has been highlighted and the sequencing 
primers indicated 
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4.2.3 Vector dephosphorylation 
To prevent re-ligation of the linearised cloning vehicle, phosphate groups from both 
termini were removed, using alkaline phosphatase. 1 ug of linearised vector made up to 
20 ul with sterile water, was added to 2 ul (1 unit/ul) calf intestinal alkaline phosphatase 
(CIAP) and 2.5 ul lOx CIAP buffer (0.5 M Tris-HCl, 10 m M MgCl 2 , 1 raM ZnCl 2 , 
10 mM spermidine). The solution was incubated at 37°C for thirty minutes, before a 
further 2 ul o f CIAP was added and incubated for a further 30 minutes at 37°C. 
The phosphorylated DNA was purified by extraction with an equal volume o f 
phenolxhloroform (50:50 v/v), and centrifuged at 4000g (Sigma, 2-15) for ten minutes. 
The upper phase was collected, and added to 3x volume of 100% ethanol, and 1/10 
volume of 3 M sodium acetate. The solution was incubated at -20°C for fifteen minutes, 
before being centrifuged at 4000g (Sigma, 2-15) for ten minutes. The pellet was collected 
and washed in 70% (v/v) ethanol, before being air dried and resuspended in 10 u.1 of TE 
buffer (see appendix A.20). 
4.2.4 Vector-DNA ligation 
Following the removal o f the phosphate ends, the vector was ligated by adding 1 u.g of 
dephosphorylated vector DNA and 1 \ig o f desired insert DNA (as described in 4.2.4) to 
1 ul (3 u/u.1) T4 DNA Ligase, lu.1 lOx T4 DNA Ligase buffer, and sterile water to a final 
volume of 10 u.1. This solution was incubated overnight, and run a sample on agarose gel 
to confirm ligation (2.2.1). 
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4.2.5 Vector transformation into bacterial cells 
The cloning protocols used for each vector were slightly different. The LX-GFP 
retroviral generation requires the insertion of DNA into the vector via a digestion, 
dephosphorylation and ligation pathway, as described previous 4.2.2-5), whereas the CT-
TOPO-GFP acquires the insert as described in 2.2.6. 
The following transformation protocols for each of the vectors are similar. 
2 ul o f the LX-GFP vector-DNA mix or the CT-TOPO-GFP-DNA mix was added to 
MAX efficiency Stbl2 (Invitrogen, Paisley, Scotland #10268-019) and one shot TOP 10 
E.coli (Invitrogen, #C4040-10) competent cells respectively, and incubated on ice for 
thirty minutes. 500 \i\ o f SOC medium (Invitrogen) was added and agitated on a platform 
shaker for thirty minutes at 37°C. Following incubation, 50-100 ul o f mix was plated out 
onto LB agar plates (see appendix A.9) containing 50 ug/ml ampicillin, and incubated 
overnight at 37°C. Colonies that developed were analysed by RT-PCR to confirm inserts 
(2.2). 
4.2.6 DNA extraction from bacterial cells 
Clones containing the required inserts were inoculated into 10ml LB broth (see appendix 
A. 10) containing 50 u.g/ml ampicillin and incubated overnight at 37°C on an orbital 
shaker. Plasmid DNA was extracted from the bacterial cells using Promega miniprep kit, 
following the manufacturer's instructions. Briefly, the cultures were centrifuged at 4000g 
(Sigma 2-15) for ten minutes, and the pellet of bacterial cells were resuspended in 250 u.1 
resuspension buffer and transferred to a microcentrifuge tube containing 250 ul o f lysing 
buffer. 350 u.1 of neutralisation buffer was added to this mix, before the solution was 
centrifuged at 4000g (Sigma 2-15) for ten minutes and the supernatant transferred to the 
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QIAprep column. After the supernatant had been applied, the column was centrifuged at 
4000g (Sigma, 2-15) for 60 seconds, and the flow-through discarded. 0.5 ml of wash 
buffer was added into the column and a further centrifugation step was carried out as 
before. The spin column was washed further, the flow-through discarded and 50 ul TE 
buffer (A.20) was applied to the column, following an identical centrifugation step as 
before, the eluted DNA was stored at -20°C. 
The vector DNA was then sequenced using DNA sequence specific forward and reverse 
sequencing primers particular for that vector, as shown in B. l -5 . 
4.2.7 Calcium phosphate transfection 
Vector constructs were incorporated into cultured cells in some experiments by using a 
calcium phosphate transfection technique. This procedure was carried out using the 
calcium transfection kit (Sigma, Poole, Dorset, England), following the manufacturers 
instructions. Briefly, COS-7 (CT-TOPO-GFP) or Phoenix cells (LX-GFP) were plated 
out in sterile 6 well plates at a density of 2 x l 0 5 cells per well, 24 hours prior to 
transfection. Under sterile conditions, 5 fig (in 10 u.1 sterile water) of purified DNA 
(4.2.5) was mixed with 6 ul o f calcium phosphate, made up to 50 ul with sterile water 
that was added drop wise into 60 u.1 o f HEPES that was being vortexed (see appendix 
A.5) (HATI Rotamixer). This was left at room temperature for ten minutes, before being 
transferred to the tissue culture plates containing the pre-plated cells, in 5ml of fresh 
media. These were incubated at 37°C at 5% CO2 for twelve hours when a fu l l media 
change was carried out. After a total o f forty-eight hours following transfection, the cells 
were analysed for GFP fluorescence by f low cytometry. Each set of transfection 
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experiments using CT-TOPO-GFP(aP) was carried out twice to generate two independent 
sets of data in each cell type. 
4.2.8 Electroporation 
CGR8 ES cells were grown in the presence of LIF, and harvested (3.1). These cells were 
collected and centrifuged at lOOOg for five minutes (Sigma, 2-15). The supernatant was 
removed and 3 x l 0 6 cells were resuspended in 1ml ice cold PBS (see appendix A.15). 
10 jag of purified linearised vector DNA (see 4.2.2) was added to the cell suspension and 
incubated for five minutes. The 1 ml mix was placed into pre-chilled electroporation 
cuvettes and shocked at 240 volts (BTX electronic genetics - ECM395 electrocell 
manipulator). The cells were than incubated on ice for ten minutes before being added to 
10 ml fresh CGR8 media, and transferred to culture flasks. Twenty-four hours following 
electroporation, the cells were put under antibiotic selection. This selection was achieved 
400 ug/mL of G418 (a neomycin analogue). Previous work had shown that for these cells 
lines, this concentration of antibiotic gave optimal selective properties (data not shown). 
4.2.9 Flow cytometry 
This facility was used at The University of Durham, operated by Ms. Trudy Horton 
(Beckman Coulter Diagnostics, using EXPO Cytometer software). For each set of f low 
cytometry data, 10,000 events were analysed. 
Flow cytometry is carried out in addition to using fluorescent microscopy to detect 
expression i f GFP, as lower levels of expression can be detected using f low cytometry 
then microscopy, which relies on the human eye. 
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4.2.10 Retroviral transduction of cultured cells 
Following the calcium phosphate transfection of the LX-GFP vector containing the insert 
(see 4.2.7) into the packaging cell lines (Phoenix), the cells were further incubated in 
tissue culture flasks containing fresh media, until confluent. When confluent, the media 
was replaced with 5 ml o f medium and cells were incubated for a further forty-eight 
hours. The supernatant was then removed and centrifuged for five minutes at lOOOg 
(Sigma, 2-15), to remove any remaining packaging cells. The supernatant was then 
filtered (0.45 um), and collected in a sterile universal tube. 
2ml of supernatant was added to 3ml o f fresh media on top o f 2x10 s previously grown 
3T3 or CGR8 cells giving a total of 5ml of media in the tissue culture flask, 4 |ig/ml o f 
polybrene (GibcoBRL) was added to aid the transduction process. The media was 
changed and the presence of GFP was analysed by flowcytometry after forty-eight hours. 
Each set of transduction experiments using LX-GFP(aP) was carried out twice to 
generate two independent sets o f data in each cell type. 
4.2.11 Genomic analysis of cultured cells 
Genomic DNA was extracted using the Promega, (Southampton, Hampshire, England) 
Wizard genomic DNA purification kit. Briefly, the cells were harvested, washed in 1 ml 
PBS (see appendix A. 15) and collected in a 1.5ml eppendorf tube. 600 ul of nuclei lysis 
solution was added, and the solution was agitated using a pipette until no cell clumps 
remained. 3 u.1 of RNase solution was added to the nuclear lysate and the tube mixed by 
inverting 3-4 times before being incubated at 37°C for fifteen minutes. 200 yd of protein 
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precipitation solution was added and vortexed at high speed for twenty seconds (HATI 
rotamixer). The sample was then spun at 13,000g (Sigma 2-15) for four minutes. 
The supernatant was collected and DNA precipitated with 600 ul of propan-2-ol. The 
solution was gently mixed by inversion until threads of DNA appeared. Precipitated 
DNA was pelleted by centrifugation for one minute at 4000g (Sigma, 2-15). The 
supernatant was carefully removed and discarded and the remaining pellet was washed in 
70% (v/v) ethanol. Once the ethanol was removed, the pellet was air-dried and 
resuspended in 100 ul rehydration solution. 
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4.3 Results 
Evidence presented in this thesis from in situ and wholemount data suggested that Hoxa-
9 is expressed in a spatial (in the heart atria and ventricle), and temporal (at E9.5 and 
10.5) manner in developing cardiomyocytes within the embryonic heart. 
The expression o f Hoxa-9 in differentiating ES cells suggested that Hoxa-9 is expressed 
during early stages o f haematopoietic commitment. 
In order to answer the question as to why Hoxa-9 is being expressed at specific sites 
during these critical times in development, this study must further investigate a functional 
role. To identify a functional role for Hoxa-9 during these developmental processes, 
genomic manipulation techniques were adapted to overexpress Hoxa-9 in ES cells. 
The overexpression of genes in host cells can be achieved in a temporary (transient) or 
permanent (stable) manner. Transient transfection allows a rapid high level of expression, 
but then the expression disappears as the cells fail to stably integrate the DNA, and hence 
they lyse. Stable transfection obtains moderate levels of expression over a continuous 
period of time in culture following stable integration o f the expression vector in the host 
cell genome. 
4.3.1 Stable transfection of C T - T O P O - G F P in embryonic stem cells: 
4.3.1.1 Electroporation of C T - T O P O - G F P in embryonic stem cells; 
The fu l l length coding sequence o f Hoxa-9 cloned in the CT-TOPO-GFP reporter vector 
(see figure 13, page 46) was electroporated into ES cells as described in 4.2.8. Following 
transfection, the CGR8 ES cells were cultured (see 3.2.1) for forty-eight hours before 
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GFP expression was analysed using f low cytometry and fluorescent microscopy, shown 
in figure 64. 
For each set o f overexpression experiments in this study, a control transfection was 
carried out using an 'empty vector' to account for any false positive data following Hoxa-
9 transfections, and a mock transfection containing no DNA, shown in figures 64-70 as 
'negative'. This latter cell population was used to set up logical gate margins for the f low 
cytometry data. 
4.3.1.2 G F P expression analysis; 
The CGR8 ES cells transfected with the empty vector (CT-TOPO-GFP), showed an 
expected high level o f GFP expression seen using fluorescent microscopy (figure 64), 
compared to mock transfected cells where GFP expression was not visible. 
These GFP expression findings using fluorescent microscopy were confirmed using f low 
cytometry. The empty vector transfected cells generated a high peak of fluorescence 
along the FL-1 y-axis (figure 64), demonstrating that 98.6% of transfected cells expressed 
GFP within the gates (figure 71). This result confirmed the efficiency of using 
electroporation to transfect ES cells with CT-TOPO-GFP constructs. However, f low 
cytometry confirmed that the ES cells transfected with the Hoxa-9 reporter gene (CT-
TOPO-GFP-a<?) were not overexpressing GFP and therefore Hoxa-9, confirmed using 
PCR. 
One possibility is that transcription of Hoxa-9/GFP may take longer to be detected, and 
therefore cells were analysed using the same methods following six further passages; and 
similar undetectable levels were obtained (figure 65). 
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In order to examine whether CT-TOPO-GFP-aP had been incorporated into the genome, 
genomic DNA and RNA (treated with DNase to exclude genomic contamination) was 
extracted from the cells forty- eight hours after transfection and at passage 7 to analyse 
incorporation and expression. PCR analysis (described 2.2.1) was carried out to detect the 
presence of CT-TOPO-GFP-o9 construct by using primers specific for the Hoxa-9 
sequence (shown in B . l ) . 
The genomic DNA data showed incorporation of CT-TOPO-GFP-aP, but consistent with 
the poorly observed GFP expression, Hoxa-9 mRNA was undetectable in RT-cDNA 
(figures 64-70). These cells, although not showing evidence o f transgene transcription, 
were further expanded under antibiotic selection (see 4.2.8). These cells grew very slowly 
in comparison to controls (data not shown), and GFP could not be visualised using 
microscopy at this stage. The poor growth o f the ES cells transfected with CT-TOPO-
GFP-o9 compromised further analysis using flow cytometry and RT-PCR. 
As stable expression (random integration of the cloning vector into the host cell genome) 
of Hoxa-9 could not be obtained in CGR8 cells, it followed to test CT-TOPO-GFP-oP 
transfection using transient expression methods. To confirm the initial efficiency of this 
method, transient expression was carried out in COS-7 cells. 
4.3.2 Transient transfection of C T - T O P O - G F P : 
4.3.2.1 Transient transfection of C T - T O P O - G F P in COS-7 cells; 
COS-7 cells were transientally transfected as before with the empty vector, the mock 
transfection and the CT-TOPO-GFP-aP. 
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4.3.2.2 G F P expression analysis; 
Forty-eight hours post calcium phosphate transfection with the CT-TOPO-GFP 
constructs, GFP expression was examined using f low cytometry in the COS-7 cells. As 
seen using fluorescent microscopy, COS-7 cells transfected with CT-TOPO-GFP-aP and 
the empty vector (CT-TOPO-GFP) showed high levels o f GFP expression (6.70% and 
31.90% respectively) within the gate margins (figures 66, 71). As can be seen in figure 
66, levels of fluorescence in both empty vector and CT-TOPO-GFP-aP confirmed 
transfection and vector efficiency and suggested vector integration and consequently 
Hoxa-9 expression. To be consistent, PCR analysis was carried out to confirm these 
COS-7 cell findings, and figure 66 demonstrates both genomic integration and Hoxa-9 
transcription. 
4.3.2.3 Transient expression using the C T - T O P O - G F P construct in E S cells; 
This transient method of CT-TOPO-GFP-a9 in COS-7 cells confirmed the efficiency o f 
the transfection method and the vector, and therefore the procedure was repeated using 
CGR8 ES cells, in place of the COS-7 cells. 
4.3.2.4 G F P expression analysis; 
Forty-eight hours after calcium phosphate transfection in ES cells, GFP expression could 
be seen using fluorescent microscopy, in ES cells transfected with CT-TOPO-GFP-oP 
compared to controls. The fluorescence levels were not as intense as those cells 
transfected with the empty vector, and this was confirmed using flow cytometry (figure 
70). 2 1 % of cells transfected with the empty vector showed fluorescence within the gate 
157 
margins along the FL-1 scale, whilst only 2.99% showed fluorescence following 
transfection with CT-TOPO-GFP-a9 (figure 74). Compared with the control and 1.61% 
of cells showing fluorescence in mock transfected cells, CT-TOPO-GFP-a9 transfected 
ES cells showed a comparatively lower level o f GFP and hence Hoxa-9 overexpression. 
4.3.2.5 Problems using the C T - T O P O - G F P - a 9 construct in E S cells 
ES cells transientally transfected with CT-TOPO-GFP-aP demonstrated a higher 
percentage of cells showing fluorescence within the gates (figure 67) than those stably 
transfected with the same expression vector (figure 65). However, the purpose of this 
overexpression study, is to differentiate ES cells that overexpress Hoxa-9 to compare 
changes in lineage commitment, and therefore transient expression is not sufficient, in 
that there is only short term overexpression. The purpose of these transient transfections 
in both ES cells and COS-7 cells was to confirm that the vector was capable o f 
overexpressing Hoxa-9 transcription in these cell lines. The data shown in figures 66-67, 
compared to controls, confirm the efficiency. 
Transient expression brought about minimal levels of expression (2.99% of cells showing 
fluorescence) compared to controls, confirming that the CT-TOPO-GFP-a9 construct is 
functioning (at low levels) in ES cells, however this method is insufficient as it only 
overexpresses Hoxa-9 short-term and therefore alternative overexpression systems were 
investigated. 
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4.3.3 Retroviral overexpression studies: 
4.3.3.1 Retroviral overexpression of Hox genes; 
Previous Hox gene overexpression reports have used retroviral gene transduction to 
produce the stable expression of Hox/'HOXgenes into target cells. For Hoxa-9, the use o f 
retroviral gene transfer has been used to overexpress these Hox genes into bone marrow 
cells to assess a functional role in the haematopoietic system of recipient mice 
(Thorsteinsdottir et al., 1997, 2001, Lawrence et al., 1997, Izon et al., 1998, Kappen et 
al., 2000), like HOXA10 (Thorsteinsdottir et al., 1997, Bjornsson et al., 2001, Buske et 
al., 2001), and HOXB3 (Sauvageau et al., 1995, 1997). 
Other unrelated studies, have successfully used retroviruses to overexpress other Hox 
genes into ES cells (Helgason et al., 1996, Keller et al., 1998, Jackson and Baird et al., 
2002). In order to overcome the previous issues of insufficient stable transfection in ES 
cells using the SV40-driven expression vector a MoMLV-based retroviral vector was 
constructed containing the fu l l length Hoxa-9 coding sequence (as described in 4.2.5-10). 
4.3.4 The application of the L X - G F P - o 9 construct: 
4.3.4.1 G F P expression analysis in the Phoenix packaging cells; 
Phoenix packaging cells were transfected with: empty vector (LX-GFP) where after 
forty-eight hours 24.1% of cells showed fluorescence within the gate margins (figure 68); 
LX-GFP-a9 construct (22.5% fluorescence) and a mock transfection (0.90% 
fluorescence). PCR analysis verified this f low cytometry data, and demonstrated that the 
LX-GFP-<39 construct had been incorporated into the phoenix cell genome and that these 
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cells were showing Hoxa-9 transcription, and therefore supernatant was collected from 
the phoenix packaging cells to infect CGR8 ES cells, as described in 4.2.10. 
4.3.4.2 G F P expression analysis following the retroviral transduction of C G R 8 E S 
cells; 
Forty-eight hours following application of the phoenix cell supernatant to the ES cells, 
the GFP expression was analysed as described previously in section 4.3.1.2. Cytometry 
showed very low levels of fluorescence in ES cells transduced with the empty vector and 
with LX-GFP-a9 (figure 69). Further PCR analysis from genomic DNA and cDNA 
suggested that the construct had been integrated into the genome of the ES cells, but had 
failed to show GFP transcription consistent with the low levels o f GFP expression shown 
by f low cytometry (figure 72). To confirm the viability o f the retroviral vector system, 
3T3 cells were transduced. 
4.3.4.3 G F P expression analysis following the retroviral transduction of 3T3 cells; 
Following application of the phoenix cell supernatant, the 3T3 cells were analysed for 
fluorescence and GFP transcription. Flow cytometry showed fluorescence in the cells 
transduced with the empty vector (3.02% of cells showing fluorescence), and in cells 
transduced with the LX-GFP-oP construct (4.83%) (see figure 70). PCR analysis 
confirmed the incorporation and transcription of the transgene using the LX-GFP-aP 
construct in 3T3 cells. 
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4.3.5 Summary 
In summary, initial stable expression in CGR8 ES cells using a conventional CT-TOPO-
GFP vector with the Hoxa-9 fu l l coding sequence insert (CT-TOPO-GFP-a9), failed to 
transcribe the transgene, although genomic DNA showed incorporation o f the construct 
into the ES cell genome. Following this unsuccessful method, the efficiency o f the CT-
TOPO-GFP-tf9 construct in ES cells was tested by transient transfections, initially in 
COS-7 cells and subsequently in CGR8 ES cells, and was confirmed using f low 
cytometry, however the products o f this transient method were insufficient for further use 
in this study. 
Previous studies using retroviral gene transfer to overexpress Hox and other genes in ES 
cells had been successful, and therefore a MoMLV-GFP (LX-GFP) based retrovirus was 
constructed containing the same Hoxa-9 insert (LX-GFP-a9). The initial viral packaging 
cells showed a high proportion o f cells showing fluorescence, and GFP transcription, and 
therefore CGR8 ES cells were infected with the active viral particles collected from the 
supernatant of the packaging cells. However, as before in ES cells, genomic 
incorporation was demonstrated but transgene transcription levels were undetectable. 
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4.4 Discussion 
ES cell overexpression data involving conventional transfection techniques and retroviral 
constructs have been successfully used to identify functional roles for candidate genes, 
including members of the Hox gene family in several developmental processes. However, 
these studies have not to date reported on the overexpression effects of Hoxa-9 in ES cell 
differentiation models and there is no data on the functional roles for Hoxa-9 in 
embryonic cardiogenic and haematopoietic differentiation pathways. In order to address 
this, two different methods o f engineering overexpression o f Hoxa-9 in ES cells; calcium 
chloride transfection and retroviral tranduction were employed in this study. Although 
low level transient transfection was observed in a limited number o f experiments, no 
stable overexpressing clones were isolated. There could be a number of possible 
explanations; these include the suitability o f the vector, the competence o f ES cells to be 
retrovirally transduced and the capacity o f ES cells to overexpress Hoxa-9. 
AAA The vector construct 
It is possible that the expression vectors used in this study were incompatible to 
overexpressing in ES cells, as transgene transcription was undetectable in these cells 
following transfection. However the evidence shown in this study, of high levels o f 
fluorescence shown by f low cytometry following transfection with the control empty 
vector, against the mock transfections, demonstrate the vector efficacy for transgene 
transcription, as measured by GFP expression using f low cytometry, but does not 
eliminate the incompatibility of the retrovirus vector as control experiments (LX-GFP), 
like the LX-GFP-oP infection showed undetectable GFP levels. However it is important 
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to note that there is evidence o f such vectors including those used here in successful 
heterologous gene overexpression in ES cells (reviewed Friedrich and Soriano, 1993, 
Helgason et al., 1996). Therefore an alternative to the vehicle construct is the desired 
gene insert. 
4.4.2 The vector insert 
It is possible that the inefficient overexpression of Hox-9 in ES cells was due to the 
function of the insert. There was insufficient cell growth observed in ES cells stably 
transfected with the CT-TOPO-GFP-oP construct, in comparison to control transfections, 
which may suggest that it was the addition of the Hoxa-9 insert in the vector that resulted 
in this poor growth phase. 
There is evidence however, to suggest that the Hoxa-9 coding sequence insert in the 
expression construct was not in itself preventing overexpression, as there was successful 
overexpression in transfected COS-7 cells, and evidence o f transient expression in ES 
cells (Figure 66-67). Also similar levels of fluorescence were observed in ES cells 
following retroviral infection of the empty vector (LX-GFP), and LX-GFP-aP 
respectively, suggesting further that it is not the Hoxa-9 insert causing transcription 
repression. 
4.4.3 The target cells 
Evidence has been shown to eliminate the possibility o f the construct and the Hoxa-9 
insert preventing overexpression in ES cells. It is therefore possible that the ES cells that 
were incompetent in overexpressing Hoxa-9, using a conventional heterologous promoter 
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and retroviral tranduction. However, there is evidence to suggest otherwise that retroviral 
mediated transduction has been used successfully to manipulate ES cells in vitro and 
shown to be a convenient means to perform insertional mutagenesis in the mouse 
(Hoeben et al., 1991, Prince et al., 1991, Tsukiyama et al., 1992). This previous evidence 
suggests that ES cells are largely compatible to ES cell overexpression, and other 
repressive mechanisms should be considered as potential causes in this study. 
4.4.4 DNA methylation 
It has been shown that retroviral expression can be repressed in numerous cell types, 
including ES cells and HSC (Asche et al., 1984, Challita et al., 1994). For example, 
retroviral expression vectors that are functional in mature haematopoietic cells fail to 
express the transgene in animals transplanted with infected stem cells (John, 1995, Krall 
and Kohn, 1996, Lei et ah, 1996). Transcriptional repression is thought to be mediated by 
both c/s-type-de novo methylation of the integrated proviruses and cell-type-specific 
trans-acting transcriptional repressors (Gautsch, 1980, Loh et ah, 1990, Hoeben et al., 
1991). The effect o f ^raws-acting factors on retroviral expression through binding o f 
specific sequences within the promoters of retroviruses has been examined in many 
studies (Petersen et al., 1991, Prince and Rigby, 1991, Tsukiyama et al., 1992). In 
contrast the role of methylation in silencing has been less clear. DNA methylation is 
thought to be a general mechanism used by cells to silence foreign DNA and may be 
involved in the cell defence against transposable elements (Yoder et al., 1997). DNA 
methylation has also been associated with the repression o f gene expression and the 
silencing o f viral control elements (Jahner et al., 1985, Cedar et al., 1988, Walsh et ah, 
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1998). ES cells have provided a good model to study the role of DNA methylation in 
retroviral silencing. First, it was demonstrated that ES cells have high de novo 
methylation activity, which leads to effective methylation of integrated retroviral vectors, 
while little or no de novo methylation activity was detected in differentiated cells (Lei et 
al., 1996). In addition ES cells have been genetically modified to alter the endogenous 
level of DNA methylation by the targeted disruption of the maintenance 
methyltransferase gene Dnmtl. ES cells homologous for this mutation proliferate 
normally with their genomic DNA highly demethylated, while differentiated cells and 
mice die due to the loss of genomic methylation (Li et al., 1992, Lei et al., 1996). 
Therefore these modified ES cells are useful to study the effect of DNA methylation on 
retroviral gene expression. 
4.4.5 Conclusions 
In situ, wholemount and in vitro ES cell expression data have suggested potential roles 
for Hoxa-9 during the development of the cardiac and haematopoietic system. It followed 
that this study should attempt to identify a functional role for Hoxa-9 during these 
developmental processes. 
Two previously used expression vector systems, including a CT-TOPO-GFP construct 
under the control of a heterologous promoter, and a retroviral vector (LX-GFP) were 
adapted to overexpress Hoxa-9 in ES cells. 
Initial stable transfections into ES cells appeared inconclusive, with Hoxa-9 transcription 
levels undetectable, however control transfections confirmed vector efficiency in ES 
cells. 
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The LX-GFP-oP retroviral infection in non-ES cells (3T3 cells) showed moderate levels 
of fluorescence compared to mock experiments, confirming transduction efficiency using 
the retrovirus system, but infected ES cells with either LX-GFP or LX-GFP-o9 showed 
undetectable fluorescence using f low cytometry. Evidence has been demonstrated from 
this report and previous findings to eliminate the possibilities of neither the vector 
constructs, not the Hoxa-9 insert causing transcription repression in ES cells, and possible 
causes have been discussed. 
The expression pattern in the embryonic heart demonstrated using wholemount and in 
situ hybridisation techniques in chapter two, may have possible implications in heart 
development and function studies. It wi l l therefore be important to continue to look at 
alternative genomic manipulation studies using Hoxa-9 to identify a function for this 
gene cardiac development, where a potential association has been initially highlighted in 
this thesis. 
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Chapter five - Final discussion 
5.1 Summary 
This study has incorporated a range of techniques to investigate the expression patterns of 
Hoxa-9 during embryonic development. One purpose was to explore the potential role o f 
Hoxa-9 during normal haematopoiesis driven by evidence for its involvement in 
abnormal haematopoiesis. In addition to finding Hoxa-9 expression in differentiated ES 
cell populations that demonstrated haematopoietic commitment, Hoxa-9 was also shown 
to be expressed in a spatial and temporal manner in the embryonic heart. Overexpression 
techniques were applied to the ES cell model, to identify a functional role for Hoxa-9. 
There are several approaches that could facilitate finding the functions and regulatory 
roles of Hoxa-9 during these developmental processes. Such approaches have 
successfully been used in earlier reports to explore the role o f several other Hox genes 
during various developmental processes, including haematopoiesis. Broadly speaking 
they result in either loss-of-gene-function, or gain-of-gene-function. (Shen et al., 1989, 
Takeshita et ah, 1993, Lawrence et al., 1995, 1997, L i l l et al., 1995, Helgason et al., 
1996, Thorsteinsdottir et al., 1997, 2002, Crooks et al., 1999, Kappen et al., 2000, Buske 
et al., 2001, Yaron et al., 2001). 
5.1.1 Future work 
Given more time, there are numerous alternative experiments that could be carried out to 
identify a functional role for Hoxa-9 during cardiogenesis. These future experiments are 
important as a potential association between developmental stages o f cardiogenesis and 
Hoxa-9 expression has been shown, which have the potential to suggest a functional role 
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for Hoxa-9 during the development of the embryonic heart. This work would allow a new 
insight into the role o f Hoxa-9 during development, other than those areas previously 
studied as well as providing potential therapeutic applications in heart development 
malformations. 
5.1.1.1 Testing DNA methylation 
It has been suggested that DNA methylation may be a potential cause of repression in the 
transduced ES cells in this study. Future work could investigate this problem by applying 
bisulphite based cytosine methylation analysis to the genomic DNA extracted from the 
ES cells to test for methylation. This method is based on a chemical modification o f 
cytosine residues (methylation) in the presence of sodium bisulphite (Frommer et al., 
1992). In the first step o f the bisulphite reaction, cytosines are sulfonated and deaminated 
converting them to uracil sulphonate. A subsequent desulphonation at a basic pH 
completes the conversion from cytosine to uracils. After bisulphite treatment the 
chromosomal region of interest is PCR-amplified and the PCR products sequenced. Only 
methyl-cytosines are detected as cytosines in this sequencing reaction, whereas all 
unmethylated cytosines appear as thymidines (Olek et al., 1996). This sequence could be 
compared to controls to identify areas of methylation in the DNA of infected ES cells. 
Other future work could include alternative genomic manipulation techniques using 
Hoxa-9 in the ES cell model. Overexpression techniques are invaluable in identifying 
functional roles for candidate genes throughout development, and their advances in 
understanding the role o f Hox genes in haematopoiesis has been invaluable. In this thesis 
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two different previously successful, overexpression methods were applied to Hoxa-9 in 
an in vitro ES cell model, however, these results were inconclusive. One approach for 
overexpressing Hoxa-9 in ES cells could be carried out using conditional expression 
vectors - an alternative vector system to those used previously in this thesis which allows 
a regulatable method of overexpressing transgene under the control o f a selected 
antibiotic promoter. 
5.1.1.2 Conditional overexpression 
This method allows the regulatable gene expression in a wide variety of cell types, which 
could include the ES cell model previously used in this manuscript. One convenient 
method is to use a tetracylin-inducible high-level gene expression system as described by 
Gossen and Bujard (Gossen and Bujard, 1992). In conjunction with a packaging cell line 
as before, the retroviral 'Tet' vectors produce infectious, replication-incompetent 
retrovirus that can be used to introduce a gene of interest into a selected cell line. 
This method would allow the controlled overexpression of Hoxa-9 at selected times 
during ES cell differentiation in vitro, by the addition (activation) or removal 
(suppression) of tetracycline to the culture. This expression could be implicated into the 
equivalent stages during differentiation at crucial times o f Hoxa-9 expression during 
development e.g. E9.5 during cardiogenesis differentiation. This could also be applied to 
the haematopoietic pathway of differentiation. Any changes in Hoxa-9 gene expression 
compared to control experiments, or changes in commitment could then be monitored to 
identify a functional effect. 
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Bjornsson (Bjornsson et al., 2001) used a Tet-retroviral vector system to generate 
transgenic mice overexpressing HOXA10 that could be induced or repressed depending 
on the presence or absence o f tetracycline. Consequently, a vector containing the 
tetracycline transactivating gene was used to induce expression o f the HOXA10 gene in 
bone marrow cells from the transgenic mice. This method of using a conditional 
expression vector under the control o f a transactivating gene, could be applied using 
Hoxa-9. This method would not only identify a potential function for the gene in the 
whole animal model, as a transgenic, but the model could be used to identify target genes 
of Hoxa-9 other than in leukaemia, by screening and analysing changes in alternative 
candidate gene expression following the generation o f the Hoxa-9 transgenic. 
As well as overexpression techniques to identity functions for Hoxa-9 during embryonic 
development, loss-of-function studies could also be used. 
5.1.1.3 Anti sense 
Several other loss-of function Hox gene studies, excluding Hoxa-9, have used the anti-
mRNA, or anti sense method to silence gene expression (Shen et al., 1989, Takeshita et 
al, 1993, L i l l et al., 1995). 
The principals of one anti sense approach could also be applied to this investigation. Loss 
of function would be achieved by employing an oligonucleotide that acts as an alternative 
binding site or decoy, for protein stabilising elements that normally interact with a given 
mRNA (Beelman et al., 1995, Liebhaber et al., 1996). By attracting away mRNA-
stabilising protein, the decoy induces instability, and ultimately destruction of the mRNA. 
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However, this technique has been replaced recently by the advanced RNAi (RNA 
interference) method. 
5.1.1.4 RNAi 
A newly developed approach would be to affect RNA interference or post-transcriptional 
gene silencing (Sharp, 1999, Gura, 2000). RNAi employs a gene-specific double-stranded 
RNA which, when introduced into a cell, leads to diminution o f the targeted mRNA. The 
actual mechanism whereby this is accomplished is poorly understood but reports suggest 
that the it lies with the size and necessity for processing the targeted dsRNA (Grishok et 
ai, 2000, Zamore et ah, 2000). In C.elegans and Drosophila this is a highly reproducible 
method for disrupting gene expression. One obstacle in mammals is that dsRNAs longer 
than 30nt wi l l activate antiviral response, leading to non-specific degradation of RNA 
transcripts and a general shutdown of host cell protein translation (Baglioni and Nilsen, 
1983, Williams, 1997). As a result, the long dsRNA generally does not produce RNAi 
activity, and RNAi therefore is not a general method used in silencing genes in 
mammalian cells. This obstacle was overcome by Tuschl and colleagues (Elbashir et al., 
2001) who found that gene-specific suppression in mammalian cells can be achieved by 
v/Yra-synthesised siRNA (small interfering RNA) that are 21nt in length, long enough to 
induce gene-specific suppression, but short enough to evade the host interferon response. 
Sui (Sui et ah, 2002), developed a DNA vector-based approach to achieve RNAi in 
mammalian cells, by which small RNAs are predicted to be synthesised from a DNA 
template under the control of RNA polymerase I I I promoter in transfected cells. RNA 
polymerase I I I (pol III) has the advantage of directing the synthesis of small non-coding 
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transcripts whose 3' ends are defined by termination within a stretch o f 4-5 thymidines 
(Bogen hagen et al., 1980). These properties make it possible to use DNA templates to 
synthesis, in vivo, small RNAs with structural features close to what has been found to 
be required for active siRNAs synthesis in vitro (Elbashir et al., 2001). 
Using this DNA-vector based RNAi approach, siRNA coding sequences (<21nt) o f 
Hoxa-9 would have to be determined, and demonstrate that it shares no homology with 
any other Hox gene, this fragment would then be inserted into the reporter plasmid, which 
ideally would contain GFP and transfected into the ES cells. The level o f GFP expression 
from the empty vector without the siRNA insert, could be compared to that of the siRNA 
containing plasmid to confirm the efficiency of silencing. Once confirmed changes in 
commitment in ES cell derived-haematopoietic and cardogenesis would be compared 
with controls. 
One method in generating loss of function is the Cre-loxP recombination method. Unlike 
the other method mentioned, Cre-loxP recombination allows gene silencing in specific 
tissues. Out of all the potential methods discussed, this method appears most suitable for 
identifying Hoxa-9 function in the cardiac and haematopoietic systems, as Hoxa-9 
expression could be under the control of either Nkx2.5 (heart) or SCL (primitive 
haematopoietic) promoters, which are specific to those tissues and the effects can be 
studied in these organs respectively. 
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5.1.1.5 Cre-loxP recombination 
The natural function o f the Cre recombinase is to mediate recombination between two 
LoxP sequences that are the same orientation, leading to the excision o f the intervening 
sequence between the two sites. Using gene targeting, loxP sequences can be stitched into 
a desired gene or chromosomal location, and the subsequent provision of a gene 
encoding the Cre product can result in an artificially generated site-directed 
recombination event. In lethal knockouts, methods have been developed to inactivate 
expression o f the target gene in only selected predetermined cells of the animal, and 
therefore the animal can survive. However, previous Hoxa-9 knockout studies have not 
shown lethality (Fromental-Ramain et al., 1996, Lawrence et al., 1997, Izon et al., 1998) 
and therefore this method would not be suitable in this study. 
The following diagrams suggest potential ways o f identifying a functional role of Hoxa-9 
in the differentiating ES cell model, and tissue specific deletion of Hoxa-9 using Cre-
loxP recombination techniques. 
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Figures 72-73 illustrate methods in which three loxP sites are introduced along with a 
marker e.g. Lac-Z at the target locus o f Hoxa-9. Cre recombinase is consequently 
transfected, and transient expression results in the recombination between the introduced 
loxP sites to give different products. Type I recombinants are used to generate mice in 
which the target locus is flanked with loxP sites. Such mice can be mated with previously 
constructed transgenic mice which carry an integrated construct consisting of the Cre 
recombinase gene linked to a tissue specific promoter (shown in figure 5.1b). Offspring 
which contain both the /oxP-flanked target locus plus the Cre gene w i l l express the Cre 
gene in the desired tissue type, and the resulting recombination between the loxP sites in 
these cells results in tissue-specific inactivation o f the Hoxa-9 gene. The specificity of the 
promoter using the Cre-LoxP method, is critical, and it is important to ensure that the 
promoter used is specific to the target tissue only, and therefore the promoters suggested 
would be suitable for this study. 
5.1.2 Further potential roles for Hoxa-9 in development from this study 
These potential future work experiments may identify the function of Hoxa-9 in heart 
development to associate with the previously unreported expression pattern shown in this 
thesis. 
The reason for this spatial and temporal pattern in the embryonic heart is difficult to 
conclude from expression data alone, without any supporting functional data, and 
therefore the implications of Hoxa-9 in heart development can only be speculated at this 
stage by analysing previously functional roles o f Hox genes in other developmental 
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processes and comparing this data with the expression patterns of Hoxa-9 in the 
developing heart in conjunction with the morphological events that occur at those times. 
Hox genes have been expressed and implemented in several proliferation processes 
during development for example, blood cell production, including HSC expansion (see 
figure 4), gut organogenesis (Duluc et al., 1997, Sekimoto et al., 1998), mammalian limb 
development (reviewed Krumlauf, 1992), and chondrocyte proliferation (Selleri et al., 
2001). Previous examples of Hoxa-9 expression in proliferating myeloid and T-cells 
(Lawrence et al, 1997, Anderson et al., 1998, Izon et al., 1998), and in the uncontrollable 
diseased state of myeloid cells - acute myeloid leukaemia have been highlighted 
(Nakamura et ah, 1996a, Kroon 2000). 
Regarding these previous studies there may be a possibility that in the developing 
embryonic heart, Hoxa-9 is differentially regulating cell proliferation, first in atria cells 
between E9.5-E10.5 and then in both the atria and the ventricle cells at E l 2 . During heart 
development at E9.5 the atria and ventricular chambers are identified and become more 
established. There is also separation of the cardiac tube into the two chambers and the 
outflow tract, which is another feature that we see staining for Hoxa-9 expression. 
It is also likely that Hoxa-9 has a similar regulatory proliferation role in the early 
haematopoietic cells. It was at this early stage when Hoxa-9 was demonstrated being 
expressed in early differentiating ES cells, and coincidentally HSCs at this time, show 
high proliferation potential in becoming the different blood cell precursors, and therefore 
require the expression of such genes. 
This potential proliferative role, as well as defining i f changes in Hoxa-9 expression are a 
requirement or a by-product of heart development could be determined by all the 
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methods discussed in this chapter, but more specifically using the Cre-loxP recombinase 
study in heart specific tissue (controlled by an Nkx2.5 promoter). 
This spatial and temporal patterning o f Hoxa-9 demonstrated in this thesis in the 
embryonic heart has previously been seen with Hoxa-9 in the developing digestive tract 
of the mouse (Sekimoto et al., 1998) using wholemount in situ hybridisation. At E9.5 
Hoxa-9 (and Hoxa-7), signals were detected in visceral mesoderm at the mid and hind gut 
levels, and showed sharp rostral borders at the ileum/caecum boundary. This mesoderm-
associated Hox gene expression is consistent and might be upstream of inductive signals 
transmitted from the mesenchymal layer (Sekimoto et al., 1998). The molecules 
responsible for the above epithelial-mesenchymal inductive signalling remain unclear, 
although a number of genes have been identified as candidates, such as Shh, the TGF-fi 
superfamily, the Wnt family, the FGF family, and several cell adhesion molecules. It 
remains to be determined which o f these genes are components o f the downstream Hox 
code in the gut. These molecules could also be responsible for inductive Hoxa-9 
signalling in the developing heart. It would be o f interest in this study, to analyse their 
expression levels in conjunction with those of Hoxa-9, and potentially apply the Cre-loxP 
technique to these genes in the heart using the Nkx2.5 promoter, to identify any 
responsive changes in Hoxa-9 expression. This method may identify potential control 
mechanisms of Hoxa-9 in the heart, and suggest possible activation pathways that could 
be further manipulated to investigate further Hoxa-9 in heart development. The 
involvement of such candidates control genes in the upstream signals for the 
establishment of the Hox code in the heart wi l l be important for understanding tissue 
morphogenesis. 
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The mechanisms involved in Hox gene regulation in tissues are relatively unclear, and 
require further investigation. It would be possible to apply gene trap screening to the in 
vitro ES cell model used in this thesis to screen for candidate genes expressed during 
cardiomyocyte and haematopoietic progenitor differentiation. Kluppel (Kluppel et al., 
2002) described a novel gene trap protocol to screen for target genes that are regulated 
during inductive events in undifferentiated and differentiated mouse embryonic stem 
cells. This approach integrated several features that allowed in vitro screening o f large 
numbers of gene trap clones prior to generating lines of mutant mice. Moreover, targets 
of spatially and temporally restricted signalling pathways were analysed by screening 
undifferentiated ES cells versus ES cells differentiated into embryoid bodies. This 
method could be employed to screen candidate Hox target genes and mediators o f 
signalling that function during different stages of heart development. 
During embryonic heart development, there are several genes identified that control heart 
morphogenesis and function which include Nkx2.5, GATA-4, Mesp2C, Mef2, and BMP-2. 
BMP-2 has been previously implicated in the activation pathway of Hox genes in 
response to Shh regulate the transcription of Hox in the growth stage o f skeletal and 
mesenchyme tissue development (Iimura et al., 1994, Roberts et ah, 1995, Watanabe et 
al., 1998). In the heart BMP-2 is expressed in early cardiac tissue and is thought to 
initialise early cardiac commitment stages (see figures 2.4f-l). In comparative terms, this 
early in vivo E7.5 stage is approximately equivalent to days 2-3 of in vitro ES cell 
differentiation. Incidentally, it is from around this stage that Hoxa-9 expression was 
detected to this model, and continued up to day 10 o f cardiomyocyte differentiation. It is 
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therefore possible that candidate genes such as BMP-2 could be regulating Hoxa-9 
expression during embryonic heart development. This theory could be tested as before by 
carrying out BMP-2 knockouts using Cre-loxP recombination with BMP-2 in the heart, 
and analysing effects on Hoxa-9 expression. The use o f conditional expression vectors 
could also be used to regulate BMP-2 expression in differentiating ES cells at specific 
stages when Hoxa-9 was initially detected and undetected during cardiogenesis (d2 and 
dlO) to examine the effects on Hoxa-9 expression. Alternatively, Hoxa-9 could be 
overexpressed in a similar manner during early stages when BMP-2 has been previously 
identified in heart development (d2-4). Following Hoxa-9 overexpression, BMP-2 
expression at these developmental stages could be examined in response to Hoxa-9 
activation. These suggested methods would help identify the regulation mechanisms 
between Hoxa-9 and BMP-2 in cardiomyocytes and heart development. The 
identification of Hox gene regulatory molecules is crucial in understanding the temporal 
and spatial expression patterns of these genes during normal development, and further 
understanding developmental malformations as a result o f Hox gene dysregulation. 
The Hoxa-9 loss of function may produce a phenotype in the developing heart that may 
have large implications on heart development and future therapeutic malformation 
studies. Although previous loss of function studies have shown no lethality (Fromental-
Ramain et al., 1996, Lawrence et al., 1997, Izon et al., 1998), the structure and function 
of the resulting chimeras was not analysed, however, just because there was no lethality 
does not mean that Hoxa-9 does not have an influencing function in heart development, it 
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is important however to understand and apply Hox gene redundancy and substitution to 
all these single gene knockout studies. 
5.1.3 Loss of function in vertebrates 
Homologous recombination in mouse ES cells, transgenic mice with mutated Hox genes 
have generated data in vertebrates on loss o f function phenotypes (reviewed McGinnis 
and Krumlauff, 1992). These experiments provide direct support for the roles o f Hox 
genes in patterning regional diversity in several developmental processes including the 
brachial region of the head (Wilkinson et al., 1989, Lumsden, 1990, Hunt and Krumlauf, 
1991a). Null alleles of Hox-1.5 (Hoxa-3) (Chisaka and Capecchi, 1991) and Hox-1.6 
(Hoxa-1) (Lufkin et al., 1991), display recessive lethal phenotypes in neonatal animals 
resulting from complex morphological defects first apparent in early embryogenesis. The 
mutant phenotypes are largely confined to the head and thorax, but there are no obvious 
transformations o f axial structures. Instead, malformations appear that are not restricted 
to a single tissue or cell type and can comprise derivatives from several germ layers 
(Chisaka and Capechhi, 1991, Lufkin et al., 1991). These loss o f function mutant 
phenotypes therefore resemble those of Lab and Dfd genes in that they are not homeotic 
transformations but structural deficiencies. 
5.1.3.1 Hox gene compensatory mechanisms and redundancy 
The observation o f loss of function transformations in Drosophila is dependent on the 
overlapping domains o f expression of other HOM-C genes. This is more complex in the 
vertebrates in light of the Hox cluster duplications, which have generated paralogous 
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genes with nearly identical domains o f expression (Gaunt et ah, 1989, Hunt et al., 
1991 b). The absence of expression o f one paralogue may be compensated by another. In 
the Hox-1.5, Hox-1.6 mutants, within the affected regions of the head, not all structures 
that normally express the mutated genes have abnormal features. In particular, the 
rhombomeres, and major domains o f Hox expression, appear completely normal, despite 
the fact that neural crest derivatives migrating from the rhombomeres are affected. 
Paralogous genes do not have identical rhombomere boundaries o f expression, and levels 
are uniformly distributed at early stages, with differences in expression. This mutant 
study provides support for the concept o f limited functional compensation or redundancy 
in some, but not all tissues, and this may be one of the reasons for the lack of obvious 
homeotic transformations observed in mice. 
Loss o f function studies of Hox genes have provided invaluable evidence for functional 
roles for several Hox genes during crucial developmental stages. However, in considering 
Hox gene redundancy and compensatory mechanisms it may be important to study the 
Hoxa-9 paralogues, including Hoxb-9, c-9 and d-9 either as double mutants with Hoxa-9, 
or as comparable single knock outs. Incidentally none of these paralogues have been 
implicated in leukaemia, haematopoiesis or cardiogenesis. 
5.1.4 Summary 
Although a functional role for Hoxa-9 could not be found in the embryonic heart and 
primitive haematopoiesis from the data in this current study, prospective future work has 
been suggested and discussed. However, this thesis has identified a spatial and temporal 
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expression pattern of Hoxa-9 during murine embryonic development in the heart atria, 
ventricles and vasculature that has not been previously reported. This expression data has 
been related to previous findings of Hox genes in spatial and temporal expression 
patterning, and potential roles suggested. It is therefore important to understand further 
the functions of Hoxa-9 during cardiomyocyte development in embryogenesis and in 
particular to examine any influential implications that the data discovered in this thesis 
may have on the future o f heart development studies. 
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Materials and methods appendix A 
All chemicals used were supplied by Sigma, Poole, Dorset, England unless stated 
otherwise. 
A.l Blocking Solution 
1% (w/v) hybridisation blocking reagent (supplied by Roche, Lewes, East Sussex, 
England) 
Dissolved in lx maleic acid buffer (see appendix A l .8) 
A.2 Denaturing Solution 
0.5M NaOH 
1.5M NaCl 
Made up in ddLhO 
A.3 Detection Buffer 
lOOmM Tris-HCl, pH 9.5 
lOOmM NaCl 
50mM MgCl 2 
A.4 Diethyl Pyrocarbonate (DEPC) water 
0.1%(v/v)DEPC in ddH 2 0 
Left in fume hood for twelve hours, 
and autoclaved 
A.5 2x HEPES buffered-saline 
50mM HEPES 
280mM NaCl 
1.5mM Na 2 HP0 4 
lOmM KC1 
A.6//1 situ hybridisation solution 
50% (v/v) formamide 
l%(v/v) SDS 
2xSSC, pH 4.5 
50ng/ml heparin 
50ug/ml yeast RNA 
A.7 In situ hybridisation wash 
solution 1 
50% (v/v) formamide 
5xSSC, pH 4.5 
(see appendix A. 17) 
l%(v/v) SDS 
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A.8 In situ hybridisation 
wash solution 2 
50% (v/v) formamide 
2xSSC, pH 4.5 (see appendix A. 17) 
A.9 L B Agar (1 litre) 
35g Lennox L agar 
(Sigma, Poole, Dorset, England 
#L-2897) 
A.10 L B Broth (1 litre) 
20g Lennox L broth 
(Sigma, Poole, Dorset, England #L-3022) 
A.12 Neutralisation Solution 
0.5M Tris-HCl adjust to pH 7.4 
3MNaCl 
Made up in ddH 2 0 
A. 14 NTMT 
lOOmM Tris-base 
50mM MgCl 2 
lOOmM NaCl 
0.1%Tween 20 
A.16 Phosphate Buffered Saline 
+ Tween (PBT) 
PBS + 10% (v/v) Tween 20 
A. 11 Maleic acid Buffer lOx 
lOOmM maleic acid 
150mM NaCl 
Adjust to pH 7.5 using 1M NaOH 
A.13 Noble agar 
0.6 or 1.2% (w/v) noble agar in 
ddH 2 0 
A.15 Phosphate Buffered 
Saline (PBS) 
Sigma, Poole, Dorset, 
England tablets containing: 
0.01M phosphate buffer, 
0.0027M KC1, 
A.17 Sodium 
chloride/sodium citrate 
(SSC) 20x 
3M NaCl 
0.3M Na3citrate.2H20 
Adjust to pH 7.0 with 1M 
HC1 
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A.18TAE buffer (50x) - 1 litre 
242g Tris-base 
37.2g N a 2 E D T A . H 2 0 
57.1ml glacial acetic acid 
A.20 T E Buffer 
lOmM Tris-HClpH 7.5 
ImM EDTA, pH 8.0 
A.19 TBST lx 
0.14M NaCl 
2.7M KC1 
25mM Tris-HCl, pH 7.5 
0.1%Tween 20 
A.21 6x TOPO Cloning 
'Stop' solution 
0.3MNaCl 
0.06M MgCl 2 
A.22 Wash Solution 1 
2x SSC (se appendix A. 17) 
0.1% SDS 
A.23Wash Solution 2 
0.5x SSC (see appendix A. 17) 
0.1% SDS 
A.24 Wholemount hybridisation solution 
50% (v/v) formamide 
5xSSC, pH 4.5 
(see appendix A. 17) 
1% (v/v) SDS 
50|ig/ml heparin 
50|ig/ml yeast RNA 
A.25 Wholemount post 
hybridisation wash solution 1 
50% (v/v) formamide 
5xSSC, pH 4.5 
(see appendix A. 17) 
l%(v/v) SDS 
A.26 Wholemount post hybridisation 
wash solution 2 
0.5M NaCI 
0.01M Tris-HCl, pH 7.5 
0.1%Tween 20 
A.27 Wholemount post 
hybridisation wash solution 3 
50% (v/v) formamide 
2xSSC, pH 4.5 
(see appendix A. 17) 
Sequence Appendix B 
All accession numbers used in this thesis are from the Genbank database 
B.l Mus Musculus homeobox A9 NM 010456 
1201 a c a t g a a a t c t g c a g t t t c a t a a t t t c g g c g g g t c g g g c t gggccggcca ggcgcgggct 
1261 
Hoxa-9 
acaatgg 
a c t g c a a t g g 
For PCR primer 
ccaocaccgg ggc 
ccaccaccgg g g c c c t g g g c a a c t a c t a t g t g g a c t c c t t c c t g c t g g g c 
1321 g c c g a c g c t g c t g a t g a g c t gggtgcggga c g c t a c g c t c cagggaccct g g g t c a a c c c 
1381 ccaaggcagg c g g c a g c t c t ggccgaacac c c c g a c t t c a g t c c t t g c a g c t t c c a g t c c 
1441 aaggcggcgg t g t t t g g t g c c t c g t g g a a c c c a g t g c a c g cggcgggcgc c a a t g c g g t g 
1501 c c t g c t g c a g t g t a t c a t c a ccaccaccac c c c t a c g t g c a t c c c c a g g c g c c c g t g g c g 
D e l e t i o n i n a l t e r n a t i v e l y s p l i c e d Hoxa-9 
1561 gcggcggcgc cggacggcag g t a t a t g c g c t c c t g g c t g g aacccacgcc c g g t g c g c t c 
1621 t c c t t c g c g g g c t t a c c c t c c a g c c g g c c t t a t g g c a t t a a a c c t g a a c c g c t c t c g g c c 
1681 agaaggggtg a c t g t c c c a c g c t t g a c a c t c a c a c t t t g t c c c t g a c t g a c t a t g c t t g t 
1741 g g t t c t c c t c c a g t t g a t a g agaaaaacaa cccagcgaag 
Cla 1 
g c g c c t t c t c cgaaaacaat 
1801 gccgagaatg agagcggcgg agacaagccc c c c a l j c g a t c c c a a t a a c c c g g c t g c c a a c 
1861 t g g c t a c a t g c t c g c t c c a c tcggaagaag 
c 
c g a t g c c c t t acacaaaaca c c a g a c g c t g 
1971 gaactggaga a g g a g t t t c t g t t t a a c a t g t a c c t c a c a c gggaccgcag g t a c g a g g t g 
1981 g c c c g g c t g c t c a a c c t c a c cgaaaggcag g t c a a g a t c t g g t t c c a g a a c c g c a g g a t g 
2041 aaaatgaaga 
Hoxa-9 Rev PCR primer 
g t t c c t g g c t c g t t t t c t g c 
aaatcaacaa ggaccgagca aaagacgagt g a g c c t t t t a g g g g c t c a t c 
2101 taaaaagaga gcaagctaga aagaaaaaga a a g g a c t g t c c g t c t c c c t c t g t c t c c t c t 
B.2 pcDNA1.3/CT-GFP-TOPO 
751 a c a a c t c c g c c c c a t t g a c g caaatgggcg g t a g g c g t g t acggtgggag g t c t a t a t a a 
811 g c a g a g c t c t c t g g c t a a c t agagaaccca 
sequencing primer 
c t c a c t a t a g gg 
871 c t c a c t a t a g ggagacccaa g c t g g c t a g t 
931 t c c a g t g t g g t g g a a t t g c c c t Hoxa-9 
T7 Forward 
t a a t a c g a 
c t g c t t a c t g g c t t a t c g a a a t t a a t a c g a 
t a a g c t t g g t a c c g a g c t c g g a t c c a c t a g 
EcoRV 
PCR i n s e r t a a g g g c a a t t c t g c a d a t a t 
974 agcacagtgg c g g c c g c t c g a g t c t a g a a t ggctagcaaa ggagaagaac t t t t c t t c a c 
1034 t g g a g t t g t c c c a a t t c t t g t t g a a t t a g a t g g t g a t g t t aatgggcaca a a t t t t c t g t 
GFP Reverse sequencing primer 
c g a t g t a t g c c t t t c g a a tggg 
1094 cagtggagag g g t g a a g g t g a t g c t a c a t a c g g a a a g c t t a c c c t t a a a t t t a t t t g c a c 
1054 t a c t g g a 
B.3 pBluescript II KS+ 
T7 For sequencing primer 
t a a t a c g a c t c a ctatagggc 
598 t t g t a a a a c g a c g g c c a g t g agcgcgcgta a t a c g a c t c a c t a t a g g g c g a a t t g g a g c t c c a c c g c g g t 
Smal Eco RI H i n d I I I 
568 ggcggccgct c t a g a a c t a g t g g a t c q c c c gggctgcadg a a t t c g a t a t c a a g c t t a t c g a t a c c g t c g 
T3 Rev sequencing primer 
gggaaa t c a c t c c c a a t t a a 
628 acctcgaggg ggggcccggt a c c c a g c t t t t g t t c c c t t t a g t g a g g g t t a a t t g c g c g c t t g g c g t a a t 
688 c a t g g t c a t a g c t g t t t c c 
268 
B.4 Mus Musculus ventricular myosin light chain 
(vMLC) NM_010861 
1 c c t c g a a c t c t c c a g a g g t g g c a a c t g g c c t c a g a c a c c a t g g c a c c t t t g t t t g c c a a g 
61 aagcggatag aaggcgggac g t c c a a c g t g t t c t c c a t g t t t g a g c a g a c c c a g a t c c a g 
121 g a g t t c a a g g a a g c c t t c a c a a t c a t g g a c cagaacagag 
vMLC FOR PCR primer 
c g g c t t c a t cgacaagaat 
a c g g c t t c a t cgacaagaat 
181 
g 
gacctaaggg a c a c a t t t g c t g c c c t a g g a cgagtgaacg t g a a a a a t g a a g a g a t c g a t 
241 g a a a t g a t c a aagaggctcc a g g t c c a a t t a a c t t c a c c g t g t t c c t c a c g a t g t t t g g g 
301 g a g a a a c t t a aaggggctga t c c t g a a g a g a c c a t t c t c a a c g c a t t c a a g g t g t t t g a t 
361 cccgagggca a a g g g t c a c t gaaggctgac t a t g t c c g g g a g a t g c t g a c cacacaagca 
421 g a g a g g t t c t ccaaagagga g a t c g a c c a g a t g t t c g c a g c c t t t c c c c c t g a c g t t a c c 
481 g g c a a t c t t g a t t a t a a g a a t t t g g t c c a c a t c a t t a c c c acggagaaga gaaggactga 
541 g c c c t g a a c c a c a g c c t c a g g t g a c c c a c a g c c c a c t c t c c a t c c c a g g g c t g t g c g c a a 
vMLC REV PCR primer 
t t g t c c t tcagaaccga gac 
601 ataaacagga a g t c t t g g c t c t g 
B.5 LX-GFP retroviral vector - a gift from Dr. L Fairbarin, University of Manchester 
1 3 0 1 A C C T T C T G C T C T G C A G A A T G G C C A A C C T T T AACGTCGGAT GGCCGCGAGA 
1 3 5 1 C G GCACCTTT AACCGAGACC T C A T C A C C C A G G T T A A G A T C A A G G T C T T T T 
1 4 0 1 CACCTGGCCC GCATGGACAC CCAGACCAGG T C C C C T A C A T CGTGACCTGG 
5 ' s e q u e n c i n g p r i m e r 
GTCAAGCCCT T T G T A C A C C C 
1 4 5 1 G AAGCCTTGG C T T T T G A C C C CCCTCCCTGG GTCAAGCCCT T T G T A C A C C C 
1 5 0 1 T A A G CCTCCG C C T C C T C T T C C T C C A T C C G C C C C G T C T C T C C C C C T T G A A C 
1 5 5 1 C T C C T C G T T C GACCCCGCCT CGATCCTCCC T T T A T C C A G C C C T C A C T C C T 
B a m H l s i t e 
1 6 0 1 T C T C TAGGCG C C G G A A T T A G C T T A T C G A T A G G G G J G A T C C G C C C C T C T C C C 
3 ' S e q u e n c i n g P r i m e r 
CGCTTGGAAT AAGGCCGGTG 
1 6 5 1 TCCCCCCCCC C T A A C G T T A C TGGCCGAAGC CGCTTGGAAT AAGGCCGGTG 
1 7 0 1 T G C G T T T G T C T A T A T G T T A T T T T C C A C C A T A T T G C C G T C T T T T G G C A A T G 
1 7 5 1 TGAGGGCCCG GAAACCTGGC C C T G T C T T C T TGACGAGCAT TCCTAGGGGT 
1 8 0 1 C T T T C C C C T C TCGCCAAAGG A A T G C A A G G T C T G T T G A A T G TCGTGAAGGA 
1 8 5 1 A G C A G T T C C T C T G G A A G C T T C T T G A A G A C A A A C A A C G T C T GTAGCGACCC 
1 9 0 1 T T T G C A G G C A GCGGAACCCC CCACCTGGCG ACAGGTGCCT CTGCGGCCAA 
1 9 5 1 AAGCCACGTG T A T A A G A T A C A C C T G C A A A G GCGGCACAAC CCCAGTGCCA 
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B.6 Mus Musculus homeobox C9 - gi: 6680254 
IMAGE cDNA clone similar to Hoxc-9 - gi: 4059801 
Hoxc-9 
IMAGE 
g t t c a t a c a a t a a t c t t a t g t a t g t a a a a c c c t g t t a c g a t g t c g g c g a c g g g g c c c a t c 3 69 
M M I I I I I I I M M I I ) I I I I I I I I I I I I I I I I I I I I I ! I I I I I I I I I I I I I I I I 1 I I I 
g t t c a t a e a a t a a t c t t a t g t a t g t a a a a c c c t g t t a c g a t g t c g g c g a c g g g g c c c a t c 60 
Hoxc-9 a g t a a c t a t t a c g t g g a c t c g c t c a t c t c t c a c g a c a a t g a a g a c c t c c t a g c g t c c a g g 429 
I I I I I I I I I I I I I I I I I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I M I I I I 
IMAGE a g t a a c t a t t a c g t g g a c t c g c t c a t c t c t c a c g a c a a t g a a g a c c t c c t a g c g t c c a g g 120 
Hoxc-9 t t t c c g g c c a c c g g g g c t c a c c c t g c c g c c g c c a g a c c c a g c g g c t t g g t g c c g g a c t g t 4 89 
I I I M I I I M I I I I M I I I I I I I I I I I M I I I I I I M I I I I I I I I I I I I I I M I I I I I I I 
IMAGE t t t c c g g c c a c c g g g g c t c a c c c t g c c g c c g c c a g a c c c a g c g g c t t g g t g c c g g a c t g t 180 
Hoxc-9 a g c g a t t t t c c g t c c t g t a g c t t c g c g c c c a a g c c g g c t g t a t t c a g t a c g t c g t g g g c g 54 9 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I 
IMAGE a g c g a t t t t c c g t c c t g t a g c t t c g c g c c c a a g c c g g c t g t a t t c a g t a c g t c g t g g g c g 240 
Hoxc-9 c c g g t g c c c t c g c a g t c g t c t g t g g t c t a t c a c c c t t a c g g c c c c c a g c c c c a c c t c g g c 609 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE c c g g t g c c c t c g c a g t c g t c t g t g g t c t a t c a c c c t t a c g g c c c c c a g c c c c a c c t c g g c 300 
Hoxc-9 g c c g a c a c g c g c t a c a t g c g g a c t t g g c t c g a g c c g c t g t c c g g c g c c g t c t c c t t c c c c 669 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE g c c g a c a c g c g c t a c a t g c g g a c t t g g c t c g a g c c g c t g t c c g g c g c c g t c t c c t t c c c c 360 
Hoxc-9 a g c t t c c c g g c c g g g g g c c g t c a c t a c g c c c t c a a g c c c g a c g c c t a c c c g g g g c g c c g c 729 
I I I I I I I I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE a g c t t c c c g g c c g g g g g c c g t c a c t a c g c c c t c a a g c c c g a c g c c t a c c c g g g g c g c c g c 4 20 
Hoxc-9 g c c g a c t g c g g c c c g g g c g a c g g c c g c a g c t a c c c g g a c t a c a t g t a c - g g c t c g c c c g g 7 88 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I M I M I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE g c c g a c t g c g g c c c g g g c g a c g g n c g c a g c t a c c c g g a c t a c a t g t a c n g g c t c g - c c g g 47 9 
Hoxc-9 g g a a c t g c g c g a c c g c g c c c c g c a g a c g c t g c c c t c g c c c g a g g c g g a c g c g c t g g c c g g 848 
I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I I I I M I 
IMAGE gg g a c t g c g c g a c c g c g - c c c g c a g a c g c t g c c c t c g c c c g a g g c g g a c g c g c t g g c c g g 538 
Hoxc-9 cagcaagcacaaagaggagaaggccgacctggaccctagcaaccccgtggccaactggat 908 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE cagcaagcacaaagaggagaaggccgacctggaccctagcaaccccgtggccaactggat 598 
Hoxc-9 c c a c g c c c g t t c c a c a a g g a a g a a g c g c t g c c c c t a c a c c a a g t a c c a g a c g c t g g a a c t 968 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE c c a c g c n c g t t n c a c a a g g a a g a a g c g c t g c c c c t a c a c c a a g t a c c a g a c g c t g g a a c t 658 
Hoxc-9 g g a g a a g g a g t t t c t c t t c a a t a t g t a t t t a a c c a g g g a c c g t c g g t a c g a g g t g g c c c g 1028 
I I I I I I I I I I I I M I I I I I I I I I I I I I I I I I II I I I I I I I I I M I I I I I I I I I I 
IMAGE g g a g a a g g a g t t t c t c t t t c a t a t g t a t t t a a c c a g g g a c c c g t c g t a c g a g g t g g c c c g 718 
Hoxc-9 t g t t c t c a a t c t c a c t g a g c g g c a g g t c a a a a t c t g g t t t c a g a a c c g g a g g a t g a a g a t 1088 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
IMAGE t t g t c t c a a t c t c a c t g a g c g g c a g g t c a a a a t c t g g g t t c a g a c c c g a g g g a t g - a g a t 77 7 
B.7 Mus musculus mRNA for Hoxa-9 - gi: 3080547 
IMAGE cDNA clone similar to Hoxc-9 - gi: 4059801 
IMAGE 588 g c c a a c t g g a t c c a c g c n c g t t n c a c a a g g a a g a a g c g c t g c c c c t a c a c c a a g t a c c a g 647 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Hoxa-9 1855 g c c a a c t g g c t a c a t g c t c g c t c c a c t c g g a a g a a g c g a t g c c c t t a c a c a a a a c a c c a g 1914 
IMAGE 648 a c g c t g g a a c t g g a g a a g g a g t t t c t c t t t c a t a t g t a t t t a a c c a g g g a c c c g t c g t a c 707 
I I I I I I I I I I I I I I I I I I I I I I ! I I I I I I I I I I I I I I I I I I I I I I I I I 
Hoxa-9 1915 a c g c t g g a a c t g g a g a a g g a g t t t c t g t t t a a c a t g t a c c t c a c a c g g g a c c g c a g g t a c 1974 
IMAGE 708 g a g g t g g c c c g t t g t c t c a a t c t c a c t g a g c g g c a g g t c a a a a t c t g g g t t c a g a c c c g a 767 
I I I I I I I I I I I I I I I I I I I I I I I M I N I M I I I I I I I I I I I I I I I 
Hoxa-9 1975 g a g g t g g c c c g g c t g c t c a a c c t c a c c g a a a g g c a g g t c a a g a t c t g g t t c c a g a a c c g c 2034 
IMAGE 768 gggatga 774 
I I I I I I 
Hoxa-9 2035 aggatga 2041 
